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ABSTRACT 
Whole body and skeletal muscle mass is regulated by counterbalanced fluctuations between 
protein synthesis and breakdown rates. Protein ingestion has been shown to stimulate protein 
synthesis rates and thus is an important variable within the net protein balance equation dictating 
a positive balance. However, postprandial protein metabolism has been almost exclusively 
characterized on the ingestion of isolated protein fractions (e.g., dairy-based whey and casein and 
plant-based soy) in liquid beverages, while the majority of protein in the diet is obtained from 
whole food sources with other macronutrients available. The purpose of this dissertation was to 
improve the understanding of postprandial protein metabolism after the ingestion of protein-dense 
whole foods during resting and post-exercise recovery conditions in both healthy and diseased 
individuals. Previous work suggested a short lived stimulation of postprandial muscle protein 
synthesis rates after protein ingestion. However, these findings were made after ingestion of fast-
digested whey. In study 1, we showed that ingestion of a natural matrix of milk protein (20 % 
whey/80 % casein), resulted in a sustained release of dietary amino acids in circulation that 
coincided with prolonged postprandial elevations in intramuscular anabolic signaling and rates of 
muscle protein synthesis. In study 2, we demonstrated that production of labeled food proteins can 
be done in a cost-effective manner by supplementing the feed of laying hens with an amino acid 
tracer. The labeled eggs were used as a research tool in studies 3 and 4 to assess protein digestion 
and absorption kinetics after nutritional stimuli in health and disease. In study 3, we found that the 
ingestion of egg whites resulted in more rapid appearance of dietary amino acids in circulation 
when compared to isonitrogenous whole egg ingestion, with no differences in total dietary amino 
acid availability in circulation between the egg conditions. However, we did observe that whole 
egg ingestion resulted in a more potent postprandial muscle protein synthetic response when 
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compared with egg white ingestion. In study 4, we assessed the postprandial protein metabolic 
responses to mixed meal ingestion in maintenance hemodialysis (MHD) patients. We observed 
that basal rates of muscle protein synthesis were ~ 2.5 fold elevated in MHD patients when 
compared to controls; suggesting prolonged post-dialysis hypercatabolism. Furthermore, protein-
dense mixed meal ingestion failed to stimulate postprandial rates of muscle protein synthesis in 
MHD patients. This observation may be attributed to reduced dietary amino acid availability after 
eating a meal. Overall, the studies performed as part this dissertation show that protein dense food 
ingestion is effective to stimulate the postprandial muscle protein synthetic response in healthy 
individuals. Moreover, it seems that clinical strategies to improve skeletal muscle health should 
involve a combination of increased physical activity and protein-dense whole food ingestion to 
maximize the muscle anabolic response with health and disease. 
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CHAPTER 1: INTRODUCTION 
1.1 Introduction to protein turnover 
The turnover over of proteins is an essential biological process to all living organisms, including 
bacteria (78), plants (143), and animals/humans (222). Their turnover is necessary as proteins 
become dysfunctional/damaged over time and need to be replaced with new functional proteins. 
This cycle ultimately allows for a healthy functioning organism and its tissue. The first study to 
assess protein turnover directly in humans was conducted by Sprinson and Rittenberger in 1949 
(193). The authors provided a single dose of the isotopically-labeled amino acid 15N-glycine and 
measured the excretion of labeled nitrogen in urine for up to 72 h. The continued urinary excretion 
of labeled nitrogen indicated that 1) the body protein pools undergo constant turnover and that 2) 
any nitrogen (amino acid) losses need to be replaced by consuming protein in the diet (193). The 
first indication that rates of protein turnover may be altered across the lifespan was made nearly a 
decade later by Sharp et al. (185), who revealed that whole-body protein turnover was reduced in 
the elderly when compared to younger individuals. In the years following, numerous studies have 
demonstrated that whole-body protein turnover is (negatively) altered under a variety of clinical 
states such malnutrition (70, 190, 191), physical trauma (16), cancer (98), diabetes (140), obesity 
(140), chronic gastrointestinal disorders (138, 162) and diseases of the liver (136, 146), kidneys 
(12), and cardiovascular system (12). 
Over the last four decades, the focus of protein metabolic research has largely turned towards 
the skeletal muscle as this tissue represents the largest depot of amino acids in the body.  The first 
work to measure skeletal muscle protein synthesis was published in 1975 by Halliday and 
McKeran (79). Biopsies were obtained from the vastus lateralis between 14h and 30h of an 
unprimed continuous infusion of 15N-lysine and a rate of muscle protein synthesis was calculated 
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between the sampling points. The authors were the first to show that rates of muscle protein 
synthesis contributed to about half of total rates of whole-body protein synthesis (79), thereby 
demonstrating the important role of skeletal muscle tissue in whole-body protein turnover. A few 
years later, Rennie et al. (178) suggested that skeletal muscle protein synthesis is particularly 
sensitive to protein ingestion, and concluded that the increase in whole-body protein synthesis 
rates after mixed meal ingestion largely reflects changes of protein synthesis rates at the level of 
the muscle, which may double after feeding. Marking the advancement in stable isotope research 
methodology, the work by Rennie et al. (178) published in 1982 set the stage for many research 
groups to examine skeletal muscle protein turnover in a variety of clinical states (55, 149, 177) as 
well as after physical activity and/or nutritional manipulations (6, 133, 160, 204) using metabolic 
tracers.  
It is now well established that skeletal muscle tissue is characterized by a high degree of 
plasticity and can be altered drastically with advancing age (56), disease/physical trauma (87) ( 
including chronic kidney disease (4, 166)) and various lifestyle factors such as diet (in particular 
protein intake) (233) and physical activity (86, 198). These alterations in skeletal muscle can have 
positive and/or negative metabolic consequences that can lead to improvements or decrements in 
health (231). For these reasons the study of protein turnover, with special reference to skeletal 
muscle, continues to be of great interest to researchers. This thesis will focus on the effects of diet 
and/or acute performance of physical activity to improve whole body and muscle protein turnover 
rates in health and diseased populations. In particular, special emphasis is placed on postprandial 
protein metabolism after whole food ingestion in a wide variety of adult participants, including 
both healthy and maintenance hemodialysis patients. 
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1.2 Methods to assess protein turnover in humans 
The in vivo assessment of the whole-body or muscle protein metabolic response to divergent 
acute nutritional and/or exercise stimuli is commonly studied with isotopically-labeled amino acid 
tracers. An example of a commonly used stable isotope tracer to assess protein metabolism is 13C-
leucine (215). The additional neutron(s) of 13C-leucine makes it ‘heavier’ than the most abundant 
form of the amino acid (i.e. the tracee), which is 12C-leucine (often simply referred to as leucine). 
The tracer (e.g 13C) is chemically and functionally identical to the tracee (e.g. 12C) amino acid, but 
its additional mass enables precise detection in a biological sample with mass spectrometry. Other 
stable isotope amino acid tracers include 2H, 15N, and 18O, however labeled carbon (e.g. 13C) and/or 
hydrogen (e.g. 2H) are most commonly used for to assess  human protein metabolism due to greater 
predictability of in vivo metabolic flux when compared to nitrogen (15N) and oxygen (18O) (229).  
A widely employed protocol to assess in vivo human protein metabolism acutely involves the 
primed-continuous intravenous (IV) infusion of one or more labeled amino acid(s) (232). Protein 
metabolism is often studied during a post absorptive period (first 3 h) to provide a control 
measurement and subsequently followed by measurements during a postprandial and/or post-
exercise period (subsequent 5-7 h) (Figure 1.1).  
The information gained from these acute studies (29, 46, 90, 179, 224, 227) provides insight 
into whole body and muscle protein remodeling. The findings from these acute studies can 
subsequently be used to reasonably ‘predict’ the long-term phenotypic outcome to chronic 
exposure of the respective nutritional and/or physical activity stimuli in healthy and diseased 
populations (59, 81, 89, 131, 189, 223).  The sections below will describe the measurements of 
whole-body and muscle protein turnover in detail and highlights the important information gained 
from human metabolic studies pertinent to this thesis.  
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1.3 Whole body protein turnover in healthy individuals 
Measurements of whole-body protein turnover are made by frequent sampling of plasma 
and/or breath (221). The classic model of studying whole-body protein turnover involves the use 
of 13C-leucine (215) as the IV infused tracer, although other amino acid tracers have certainly been 
used to assess whole body protein turnover (71, 72, 91, 102, 103, 153, 205, 216). The measurement 
of protein turnover in stable isotope studies generally assumes a simplified two-pool model 
(Figure 1.2), although models with three or more pools have been used and described (14, 71, 
213). 
The two-pool model consists of an amino acid pool (e.g. the plasma or intracellular free) and 
a protein pool. The amino acids in the plasma or intracellular free pool are from protein breakdown 
and/or the ingestion of dietary protein plus intravenous tracer infusion and serve as the ‘precursors’ 
for synthesis of body protein or are irreversible lost from the free amino acid pool through 
oxidation. The determination of sample isotopic enrichment (in plasma and exhaled CO2), in 
addition to measures of plasma amino acid concentrations and total CO2 production, allows for the 
modeling of whole-body protein synthesis, breakdown, and amino acid oxidation rates (232).  
Measuring whole-body protein turnover is relatively non-invasive and provides the researcher 
with important information on the in vivo turnover of body proteins that collectively maintain 
proper function, structure and regulation of the whole body. Perhaps less appreciated in recent 
times, measures of whole-body protein turnover have provided most of our initial understanding 
on the regulation of protein turnover in response to nutritional and/or physical activity 
manipulations in vivo in humans.  
For example, the 24 h infusions in the 1980s by Clugston and Garlick (38) were amongst the 
first to reveal that fasted losses are off-set by fed gains so that overall body protein mass essentially 
 
5 
 
remains in balance over the course of a day. This observation was subsequently termed diurnal 
cycling of protein (38). Several experiments performed by the Millward group revealed that the 
magnitude of diurnal protein cycling is remarkably labile and is modulated by habitual dietary 
protein intake and physical activity levels (128, 130). These findings led to the development of a 
metabolic demand model suggesting that there is 1) an obligatory need for nitrogen and amino 
acids, which remains more or less constant irrespective of habitual dietary protein intake and 
physical activity level, and 2) an adaptive need for nitrogen and amino acids, which varies 
depending on habitual protein intake and physical activity level of the individual (128).  
These early studies provided the evidence that changes in protein balance are regulated by 
changes in protein synthesis and breakdown rates in the response to the fasting-feeding cycle. In 
particular, protein feeding results in an increase in whole-body protein synthesis and/or a decrease 
in breakdown while the postabsorptive state is marked by an increase in breakdown and/or 
decrease in synthesis (38, 84, 123, 144). There appears to be discrepancy on the relative 
contributions of protein synthesis and breakdown to the net protein balance, in particular as it 
relates to the fed-state. The early work performed by Clugston and Garlick (38) concluded that 
improvements in postprandial net protein balance mainly resulted from an increase in synthesis 
rather than suppression of breakdown. However, later work by the same group suggested that 
recycling of the tracer during the 24h infusion period likely confounded these findings and resulted 
in an overestimation of postprandial whole-body protein synthesis (123). Indeed, shorter infusions 
lasting 8-10 h (where tracer recycling is not of great concern) show that improvements in whole-
body protein balance after feeding are generally the result of decreases in breakdown alone (10, 
19, 84, 123, 137, 144), a combination of both (37, 68, 77, 103, 152, 153), or in some instances 
synthesis alone (32, 100). The apparent discrepancies may relate to the source of protein/amino 
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acids that are ingested and/or methodological differences in determining whole-body protein 
turnover between laboratories. 
The ingestion of isolated protein sources, in particular isolated dairy proteins and free amino 
acids, appear to improve net balance through changes in whole-body protein synthesis (32, 100) 
and/or through equal contribution of breakdown and synthesis (37, 68, 77, 103, 152, 153). In the 
context of whole food ingestion, net protein balance appears to be modulated mainly by changes 
in breakdown rather than synthesis rates (26, 68, 103).  
A possible explanation for the higher rates of whole-body protein synthesis with ‘fast’ digested 
isolated proteins and free amino acids maybe attributed to the increased stimulation of protein 
synthesis in the splanchnic bed; an observation likely explained by the role of the liver in 
preventing an excessive influx of amino acids in the plasma (109, 145). A further explanation may 
relate to the insulinotropic properties of isolated food sources, in particular dairy proteins (26), and 
free amino acids (208) as the rapid rise in insulinemina coupled with a postprandial rise in plasma 
amino acids is shown to result in increased gut tissue protein synthesis (45), and thus a large rise 
in whole body protein synthesis (32). Whole foods on the other hand are more slowly digested 
leading to a more gradual release of dietary amino acids into circulation (26, 209). The slower 
splanchnic release rates of dietary amino acids appear to improve net protein balance mainly by 
inhibition of breakdown as opposed to stimulation of synthesis (17, 42).  
Some evidence suggests a dose-dependent relationship between dietary protein intake and 
protein breakdown. Early work by the Millward group showed that increases in protein intake were 
inversely associated with suppression of protein breakdown in healthy adults (68, 148). Recent 
work by Kim et al. (103) confirmed these findings and showed that whole food ingestion in the 
form of beef patty containing 70 g of protein resulted in greater suppression of whole-body protein 
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breakdown when compared to a patty containing 40 g of protein. Moreover, the ingestion of this 
whole food source (e.g. beef) modulated net protein balance mainly by changes in protein 
breakdown rather than synthesis (103, 153). Similar findings (68, 93, 148, 153) have led Wolfe 
and Deutz (47) to suggest that, while synthesis may become saturated as such high intakes of 
protein, there is no theoretical upper limit to the suppression of protein breakdown with increasing 
amounts of dietary protein. While there may be an inverse relationship between protein ingestion 
and suppression of breakdown in the fed state (68, 93, 103, 148, 153), such high intakes of dietary 
protein per meal may not per se translate into a greater daily net protein balance. In particular, 
several studies indicate that such high intakes of protein are simply matched by greater protein 
losses in the fasted state, as evidenced by greater postabsortive use of amino acids as a fuel (148, 
165, 217). In addition, such high intakes of protein are unrealistic for the majority of the 
population, which generally consume 15-30 g of protein per meal (2). Therefore, strategies that 
involve the improvement of the anabolic response to more realistic feeding paradigms should be 
developed. Of particular interest are strategies that involve whole food ingestion as this is the 
manner in which protein is ingested within a normal dietary pattern. Accordingly, a major 
component of this thesis research was to improve our understanding of whole-body protein 
turnover after whole food ingestion. 
 
1.4 Whole body protein turnover in dialysis patients 
A further focus of this thesis was to study whole body protein turnover in MHD patients, and 
compare these outcomes to healthy controls. It is well-established that clinical states are 
characterized by a high degree of protein breakdown that is not compensated for with synthesis 
(176). In particular, clinical states such as malnutrition (70, 190, 191), physical trauma (16), cancer 
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(98), chronic gastrointestinal disorders (138, 162) and diseases of the liver (136, 146), kidneys 
(12), and cardiovascular system (12) have all been demonstrated to reduce net protein balance, 
either through insufficient rates of protein synthesis and/or exceedingly high rates of protein 
breakdown.  
Body protein wasting is especially prevalent in MHD patients, with annual losses of lean mass 
as high as 1-3 kg (164). Moreover, the loss in lean mass is one of the strongest predictors of 
mortality in this patient population (31, 96). The potential underlying causes for rapid protein loss 
in MHD patients is likely multifaceted and includes contributing factors such as: inflammation, 
insulin resistance, decreased nutrient intake, metabolic acidosis, hormonal imbalances, increased 
amino acid oxidation, and loss of amino acids into the dialysate (219). These factors have all been 
independently shown to reduce body protein mass (21, 35, 95, 167, 170, 188, 237), which 
illustrates the challenges to improving defects in protein turnover to support muscle mass 
maintenance in MHD patients.  
In particular, measurement of whole body protein turnover in the fasted state prior to dialysis 
revealed that whole body protein breakdown is increased when compared to healthy controls with 
no differences in protein synthesis (166). During dialysis, protein breakdown further increased, 
resulting in doubling of whole body net protein losses during dialysis when compared to pre-
dialysis (95). In the same work, Ikizler et al. (95) demonstrated that this increase in whole body 
protein breakdown persisted for at least 2 h after the dialysis period, suggesting that the deleterious 
effects of dialysis are maintained beyond the dialysis period. Moreover, it was suggested that the 
losses in whole body net protein are mainly the results of losses on the level of the muscle (95). 
Given that MHD patients dialyze almost every other day for a total of 4-6 h/day, it is important to 
develop strategies that can mitigate some of the losses in whole body- and skeletal muscle protein. 
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Work by Veeneman et al. (211) provides insight in the time-course of the increased negative 
net protein balance after dialysis. In particular, the workers compared to fasted whole body 
turnover on dialysis and non-dialysis days and showed that whole body net balance is more 
negative during dialysis then when measured the next morning after afternoon dialysis (211). A 
further finding of interest made by the workers is that protein feeding increased whole body net 
protein balance during dialysis and non-dialysis days (211) through stimulation of protein 
synthesis and reduction in breakdown.  
However, a limitation of this study is that protein was provided as small repeated meals and 
that whole body modeling was done under the assumption that first-pass absorption of dietary 
amino acids was only 20% (211). This practice of ingesting of small repeated meals was done for 
methodological purposes and is not representative of normal eating behavior (2). In addition, the 
value of first-pass extraction is likely an underestimate for MHD patients (7). As such the effect 
of meal consumption as a strategy to improve protein turnover remains to be firmly established in 
MHD patients. To properly model whole body kinetics, a novel and innovate research tool in the 
form of intrinsically-labeled food proteins allows the researcher to properly model whole body 
protein turnover with bolus feeding in a variety of populations. One of the goals of this thesis was 
to use this research tool to better understand postprandial protein metabolism in MHD patients and 
ultimately provide clinicians and dieticians with essential information on how to improve standard 
care for this population  
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1.5 Intrinsically labeled foods to improve the measurement of whole body protein turnover 
When exogenous amino acids appear in the plasma pool after food intake, the measurement of 
whole body protein turnover becomes more challenging. In the fasted state, the only amino acids 
appearing in the plasma pool, other than the IV infused amino acid tracer, are endogenous. 
Therefore, any disturbance of IV infused tracer enrichment in the plasma pool is the result of 
protein breakdown. However, in the fed state tracer ‘dilution’ from appearance of unlabeled amino 
acids are the result of both endogenous protein breakdown and exogenous dietary protein-derived 
amino acids. Many researchers ‘correct’ the measurement of whole body protein breakdown by 
simply estimating the amount of amino acids appearing in the circulation as a result of the dietary 
protein ingestion (102, 103, 211) or by feeding protein as small repeated boluses to minimize tracer 
disturbances (38, 68, 148, 215). While the former incorrectly assumes uniformity between protein 
sources and populations in term of protein digestion and absorption kinetics (17, 19, 74), the latter 
is not representative of normal eating behavior (2). As such, workers in the field have developed 
an innovative research tool in the form of intrinsically-labeled dietary proteins to reliably model 
the exogenous appearance of dietary-derived amino acids and whole body protein kinetics in 
response to food ingestion (18, 207, 209). 
Intrinsically-labeled dietary proteins have the amino acid tracer incorporated into their natural 
protein matrix. This allows the tracer to share the same metabolic fate as the representative 
unlabeled amino acid (i.e. the tracee) present in the food (20). The ingestion of intrinsically-labeled 
(e.g. 2H leucine) dietary protein during primed-continuous IV infusion with a different tracer of 
same amino acid (e.g. 13C leucine) allows the researcher to determine total leucine rates of 
appearance and subsequently model protein digestion and amino acid absorption rates and total 
plasma dietary-derived availability in circulation after the ingestion of a protein source. In other 
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words, measurement of plasma isotopic enrichment of the dietary-protein derived tracer allows for 
the reliable measurement of the exogenous ‘share’ (Exo Ra) of total amino acid flux (Total Ra). 
The use of labeled food proteins in primed-continuous IV infusion protocols have offered an 
important advantage over the classic study of whole-body protein turnover with unlabeled 
foods/amino acids, as the exogenous influx of amino acids (Exo Ra) with ingestion is reliably 
determined rather than estimated (18). As a result, the overall model of whole body protein 
turnover is improved as measures of protein breakdown can also be made more reliable (18). As 
the only routes of amino acid entry in the plasma pool are from dietary protein ingestion, IV 
infusion, and breakdown of intact proteins; the portion of total amino acid flux that remains after 
subtracting the Exo Ra (as determined with the labeled food source) plus infused tracer (Fiv) is 
endogenous (Endo Ra) thus coming from the release of amino acids from protein breakdown. 
Modified Steele equations (20, 42) were developed for the calculation of turnover under non-
steady state kinetics (i.e. after feeding), which are described in detail in the supplemental methods 
of Chapter 4.  
Using intrinsically labeled proteins it has been demonstrated that the rate of protein digestion 
and the pattern of postprandial dietary-derived amino acid availability is affected by several factors 
including protein source (17, 42, 104, 152, 209), texture (154), and macronutrient co-ingestion 
(37, 71, 72), in addition to consumer characteristics such as the habitual dietary protein intake (74) 
and age (19). Taken together, these data suggest that the measurement rather than estimation of 
exogenous influx of dietary-derived amino acids is preferred when modeling whole-body protein 
turnover. 
Credited with the development of intrinsically labeled food proteins is the group of Yves Boirie 
in France. Through their endeavors of infusing large amounts (80-90g) of stable isotope amino 
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acid tracer into two lactating dairy cows, this group successfully produced intrinsically labeled 1-
[13C]leucine labeled milk (18). Over a decade later, Luc van Loon’s research unit at Maastricht 
University in the Netherlands successfully produced intrinsically labeled 1-[13C]phenylalanine 
labeled milk by infusing two lactating dairy cows for 48 h (207). 24h after cessation of the tracer 
infusion, this group also butchered and harvested the meat of the cows, consequently providing 
them with the opportunity to also use the meat to study protein digestion and absorption kinetics 
in humans (157). Using these labeled milk and meat proteins, it is now well established that the 
rate of protein digestion and amino acid absorption is an independent and important factor that 
controls whole-body and muscle protein metabolism after the ingestion of a protein containing 
meal (42, 104). While the examples above highlight the success of producing intrinsically labeled 
proteins by IV infusion of tracer to lactating dairy cows, large amounts of people-power and 
financial resources are required for the production of labeled food protein in this fashion. 
Previously, Evenepoel et al. (57) suggested a simple, non-invasive method of producing 
intrinsically labeled protein foods by supplementing the feed of laying hens with an amino acid 
tracer. However, the potential of using labeled eggs to study model to study protein digestion and 
absorption kinetics remained to be fully established. Therefore a major focus of this thesis was to 
produce labeled eggs and employ this innovative research tool in subsequent work assessing 
postprandial protein metabolism in healthy individuals and MHD patients. 
  
Assumptions of the model of measuring whole-body protein turnover with intrinsically-
labeled food proteins 
While the use of labeled food proteins during IV tracer infusions allows for more accurate 
depiction of whole-body protein metabolism under non-steady kinetics (i.e. with protein feeding) 
there are several assumptions/limitations of the model that warrant discussion.  
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An important assumption is that the in vivo metabolic fate of the two different labels (e.g. 13C 
and 2H) used to trace the same amino acid (e.g. leucine) is similar. While this assumption has not 
been tested using intrinsically labeled proteins, a series of clever experiments by performed by 
Matthews et al. (121) may indicate that these two tracers generally provide similar flux values. In 
this work, subjects received simultaneous infusions of 13C- and 2H-leucine; one administrated 
intravenously (IV) and one intragastrically (IG). Halfway through the 7h protocol the IV infusion 
was switched to IG infusion and vice versa. Therefore, subjects received both IV and IG infusion 
of the same tracer on the same day. Comparison of fluxes with plasma 13C- and 2H-leucine 
enrichments as precursors did not reveal any differences between the two IV infused tracers. 
Splanchnic extraction, as determined by the IG route, was shown not be different between tracers 
either (121).  
A further assumption of intrinsically-labeled proteins is that a single amino acid tracer (e.g. 
leucine or phenylalanine) represents postprandial dietary-derived availability of all amino acids. 
Data by Matthews et al. (121) published nearly 35 years ago had already revealed that splanchnic 
extraction of  2H-phenylalanine is higher when compared to 13C- and 2H-leucine. Indeed, we (209) 
and others (42, 43) have used leucine-labeled food proteins and report ~ 10-20 % higher 5-6h 
postprandial dietary-derived amino acid availability than comparable data using phenylalanine-
labeled foods ((26, 71, 72, 91, 104-106, 152-155, 157, 205, 207, 223). Thus some caution is 
necessary when comparing data on dietary-derived amino acid availability from different studies 
that have used different tracers to intrinsically label the food. 
A further assumption pertinent to both labeled food proteins and IV tracer infusions is that 
tracer recycling does not occur during the measurement period. Tracer recycling occurs if the 
labeled isotope disappears in tissue or cells and then reappears in the measured protein pool (123, 
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183). Recycling of the label would results in an underestimation in total Ra as measured with IV 
infusion or an overestimation of Exo Ra as measured with labeled food proteins. Proteins that 
rapidly turnover become highly labeled during an infusion protocol and consequently provide the 
greatest potential source for isotopic re-entry during the infusion period. As mentioned, splanchnic 
and renal tissue turnover at rapid rates and the half-life of many gut-, kidney- and liver- proteins 
range from a few h to multiple days (22, 142, 199, 215). Moreover, the turnover of these proteins 
are highly responsive to the fasting-feeding cycle (22, 101). Splanchnic protein breakdown, for 
instance, is greatly suppressed with feeding and rapidly rises at the onset of fasting (22, 101). Thus 
with prolonged infusions, involving one or more fasting-feeding cycles, there is potential of re-
appearance of isotopic tracer from breakdown of highly labeled tissue proteins.  
Surprisingly little work has been performed investigating the occurrence of tracer recycling 
during these types of studies and its potential for incorrect measures of protein turnover remains 
relatively unknown. The work by Schwenk et al. (183) in 1985 was one of the first to address the 
concern of tracer recycling as they suspected label re-entry had confounded findings of one of their 
previous papers (82). Subsequently, the authors observed tracer decay to be much slower in a 
group of subjects infused for 24h compared to a group infused for 4h, suggesting re-entry of the 
label from protein breakdown with prolonged infusion periods (183). Estimates from the literature 
indicate that tracer recycling occurs ~ 1-1.5 %/h-1 (220), a value that may be higher or lower 
depending on the amino acid tracer and/or the length on infusion (3, 30, 123, 151, 172, 183, 200). 
It can be concluded from these studies that measures of whole-body protein turnover become 
unreliable after > 10-12 h of isotope infusion (3, 30, 123, 151, 172, 183, 200). While such long 
infusions were common practice in the 1980s and 1990s, nowadays protein turnover is generally 
studied during shorter infusion protocols (lasting 8-10h) involving a single fasting-feeding cycle.  
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The steady decay of dietary-derived isotope after labeled food ingestion provides further 
evidence that tracer re-entry is not occurring to any great extent with shorter protocols. Results 
from our lab (209) (Figure 3) and others (18, 42, 43, 71, 72, 77, 104, 106, 152-154, 157, 205, 207) 
indicate that once dietary-derived isotopic enrichment has peaked there is a steady isotopic decay 
in the plasma. However, critics can argue a slight plateau in dietary-derived tracer enrichment 
observed in the late postprandial phase in our work (209) and that of others (18, 42, 43, 71, 72, 77, 
104, 106, 152-154, 157, 205, 207). Even if this observation was due to label re-entry rather than 
continued release of dietary-derived label from the gut, any minor recycling occurring will have a 
negligible influence on the overall postprandial measurement of whole body protein turnover. A 
clear indication of label re-entry would be a rise in dietary-derived label enrichment in the late 
postprandial phase, however this has never been observed (18, 42, 43, 71, 72, 77, 104, 106, 152-
154, 157, 205, 207, 209). Taken together these data can be taken as a suggestion that little to no 
tracer recycling occurs during a 5h measurement period. 
A further point relates to the terminology used to describe the outcomes obtained from labeled 
food protein ingestion, namely protein digestion and absorption kinetics (18, 42, 43, 157, 207). As 
the modeling of protein digestion and absorption is based of isotopic enrichments in the plasma, 
the use of labeled food proteins does not provide a true measurement of ileal protein digestibility 
(58). Instead it provides quantitative insight in the amount of dietary-derived amino acids that 
become effectively digested and make it past first-pass splanchnic uptake. It could be argued that 
dietary-protein derived amino acid availability in circulation would be a more accurate description 
of the outcomes gained with labeled protein ingestion. 
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1.6 Measurement of muscle protein synthesis  
While it is clear that that whole-body measures provide important information on the collective 
in vivo turnover of body proteins, such measures do not allow for insight in tissue specific turnover 
(88). Individual tissues and organs turnover at different rates depending on their role and function 
and differently contribute to whole-body protein turnover (67, 199). Knowledge of their turnover 
rates requires sampling of the tissue site during the stable isotope infusion protocols. These types 
of studies have revealed that intestinal- (~ 50 %/d-1) (22, 142), renal- (~ 42 %/d-1) (199), and 
hepatic tissue protein turnover (~ 12%/d-1) (215) occurs more rapidly than skeletal muscle tissue 
(~ 1.5 %/d-1) (199). Nonetheless, the relative tissue contribution of skeletal muscle to whole-body 
protein turnover is highest of these tissues as it contributes to roughly half of total rates of whole-
body protein synthesis (199), which is explained by the high contribution of skeletal muscle to 
total body protein mass.  
Furthermore it is well established that skeletal muscle is 1) the primary organ system for 
locomotion and physical function (24) 2) plays a central role in long-term metabolic health  (231) 
through the regulation of glycemia (85), lipidemia (113) and its substantial contribution to the 
basal metabolic rate (BMR) (99) 3) its metabolic derangements to exercise/food stimuli are 
amongst the earliest of defects observed in various disease states including chronic kidney disease 
(9, 119, 139) and 4) is highly regulated by dietary- (14, 178, 196, 201, 213, 214) and/or exercise 
stimuli (14, 159, 186) and thus highly modifiable by lifestyle interventions (81, 125, 189).  For 
these reasons, measurements of muscle protein turnover are generally made during stable isotope 
studies. 
It is common that only measures of muscle protein synthesis (and not breakdown) are made in 
these types of studies. The reasons for this are two-fold; 1) alterations in synthesis rather than 
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breakdown generally serve as the primary variable dictating the change in postprandial muscle net 
protein balance (13, 159, 213, 214, 230) and 2) the measurement of muscle protein breakdown is 
methodologically challenging (238, 239). While it is a clear shortcoming that muscle protein 
breakdown is not measured in the studies related to this thesis, and the field in general, 
measurement of one equation of the net balance (e.g. protein synthesis) is generally accurate in 
predicting the long-term phenotypic outcome; at least in healthy individuals (59, 81, 89, 131, 189, 
223). The methodology pertinent to measuring muscle protein synthesis will have focus in the next 
sections.   
Approximately 1 h into the primed-continuous infusion protocol (Figure 1), an initial skeletal 
muscle sample (~30-100 mg of tissue) is obtained (11, 50). This initial 1h lead-in is necessary to 
ensure isotopic steady-state is achieved in the free amino acid pool, although some workers have 
omitted the first biopsy and have used a background plasma mixed protein enrichments (i.e. 
albumin) as a proxy for initial muscle protein-bound enrichment (28). Roughly 3 h into the infusion 
protocol the skeletal muscle is sampled again. This time is needed to ensure that enough time has 
passed for reliable determination of changes in muscle protein-bound tracer enrichment between 
the two collected biopsy samples (229). Subsequently, additional biopsy samples are collected 
during a postprandial and/or post-exercise phase to study the influence of an acute nutritional 
and/or exercise manipulations on changes in the stimulation of muscle protein synthesis rates. 
When calculating a rate of muscle protein synthesis, the measured change in protein-bound 
tracer enrichment between two sampling points is normalized to the enrichment of the precursor 
pool (i.e. the plasma free, muscle intracellular free or aminoacyl-tRNA) using the standard 
precursor-product equation (see below). Solving for this equation will provide a fractional 
synthesis rate (FSR) of muscle protein in % per unit of time (e.g. %/h-1): 
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𝐹𝑆𝑅 =
∆𝐸𝑝
𝐸𝑝𝑟𝑒𝑐𝑢𝑟𝑠𝑜𝑟∙𝑡
∙ 100%  
 
where ΔEp is the increment in muscle protein-bound tracer enrichment after an incorporation 
period, Eprecursor is the weighted mean precursor pool tracer enrichment during that incorporation 
period, and t is the incorporation period (h).  
 
1.7 Measurement of muscle anabolic signaling  
On a molecular level, protein synthesis is regulated through coordinated changes in the 
translational machinery (111). This processes of mRNA translation (i.e. protein synthesis) involves 
coordinated changes in the phosphorylated state of eukaryotic initiation, elongation and 
termination factors (i.e. eIFs, eEFs and eRFs). The mechanistic target of rapamycin complex 1 
(mTORC1), an evolutionary conserved serine/threonine protein kinase, plays a central role in the 
phosphorylation of several components of the translational machinery (218). For instance, 
mTORC1 can phosphorylate downstream targets such as p70S6K and eukaryotic translation 
initiation factor 4E-binding protein 1 (4E-BP1) (218). mTOR and is downstream targets P70S6K 
and 4E-BP1 have been shown to be responsive to the stimuli of amino acids (65, 80). In particular, 
dietary protein-derived amino acids form the main precursors for protein synthesis (20, 77) and 
their flux across the sarcolemma is facilitated by amino acid transporters (such as LAT1, SNAT2 
and CD98) resulting in subsequent activation of the mTORC1 pathway (94). Besides its nutrient 
sensitivity,  mTORC1 and targets of P70S6K and 4E-BP1 are also responsive to exercise (52), 
with further potentiation of their phosphorylated-state when the stimuli of nutrients and exercise 
are combined (132). Another pathway by which exercise increases mRNA translation involves 
phosphorylation of proteins within the mitogen-activated protein kinase (MAPK) pathway such as 
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extracellular signal–regulated kinases (ERK) 1/2 and its downstream target of eukaryotic 
translation elongation factor 2 (eEF2) (132), which can be activated independent of mTORC1 (61).  
To understand the molecular mechanism underpinning mRNA translation (i.e. protein 
synthesis) in response to the nutritional and/or exercise stimuli provided within this thesis, we used 
the Western Blotting technique to provide readouts on the phosphorylated state of proteins and 
total protein content of amino acid transporters that are acknowledged to play in important role in 
protein synthesis. Figure 4 highlights the signaling proteins and amino acid transporters studied 
within the mTORC1 and MAPK pathway as part of this thesis.  
The goal of this thesis was to combine the use of labeled food proteins with primed-continuous 
tracer infusions and the Western Blot technique to provide comprehensive insight in potential 
differences in postprandial whole-body and muscle protein metabolism after various nutritional 
and/or physical manipulations in both health and disease. The question that remains is: why go 
through the efforts of studying protein metabolism in particular as it relates to skeletal muscle 
mass?  
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1.8 The importance of skeletal muscle mass 
Historically studied for its contractile abilities, the preservation of skeletal muscle mass across 
the lifespan is important for maintaining physical function (97). Adequate maintenance of muscle 
size and strength with advancing age will allow for active involvement in family-, community-, 
and work life. Perhaps less recognized is the central role of skeletal muscle tissue in whole-body 
metabolism (231). Skeletal muscle plays in important part in the regulation of 24h glycemia, 
lipidemia, and is a major determinate of basal metabolic rate and thus total daily energy 
expenditure (231). Unsurprisingly, the maintenance of skeletal muscle mass with advancing age is 
associated with a lower risk for development of metabolic diseases such as type II diabetes (150), 
obesity (195), and cardiovascular disease (194). A greater amount of skeletal muscle mass is also 
an important predictor of survival rate in various cancers (66, 110, 120, 163, 182) and chronic 
kidney disease (234) and can facilitate healing from physical trauma (44, 161). As skeletal muscle 
is the largest protein reservoir in the body, the breakdown of muscle proteins will be the main 
supply of amino acids to vital organs and tissues to maintain the increased rate of protein turnover 
typical to clinical states (231), including chronic renal failure (166). This loss of muscle proteins 
to supply amino acids to other organs likely underpins the losses of muscle mass that is observed 
in disease states such as chronic renal failure (115). 
On a day-to-day basis, skeletal muscle mass is regulated by coordinated changes in protein 
synthesis and breakdown, which reflect dynamic protein turnover (129). Over a prolonged period 
over time the cyclic nature of turnover results in maintenance (synthesis = breakdown), loss 
(synthesis < breakdown) or gain (synthesis > breakdown) in skeletal muscle mass. For most 
individuals, physical activity and diet (in particular dietary protein) will be the main factors that 
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influence skeletal muscle protein turnover and ultimately determine phenotypic outcome (i.e. 
changes in skeletal muscle mass and function).  
Performing an acute bout of resistance (14, 159) and/or endurance exercise (186)  upregulates 
skeletal muscle protein turnover with muscle protein synthesis being suggested as the major 
variable (as opposed to breakdown) to alter protein turnover (159). The other main anabolic 
stimulus to skeletal muscle is food intake (in particular dietary protein) and much like physical 
activity, alterations in synthesis rather than breakdown is considered to be the major variable to 
improve net protein balance (13, 213, 214, 230). When combined; these two main anabolic stimuli 
act synergistically as the exercise-mediated enhancement of muscle protein synthesis to feeding 
persists for at least 24h after performing an acute bout of exercise (27). Thus the development of 
strategies that involve both physical activity and diet have the greatest potential for maintaining 
skeletal muscle health with advancing age. 
 
1.9 Physical activity  
Skeletal muscle tissue has a tremendous capacity to adapt to physical demands by altering its 
contractile, neuronal and/or metabolic capacity (60). The high degree of malleability of skeletal 
muscle is especially apparent in athletes, where specific training modalities result in very distinct 
phenotypic outcomes (i.e. endurance vs. hypertrophy/strength athletes). However, the clear 
alterations in skeletal muscle size and capacity are not limited to athletic populations as aging, 
inactivity and disease can result in substantial deconditioning of skeletal muscle tissue.  
A reduction in skeletal muscle mass, strength and function are one of the earliest manifestations 
of the aging process and are commonly referred to as sarcopenia (55). The loss of muscle with 
aging becoming apparent during the 4th decade of life with potential losses of 1-2 % per year (92, 
 
22 
 
184). These losses in skeletal muscle mass are troublesome as it results in a greater fall risk, loss 
of independence, and increased risk for the development of chronic diseases (such as obesity, 
diabetes, CVD etc.) (150, 194, 195, 231). Once manifested, recovery from these conditions is 
proven difficult for individuals with low muscle mass. Amongst hospitalized patients, sarcopenia 
is associated with an increased risk of postoperative complications (114, 174, 206), a greater 
chance of readmission (34) and higher rates of mortality (33, 212).  
In 2000, the estimated healthcare cost attributable to sarcopenia alone in the United States was 
already estimated to be $18.5 billion per year and it is likely that this amount has further increased 
in recent years (192). In the future sarcopenia is likely to become an even greater problem to public 
health as the population aged 65 and older is projected to have nearly doubled by the year 2050 
(147). Decreased physical activity levels is one of the most important underlying causes of 
sarcopenia (39). Thus strategies involving physical activity that can prevent (or slow down) the 
age-related loss of muscle mass are likely to become of increasing importance to public health. 
Irrespective of age, a growing number of adults also develop diseases such as type II diabetes 
(1), cardiovascular disease (69), cancer (187) and obesity (8), and chronic kidney disease (83) of 
which its development can be in part attributed to physical inactivity (112). Similar to aging, it 
would appear that negative alterations in skeletal muscle protein metabolism are one of the earliest 
manifestations of obesity (9), heart disease (119), cancer (139) and chronic kidney disease (4).  
Given the strong stimulatory effects of physical activity on skeletal muscle protein metabolism, 
strategies involving regular performance of physical activity hold great promise to prevent or 
improve various disease states. In particular, performing a single bout of resistance and/or 
endurance exercise can substantially upregulate skeletal muscle protein synthesis rates for up to 
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48-72 h (126, 159), thereby stimulating replacement of dysfunctional proteins with newly 
synthesized functional proteins. 
The specific skeletal muscle adaptation that occurs depends on the type of exercise (e.g. 
resistance versus endurance exercise) that is habitually performed (226). The adaptation after 
endurance based activities are generally directed towards an increase in skeletal muscle oxidative 
capacity; (e.g., mitochondrial-related proteins, angiogenic proteins, glucose transporters, etc.) 
(226), while regular performance of resistance exercise will lead to an increase in muscle 
hypertrophy and strength (51, 116). It should be noted, however, that adaptations in skeletal muscle 
are not completely divergent. In untrained adults, high intensity resistance exercise stimulates 
increases in the myofibrillar (contractile) and mitochondrial (energy-producing) sub-fractions in 
skeletal muscle (226). A stimulation of all the major protein sub-fractions in skeletal muscle is 
also observed after an acute bout of endurance exercise (23, 48, 226), especially when the 
performance of endurance exercise involves substantial mechanical loading (i.e. cycling) (48). 
However, with chronic training the acute muscle protein synthetic response (i.e. an increase in 
myofibrillar or mitochondrial) to a bout of physical activity will be more reflective of the 
phenotypic outcome (hypertrophy/strength-based vs. endurance) (226). For one of the studies in 
this thesis, resistance-based exercise was used as a model of physical activity to study the effects 
of divergent whole food manipulations on myofibrillar protein synthesis during post-exercise 
recovery. 
 
  
 
24 
 
1.10 Protein ingestion 
The other main anabolic stimulus to skeletal muscle tissue is food ingestion; particularly 
dietary protein. It has been shown that the amount (135, 153, 180, 228, 235), timing (5, 118), and 
source (animal vs. plant based) (210) of are all factors that can potentially modulate the muscle 
anabolic response after protein feeding.  
It has been suggested that ~20 g of dietary protein per meal will result in an optimal stimulation 
of myofibrillar protein synthesis in healthy young adults both in during post-exercise recovery and 
rested states (134). With aging, however, the muscle can become less sensitive to the anabolic 
properties of protein ingestion and greater intakes of dietary protein appear necessary to maximize 
muscle protein synthesis (134, 153). The reduced anabolic sensitivity to protein feeding, often 
termed ‘anabolic resistance of aging’ (25) may be caused by impairments in protein digestion and 
amino acid absorption (19), amino acid uptake in muscle (49), or a reduced amount or activation 
status of key anabolic signaling proteins (41, 64, 108). However, ingestion of ~ 35-40 g of protein 
per meal in older adults (> 40-50 y) can overcome the ‘anabolic resistance’ of aging and restore 
rates of muscle protein synthesis to a level that is similar to young adults (134). However, the 
consumption of such high amount of protein in a single meal is not realistic for the majority of the 
population, which generally consumed 15-30 g of dietary protein per meal (2). Furthermore, it is 
important to note that most of this work is done after providing protein in isolation, without the 
addition of other macronutrients. A focus of this thesis was to study postprandial muscle protein 
synthesis in aging individuals after mixed meal consumption containing moderate amounts of 
protein (20 g) in the form of a whole food source (Chapter 5). Indeed previous suggestions have 
been made that consumption of a whole food protein source may potentiate the subsequent muscle 
protein synthetic response to moderate protein feeding when compared to more isolated sources 
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of protein (55). This data may suggest that when protein is consumed as part of a whole food 
source, containing multiple macronutrients as part of its natural food matrix, this may improve the 
postprandial muscle anabolic response to moderate protein amounts and as such provides a realistic 
feeding strategy to overcome the ‘anabolic resistance’ to protein feeding in aging individuals. This 
notion was further investigated in Chapter 5 of this thesis. 
Another factor that may influence postprandial muscle protein synthesis is the timing (or 
distribution) of ingestion throughout the day. Specifically, it has been demonstrated that the 
consumption of an optimal dose of 20-35 g of protein every 3-5 h will result in greater stimulation 
of muscle protein synthesis throughout the day when compared to an uneven distribution where 
lower amounts (~10-15 g) are consumed more frequently (e.g. every 1.5h) (5, 118) or higher 
amounts (~ 40-60) are consumed infrequently (every 6-8 h) (118).  
The protein source ingested is another main factor that may influence postprandial protein 
synthesis. In multiple studies, the ingestion of whey has been shown to result in higher rates of 
protein synthesis when compared to the ingestion of isonitrogenous amounts casein (152, 197) and 
the plant-based protein soy (197, 236). This observation is likely explained by the more rapid 
digestibility and absorption of whey and its higher essential amino acid content (152). In general, 
the ingestion of animal-based sources result in greater postprandial stimulation of muscle protein 
synthesis when compared to the ingestion of isonitrogenous amounts of plant proteins (73, 158, 
197, 227, 236). These observations may be explained by the lower digestibility of plant-based 
sources and their relative low abundance in specific essential amino acids (210); a ‘disadvantage’ 
that may be overcome by consuming greater amounts of plant proteins (73) or by consuming a 
variety of sources to make for a complete amino acid profile (210).  
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Interestingly enough, most of our knowledge on postprandial protein metabolism comes from 
work studying the ingestion of isolated protein fractions (e.g., dairy-based whey and casein and 
plant-based soy) in liquid beverages (17, 26, 27, 36, 37, 42, 43, 71, 72, 91, 104, 106, 107, 152, 
155, 173, 178, 197, 201, 216, 235, 236) or ingestion of free form, crystalline amino acids (15, 40, 
127, 141, 168, 169, 202, 203, 213, 214).  
The consumption of protein or amino acid containing beverages is not common practice as the 
majority of the population obtains dietary protein as part of nutrient-dense, whole foods that 
contain a variety of macro- and micronutrients. However, far less is known about how the ingestion 
of nutrient-dense whole foods impacts postprandial protein metabolism. The major focus of this 
thesis was to study protein metabolism after the ingestion of more generalizable whole foods. 
Therefore, the literature on whole food ingestion and protein metabolism will be discussed in the 
next part of this thesis. 
 
Whole foods 
One of the earliest observations on whole food ingestion and postprandial protein metabolism 
was made by Elia et al. (53) in 1989. After having participants consume a mixed, whole foods 
meal the authors noted that the postprandial rise in circulating amino acids was attenuated when 
compared to the consumption of a meal predominantly consisting of protein (53). However, the 
lack of labeled food proteins did not allow these workers to truly assess whether postprandial 
dietary-derived amino acid availability was attenuated with mixed meal ingestion, nor was its 
potential influence on muscle protein synthesis assessed. 
Nearly two decades later, Elliot and colleagues (54) were one of the first to study muscle 
protein metabolism in response to whole food ingestion. The authors found that the ingestion of 
whole milk resulted in a greater net muscle protein balance when compared to the ingestion of 
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isonitrogenous amounts of skim milk (containing negligible amounts of fat) (54). While the 
authors were unable to provide a plausible explanation for the observation that co-ingestion of fat 
with protein improved rates of muscle protein synthesis, these findings are not exclusive. A few 
years prior Fouillet et al. (62) had shown that the addition of fat to milk protein resulted in greater 
dietary N retention in peripheral (skeletal muscle) tissue when compared to the addition of 
carbohydrates to milk protein, which resulted in greater dietary N retention in the splanchnic bed 
(62). These findings were assumed to be explained by 1) a reduced rate of gastric emptying with 
carbohydrate intake thereby delaying systemic appearance of dietary-derived amino acids and 2) 
the insulinemic response to carbohydrate co-ingestion which is shown to upregulate splanchnic 
protein synthesis (45). In recent years, this hypothesis was confirmed by work from van Loon’s 
research group. Using the novel technique of labeled food proteins, the authors revealed that the 
consumption of carbohydrates with casein protein resulted in attenuated appearance of dietary-
derived amino acids in circulation (37, 71), while the ingestion of fat with casein protein did not 
impact systemic deliverance of dietary-derived amino acids (72). In their work, the addition of fat 
or carbohydrates did not modulate the muscle anabolic response when compared to the ingestion 
of only casein protein (37, 71, 72). The differential findings of Elliot et al. (32) and the van Loon 
group (72) may relate to the mode of ingestion. Specifically, in the work by Elliot et al. (32) protein 
was ingested as part of the natural food matrix (e.g. whole milk), whereas Gorissen et al. (72) 
provided macronutrients as isolated food sources (e.g. milk fat was mixed with isolated casein 
protein). It is tempting to speculate that greater retention of intrinsic factors (such as 
micronutrients, miRNAs, growth factors, bioactive peptides etc.) in the whole food source 
compared to the ingestion of processed, isolated constituents (75, 76, 171, 181) could have 
influenced these findings.  
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 Only a handful of other studies have assessed postprandial (muscle) protein metabolism after 
whole food ingestion and have focused on beef ingestion. It was demonstrated that the ingestion 
of 30 g of protein in the form of lean ground beef (90/10 %) doubled rates of muscle protein 
synthesis above baseline in both young and older adults, an effect not further enhanced with the 
ingestion of 90 g of beef protein (196). Similar results have been made by others who found that 
postprandial rates of protein synthesis were upregulated after ingestion of a beef patty containing 
36 g (180) and 40 g of protein (103). We have recently compared the muscle anabolic response to 
isonitrogenous lean beef vs. skim milk ingestion (26). Despite divergent responses in the early (0-
2h) postprandial phase, no differences were found in total dietary-derived amino acid availability 
and stimulation muscle protein synthesis when assessed over a more representative 5h postprandial 
phase. 
Taken together these data suggests that whole food ingestion is an effective strategy to 
stimulate postprandial muscle protein synthesis in healthy adults (26, 54, 103, 180, 196), with 
some evidence suggesting that consumption of whole milk may have greater muscle anabolic 
stimulatory effects when compared to the ingestion of more isolated sources of protein (e.g. skim 
milk) (54). However, it is clear that the influence of whole food ingestion on postprandial protein 
metabolism remains largely understudied and a main focus of this thesis was to fill this research 
gap. To this end we have performed a number of studies:  
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1.11 Studied and hypothesis tested 
The primary objective of the studies in this thesis was to apply innovative methodology to assess 
the regulation of whole body and muscle metabolic responses in a detailed manner after food 
ingestion in both healthy and diseased adults. The Chapters that follow describe the studies that 
were used to gain a better understanding of the regulation of postprandial metabolic responses in 
vivo in humans in both health and disease-states.   
Chapter 2:  Sustained postprandial muscle protein synthesis rates after protein ingestion in 
healthy young males 
The temporal relationship between the postprandial release of dietary protein derived amino 
acids in circulation and their subsequent use for the stimulation of muscle protein synthesis has 
not been clearly established. Study 1 (Chapter 2) was designed to directly define the relationship 
between protein derived amino acid availability in circulation, anabolic signaling phosphorylation, 
and the subsequent stimulation of postprandial muscle protein synthesis rates in healthy adults. To 
accomplish this, we combined specifically produced labeled milk proteins with primed continuous 
IV stable isotope infusions. We hypothesized that the temporal response of dietary protein-derived 
amino acid availability in circulation coincides with increased muscle anabolic signaling and 
subsequent stimulation of postprandial protein synthesis after protein ingestion. Performing this 
work was important to provide a clear understanding of the relationship between postprandial 
dietary-derived amino acid availability and the subsequent stimulation of muscle protein synthesis. 
The goal of this study was to set a benchmark for future work studying protein metabolism to 
divergent nutritional stimuli in health and disease. 
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Chapter 3: Development of intrinsically-labeled eggs and poultry meat for use in human 
metabolic research. 
Intrinsically-labeled food proteins are not commercially available and thus have to be produced 
by the researcher. Chapter 3 details study 2 of this thesis and our efforts in producing intrinsically 
labeled proteins and aimed to provide the research field with an easy and cost-effective approach 
to producing intrinsically labeled food proteins to measure postprandial protein handling. 
Previously, researchers have primarily focused on manufacturing intrinsically-labeled cow derived 
food products (i.e. milk and beef) for use in human metabolic research (6-8). The labeled milk and 
beef were produced by prolonged intravenous (IV) infusions of stable isotope tracer into lactating 
dairy cows. The purpose of this study was to extend on previous efforts in cows (18, 175, 207) and 
chickens (57, 63, 122) to demonstrate the feasibility of producing nutritionally complete and 
intrinsically L-[5,5,5-2H3]leucine labeled dietary proteins (i.e. egg and poultry meat) at a modest 
production price point by the use of a non-invasive oral tracer administration method in egg laying 
hens. In addition, we wished to apply these labeled foods in humans as a proof-of-principle to 
assess in vivo dietary protein digestion and absorption kinetics and subsequent postprandial muscle 
protein accretion. Our rationale behind this approach was that chickens are naturally small animals, 
which makes their management and resource cost ideal for the researcher. We hypothesized that ~ 
1/10th of the amount of tracer (45g) would be required to produce labeled eggs sufficiently enriched 
to model postprandial whole-body and muscle protein metabolism  in the consumer as compared 
to cow experiments (400 g) (207).  
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Chapter 4: Consumption of whole eggs promotes greater stimulation of postexercise muscle 
protein synthesis than consumption of isonitrogenous amount of egg whites in young men 
Co-ingestion of protein with other macronutrients has been shown to modulate dietary protein 
digestion and amino acid absorption kinetics when consumed as a liquid beverage (37, 71, 72). 
However, the effects of co-ingestion of fat and protein as part of the natural food matrix on dietary 
protein digestion and absorption kinetics and the subsequent postprandial muscle protein synthetic 
response during recovery from resistance exercise remains to be established. To examine the 
influence of protein co-ingestion with fat within a natural food matrix, Chapter 4 compared the 
consumption of three whole eggs (18 g protein and 17 g fat) to an equivalent amount of protein 
from egg whites (18 g protein and 0 g fat) by combining primed constant infusion methods with 
the ingestion of specifically produced L-[5,5,5-2H3]leucine labeled eggs in healthy young adults.  
We hypothesized that the consumption of whole eggs will result in a delayed appearance 
of dietary protein derived amino acid in systemic circulation. However, we expect that the total 
amount of dietary protein derived amino acid availability throughout the 5 h postprandial phase to 
be similar between the two conditions with no subsequent difference in the stimulation of the 
postprandial muscle protein synthetic response. 
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Chapter 5: Differential whole body and skeletal muscle protein metabolic responses to meal 
ingestion in maintenance hemodialysis patients.  
Maintenance hemodialysis (MHD) is the most common method used to treat end-stage renal 
disease. Muscle wasting is a common feature in MHD patients, and forms a key factor responsible 
for the decline in muscle strength and loss of functional capacity in this patient population (117). 
The mechanisms responsible for the loss of muscle mass in MHD patients are not well defined, 
but likely relate to disturbances in protein metabolism from several co-morbid conditions (e.g., 
insulin resistance, chronic inflammation, metabolic acidosis, and hormonal abnormalities) (117). 
As a result MHD patients experience substantial whole body and muscle protein proteolysis that 
is maintained well beyond the dialysis period. However, it is currently unknown if protein-rich 
meal ingestion can improve whole body net balance and stimulate muscle protein synthesis in 
MHD patients and can thus mitigate some of the losses in body protein mass. 
In Chapter 5 (study 4), we sought to fill this research gap and studied postprandial protein 
handling in MHD patients after the consumption of a mixed meal and compared these outcomes 
to healthy controls. We hypothesized that the postprandial protein handling in MHD patients will 
be impaired versus healthy controls.  
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1.12 Figures 
Figure 1.1 
  
 
 
 
  
 
 
Example of primed-continuous stable isotope infusion protocol to assess protein metabolism in 
humans. 
 
Figure 1.2 
 
 
 
 
 
 
 
 
Simplified two-pool model to assess protein metabolism in humans. 
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Figure 1.3 
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Time course of isotopic enrichment after ingestion of L-[5,5,5-2H3]leucine-labeled eggs and meat. 
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Figure 1.4 
 
 
Intramuscular signaling pathways and amino acid transporters involved in the regulation of protein 
synthesis (mRNA translation). An arrow indicates a stimulatory effect; a blunted end line indicates 
a repressive effect. 
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2.1 Abstract 
We aimed to determine the effect of ingesting a single meal-like amount of protein on digestion 
and absorption kinetics and the subsequent time-dependent regulation of postprandial muscle 
protein synthesis rates in vivo in humans. Seven healthy young males (age: 22±1 y, BMI: 24.8±1.2 
kg/m2) received primed continuous L-[ring-2H5]phenylalanine and L-[ring-3,5-2H2]tyrosine 
infusions and ingested intrinsically L-[1-13C]phenylalanine-labeled milk protein concentrate (38 g 
protein, 4.17 g carbohydrate, 1.4 g fat). Biopsies were collected from the vastus lateralis in the 
basal-state and 60, 120, 180 and 300 min after protein ingestion. Exogenous phenylalanine 
appearance in circulation rapidly increased after protein ingestion (P<0.001). Dietary protein-
derived phenylalanine released in the circulation was 13±2% of the total intake within the first 60 
min, followed by 14±1%, 12±1% 10±0%, and 9±1% within the subsequent 60-120, 120-180 min, 
180-240 and 240-300 min of the postprandial period, respectively (total 56±4% over the 300 min 
period). mTORC1 phosphorylation increased at 120 min (22±8% above basal) after protein 
ingestion and remained elevated throughout the remainder of the postprandial period (all, P<0.05). 
Myofibrillar protein synthesis rates tended to increase (absolute change from basal: 0.010±0.008 
%/h) immediately following protein ingestion between 0-60 min (P=0.10). Myofibrillar protein 
synthesis rates were significantly increased between 60-120 min (0.035±0.012 %/h) and 
myofibrillar protein synthesis remained elevated between 120-180 min (0.019±0.005 %/h) and 
180-300 min (0.016±0.004 %/h) after protein ingestion when compared to basal rates (all, P<0.05). 
Our results show that muscle protein synthesis rates increased 60 min after protein ingestion and 
remain elevated above baseline values for at least 5 hours during the postprandial period in healthy 
young males.   
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2.2 Introduction 
Skeletal muscle mass undergoes constant protein remodeling through coordinated changes in 
breakdown and synthesis. The increase in postprandial muscle protein synthesis rates after each 
meal is important for skeletal muscle mass maintenance , most notably through the stimulation of 
synthesis in the myofibrillar protein fraction (18). It is generally believed that dietary protein- 
derived amino acid availability in circulation is an independent and key regulator of the 
postprandial muscle protein synthetic response in humans (9, 16). Suggestions have been made 
that once enough dietary amino acids become available in circulation to signal muscle 
nutrient/anabolic signaling mechanisms, the stimulation of muscle protein synthesis is quite 
transient in nature and is subsequently inhibited despite prolonged elevated plasma amino acid 
concentrations after protein feeding (1, 2). This phenomenon has been referred to as the muscle-
full effect (1). However, the direct measurement of the temporal relationship between the 
postprandial release of dietary protein-derived amino acids in circulation, phosphorylated-state of  
anabolic signaling pathways, and the subsequent stimulation of muscle protein synthesis rates after 
protein ingestion has not been clearly established.  
Combining the consumption of intrinsically-labeled dietary proteins with primed continuous 
intravenous (I.V.) stable isotope amin acid infusions and muscle biopsy collections allows for 
direct insight into the effect of dietary amino acids on the time course of the phosphorylation of 
anabolic signaling proteins involved in translational control and the stimulation of postprandial 
muscle protein synthesis rates (5, 22). Therefore, the purpose of our current work was to apply 
primed continous I.V. infusions of L-[ring-2H5]phenylalanine and L-[ring-3,5-
2H2]tyrosine with 
the ingestion of specifically produced intrinsically L-[1-13C]phenylalanine labeled milk protein 
concentrate to assess dietary protein-derived amino acid availability in circulation and the time 
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course of the phosphorylation of mTORC1 and the stimulation of muscle protein synthesis rates 
in healthy young males. We hypothesized that the temporal release of dietary protein-derived 
amino acids into circulation coincided with increased phosphorylation of mTORC1 and the 
stimulation of postprandial muscle protein synthesis rates after protein ingestion in healthy young 
males.  
2.3 Methods 
Subjects 
Seven healthy, young men (age: 22±1 y) were examined in the current study. Participant 
characteristics are presented in Table 1. All participants were informed about the experimental 
procedures to be used, the purpose of the study, and all potential risks before giving written 
consent. The study conformed to all standards for the use of human participants in research as 
outlined in the Helsinki Declaration and was approved by the local Institutional Review Board at 
the University of Illinois at Urbana-Champaign.  
 
Experimental protocol 
Participants reported to the laboratory at 0700 h after an overnight fast and having refrained 
from strenuous physical activity for at least 3 d prior to the experimental trial. A Teflon catheter 
was inserted into a heated dorsal hand vein for repeated arterialized blood sampling and remained 
patent by a 0.9% saline drip. After taking a baseline blood sample (t=-180), the plasma 
phenylalanine and tyrosine pools were primed with a single dose of L-[ring-2H5]phenylalanine 
(2.0 µmol·kg-1), L-[ring-3,5-2H2]tyrosine (0.615 µmol·kg
-1) after which a continuous L-[ring-
2H5]phenylalanine (0.05 µmol·kg
-1·min-1) and L-[ring-3,5-2H2]tyrosine (0.015 µmol·kg
-1·min-1 
intravenous infusion was initiated (t=-180 min) and maintained over the experimental infusion 
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trial. Participants received biopsies of the vastus lateralis before (t=-120 and 0 min) and after 
(t=60, 120, 180 and 300 min) the ingestion of 38 g of dietary protein (3.46 g leucine). Dietary 
protein was provided as intrinsically L-[1-13C]phenylalanine milk protein concentrate dissolved in 
300 ml of water (see below for details). Biopsies were collected in the middle region of the vastus 
lateralis (approximately 15 cm above the patella) with a Bergström needle that was custom 
modified for manual suction under local anesthesia (18). Muscle samples were freed from any 
blood, fat, and visible connective tissue and immediately frozen in liquid nitrogen prior to storage 
at -80°C until further analysis. Multiple blood samples were collected in EDTA containing tubes 
before (t=-180, -120, -60, -0 min) and after protein ingestion (t=30, 60, 90, 120, 180, 240 and 300 
min). The blood samples were immediately analyzed for whole blood glucose concentrations 
(2300 Stat Plus, YSI Life Sciences, Springs, OH) and centrifuged at 3000 × g for 10 min at 4°C. 
The plasma samples were subsequently stored at -20°C for future analysis.  
 
Intrinsically labeled milk protein 
Intrinsically L-[1-13C]phenylalanine labeled milk protein concentrate (MPC 80) was obtained 
by infusing L-[1-13C]phenylalanine into a lactating Holstein cow, collecting the milk, and 
purifying the milk protein concentrate as previously described (6, 17, 21). The L-[1-
13C]phenylalanine enrichment in the milk protein concentrate was measured by GC-MS (Agilent 
6890N GC coupled with a 5973 inert MDS; Little Falls, DE) and averaged 38.3 MPE. The MPC 
80 met all chemical and bacteriologic specifications for human consumption. The beverage 
provided to participants contained 38 g protein (3.46 g leucine), 4.17 g carbohydrate and 1.4 g fat. 
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Plasma analyses  
Plasma insulin concentrations were determined using a commercially available enzyme-linked 
immunosorbent assays (Alpco Diagnostics; Salem, NH). Plasma amino acid concentrations and 
enrichments were determined by GC-MS (Agilent 7890A GC/5975C; MSD, Little Falls, DE). 
Specifically, internal standards of [U-13C6]leucine, [U-
13C9
15N]phenylalanine, and [U-
13C9
15N]tyrosine were added to the plasma samples. The plasma was deproteinized on ice with 5-
sulfosalicylic acid. Free amino acids were purified using cation exchange AG 50W-X8 resin (mesh 
size: 100-200, ionic form: hydrogen) (Bio-Rad Laboratories, Hercules, CA) columns. The free 
amino acids were converted to their tert-butyl dimethylsilyl (TBDMS) derivative before analysis 
by GC-MS. The amino acid concentrations were determined using electron impact ionization by 
monitoring ions at mass-to-charge (m/z) ratio 302 and 308 for unlabeled and [U-13C6]-leucine 
respectively, 336 and 346 for unlabeled and [U-13C9
15N]-phenylalanine respectively, and 466 and 
476 for unlabeled and [U-13C9
15N]-tyrosine respectively. The plasma phenylalanine and tyrosine 
13C and 2H enrichments were determined using selective ion monitoring at m/z 336, 337, and 341 
for unlabeled and labeled (1-13C and ring-2H5)phenylalanine respectively,  m/z 466, 468, and 470 
for unlabeled and labeled (ring-3,5-2H2, and ring-
2H4)tyrosine respectively. Standard regression 
curves were applied from a series of known standard enrichment values against the measured 
values to assess the linearity of the mass spectrometer and to account for any isotope fractionation 
which may have occurred during the analysis. Phenylalanine and tyrosine enrichments were 
corrected for the presence of both the 13C and 2H isotopes.  
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Muscle analyses  
Myofibrillar proteins were extracted from ~50 mg of wet muscle by hand-homogenizing in 
ice-cold homogenization buffer (10 µL∙mg-1) using a Teflon pestle. Homogenates were centrifuged 
at 700 × g for 5 min at 4ºC. The resultant supernatant was removed and the pellet was washed with 
500 µL distilled water. Subsequently, the samples were centrifuged at 700 × g for 10 min at 4ºC. 
The remaining myofibrillar proteins pellet was solubilized by adding 1 mL of 0.3 м NaOH and 
heating at 50ºC for 30 min with vortex mixing every 10 min. Samples were centrifuged at 700 × g 
for 5 min at 4ºC. The supernatant containing the myofibrillar enriched protein fraction was 
collected and the collagen pellet was discarded. Myofibrillar proteins were precipitated by adding 
1 mL of 1 м PCA and centrifuging at 2500 × g for 10 min at 4ºC. The myofibrillar protein pellet 
was washed twice with 70% ethanol. The amino acids were liberated by adding 2 mL of 6 м HCL 
and heating overnight at 110°C. Free amino acids were purified using cation exchange AG 50W-
X8 resin (mesh size: 100-200, ionic form: hydrogen) (Bio-Rad Laboratories, Hercules, CA) 
columns before analysis of L-[ring-2H5]phenylalanine enrichments by GC/MS.  
To reduce the signal-to-noise ratio during GC-MS analysis at low tracer enrichments, the 
phenylalanine from the myofibrillar protein hydrolysates were enzymatically decarboxylated to β-
phenylethylamine (7) prior to tBDMS derivatization (19, 20). Enrichments of the protein bound 
samples were determined by selected ion monitoring for β-phenylethylamine-tBDMS mass to 
charge ratio at 183 (m+5) to 180 (m+2) and a single linear standard curve (to avoid slope influences 
on the measured TTR) from mixtures of known m+5 to m+2 ratios. To avoid saturation of the MS 
and eliminate bias due to any potential concentration dependencies (14), the split ratio was adjusted 
prior to the injection of each sample so that nearly equal amounts of phenylalanine were injected 
for all samples and standards. 
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Muscle intracellular free amino acids were extracted from a separate piece of wet muscle 
(~30 mg) using a Teflon-coated pestle and ice-cold 2% PCA and then centrifuged at 10000 × g at 
4˚C for 10 min. The supernatant was then collected and this process was repeated 2 more times. 
The supernatant was taken as the muscle intracellular free amino acids and subsequently purified 
using cation exchange chromatography (Dowex 50W-X8-200 resin; Acros Organics, Geel, 
Belgium) before analysis by LC/MS/MS. The phenylalanine 13C and 2H enrichments were 
determined by multiple reaction monitoring (MRM) at m/z 166.0  103.0, 167.0  104.0 and 
171.0  106.0 for unlabeled and labeled (L-[1-13C] and ring-2H5)phenylalanine, respectively. 
Software Analyst 1.6.2 was used for data acquisition and analysis. Phenylalanine enrichments were 
corrected for the presence of both 13C and 2H isotopes. 
 
Western blotting 
A portion of whole muscle homogenates isolated during the myofibrillar protein extractions 
was used for Western blotting analysis. Protein content of the homogenates was determined by 
Bradford Assay (Bio-Rad Laboratories, Hercules, CA) and then equal amounts of protein were 
separated by SDS-PAGE before being transferred to polyvinyl difluoride membranes for blotting. 
After blocking, membranes were incubated in primary antibodies overnight at 4oC to determine 
the phosphorylation status and total protein content mammalian target of rapamycin complex 1 
(mTORC1) at Ser2448 and total protein content of large neutral amino acid transporter (LAT1/ 
SLC7A5) (Bioss Antibodies, Woburn, MA). Membranes from the respective proteins were then 
incubated with appropriate secondary antibodies and protein content was detected using West 
Femto Maximum Sensitivity substrate (SuperSignal, Thermo Scientific, Waltham, MA) and the 
ChemiDoc-It2 Imaging System (UVP, Upland, CA). After detection of phosphorylated proteins, 
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membranes were stripped with western blot stripping buffer (Restore, Thermo Scientific, USA) 
and re-incubated with antibodies against total protein (Cell Signaling Technology, Danvers, MA). 
Western blot data were normalized to an internal control (-tubulin). Bands were quantified using 
ImageJ software (NIH), normalized to a control sample run on each blot to account for inter-blot 
variability, and expressed as fold change from basal.   
 
Calculations 
Ingestion of L-[1-13C]-phenylalanine-labeled protein, intravenous infusion of L-[ring-2H5]-
phenylalanine and L-[ring-3,5-2H2]-tyrosine, and arterialized blood sampling were used to assess 
whole-body amino acid kinetics in non-steady state conditions. Total, exogenous, and endogenous 
rate of appearance (Ra) and plasma availability of dietary protein-derived phenylalanine (i.e., the 
fraction of dietary protein-derived phenylalanine that appeared in the systemic circulation), were 
calculated using modified Steele’s equations (4, 10) as described previously (12). Furthermore, 
total rate of phenylalanine disappearance (Rd), utilization of phenylalanine for protein synthesis, 
and phenylalanine hydroxylation (first step of phenylalanine conversion to tyrosine) were 
calculated (12).   
Myofibrillar protein fractional synthetic rates (FSR) were calculated using the standard 
precursor-product equation: 
 
FSR =
∆Ep
Eprecursor∙t
∙ 100% (9) 
 
where ΔEp is the increment in myofibrillar protein-bound L-[ring-
2H5]-phenylalanine enrichment 
after an incorporation period (tracer-to-tracee ratio, TTR), Eprecursor is the weighted mean plasma 
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L-[ring-2H5]-phenylalanine enrichment or the muscle free pool during that incorporation period 
(TTR), and t is the incorporation period (h). Muscle biopsies at t=-120 and 0 min were used for 
basal FSR andbiopsies at t=60, 120, 180 and 300 min were used for postprandial FSR.  
 
Statistics 
Differences in time-dependent blood and muscle measurements were tested one-way repeated-
measures ANOVA (time). When statistically significant time effects were observed LSD post hoc 
tests were performed to locate differences. Differences were considered statistically significant at 
P<0.05. All calculations were performed using IBM SPSS Statistics (version 24, Chicago, IL) 
unless otherwise designated. All data are expressed as mean ± SEMs.  
 
2.4 Results 
Plasma metabolites 
Plasma glucose concentrations were increased above fasted values (t=0 min) at 30 min of the 
postprandial period reaching a peak concentration of 81 ± 1 mg·dL-1 (P=0.03; Figure 1A). 
Similarly, plasma insulin concentrations were increased above fasted values at 30 min of the 
postprandial period reaching a peak concentration of 19 ± 4 µIU·mL-1 at 30 (P=0.02; Figure 1B). 
Plasma phenylalanine- (Figure 2A), tyrosine- (Figure 2B) and leucine (Figure 2C) concentrations 
increased rapidly after protein ingestion and remained elevated above fasted values during the 
entire post-prandial phase (all P<0.05). Peak plasma concentrations for all three amino acids were 
observed at 30 min after protein ingestion with values of 97 ± 5, 116 ± 10, and 335 ± 32 µmol·L-1 
for phenylalanine, tyrosine, and leucine, respectively.  
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Plasma amino acid enrichments 
Plasma L-[1-13C]-phenylalanine enrichment increased rapidly after protein ingestion and 
remained elevated above fasted values during the entire post-prandial phase (all, P<0.05; Figure 
3A). Peak plasma L-[1-13C]-phenylalanine enrichment was observed at 30 min after protein 
ingestion with a value of 14 ± 2 MPE. Plasma L-[ring-2H5]-phenylalanine enrichment (Figure 3B) 
decreased after protein ingestion (time effect: P<0.01) and remained reduced below fasted values 
(t=0 min) until 60 min after protein ingestion (all, P<0.05). Plasma L-[ring-3,5-2H2]tyrosine 
(Figure 3C) decreased after protein ingestion (time effect: P<0.01) and remained reduced below 
fasted values (t=0 min) until 120 min after protein ingestion (all, P<0.05).   
 
Whole body amino acid kinetics 
Exogenous phenylalanine rates of appearance (representing the appearance of dietary protein-
derived phenylalanine in circulation) increased after protein ingestion and remained elevated 
above fasted values during the entire post-prandial phase (all, P<0.01; Figure 4A). Peak plasma 
exogenous phenylalanine rates of appearance were observed at 30 min after protein ingestion and 
reached a value of 313 ± 48 nmol phenylalanine·kg-1·min-1. The amount of dietary protein-derived 
phenylalanine that appeared in circulation over the 300 min postprandial period was calculated to 
be 58±4%. The amount of dietary protein-derived phenylalanine that appeared in circulation 
during min 0-60, 60-120, 120-180, and 180-240 and 240-300 min was 13±2, 14±1, 12±1, 10±0 
and 9±1%, respectively (Figure 4B). While dietary-protein-derived amino acid availibity 
remained elevated above fasted values (t=-60-0 min) throughout the entire postprandial period (all 
P<0.05), dietary derived amino acid availibity was significantly higher between 60-120 min when 
compared to later time points (120-180, 180-240 and 240-300 min) (P<0.05). 
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Whole body protein breakdown rates (Figure 5A) decreased after protein ingestion (time 
effect: P<0.01) with the lowest value of 572 ± 37 nmol phenylalanine·kg-1·min-1 observed at 90 
min after ingestion. Whole body protein oxidation rates (Figure 5B) increased after protein 
ingestion (time effect: P<0.01) and remained elevated above fasted values during the entire post-
prandial phase (all P<0.05) with a peak value of 136 ± 14 nmol phenylalanine·kg-1·min-1 observed 
at 60 min after ingestion. Whole body protein synthesis rates (Figure 5C) increased after protein 
ingestion (time effect: P<0.01) and remained elevated above fasted values (t=0 min) until 180 min 
after ingestion (all P<0.05) with a peak value of 920 ± 17 nmol phenylalanine·kg-1·min-1 observed 
at 60 min after ingestion. Consequently, whole body net protein balance increased after protein 
ingestion (time effect: P<0.01) (Figure 5D) and remained elevated above fasted values during the 
entire post-prandial phase (all P<0.01) with a peak value of 258 ± 22 nmol phenylalanine·kg-
1·min-1 observed at 60 min after protein ingestion. 
 
Muscle intracellular free amino acid enrichments 
Muscle intracellular free L-[1-13C]-phenylalanine enrichments increased after protein 
ingestion (time effect: P<0.01) and remained elevated above fasted values (t=0 min) during the 
entire post-prandial phase (P<0.05; Figure 6A). Peak muscle intracellular free L-[1-13C]-
phenylalanine enrichment was observed at 120 min after protein ingestion with a value of 4.0 ± 
0.6 MPE. Muscle intracellular free L-[ring-2H5]-phenylalanine enrichments decreased after protein 
ingestion (time effect: P<0.01) and were suppressed below fasted values at 60 min after protein 
ingestion (P=0.03; Figure 6B). 
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LAT1 amino acid transport and mTORC1 phosphoryalation 
Protein ingestion did not modulate LAT1 protein content throughout the entire postprandial 
period (time effect: P=0.53; Figure 7A). mTORC1 phosphorylation increased after protein 
ingestion above baseline between 180-300 min  of the postprandial period (all P<0.01; Figure 
7B).  
 
Myofibrillar protein synthesis 
Using plasma phenylalanine enrichments as the precursor, postprandial myofibrillar protein 
synthesis rates increased at 60-120 min after protein ingestion and remained elevated above fasted 
values (t=-120-0 min) throughout the remaining postprandial period (all, P<0.05; Figure 8). In the 
first 60 minutes after protein ingestion, myofibrillar protein synthesis showed a trend towards an 
increase above fasted values (absolute change from fasted: 0.010±0.005 %/h-1; P=0.11). The 
postprandial increase in myofibrillar protein synthesis was greatest at 60-120 min after protein 
ingestion (0.037±0.01 %/h-1) and remained elevated above fasted values at 120-180 min 
(0.022±0.005 %/h-1) and 180-300 min (0.019±0.004 %/h-1). 
Using intracellular free phenylalanine enrichments as the precursor, postprandial myofibrillar 
protein synthesis rates increased at 60-120 min after protein ingestion and remained elevated above 
fasted values (t=-120-0 min) throughout the remaining postprandial period (all, P<0.05; data not 
shown). In the first 60 minutes after protein ingestion, myofibrillar protein synthesis showed a 
trend towards an increase above fasted values (absolute change from fasted: 0.025±0.014 %/h-1; 
P=0.13). The postprandial increase in myofibrillar protein synthesis was greatest at 60-120 min 
after protein ingestion (0.114±0.04 %/h-1) and remained elevated above fasted values at 120-180 
min (0.057±0.020 %/h-1) and 180-300 min (0.045±0.018 %/h-1). 
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2.5 Discussion 
Our repeated blood and muscle biopsy approach allowed us to directly compare the time course 
of the effect of dietary amino acids on the stimulation of the postprandial muscle protein synthetic 
response in healthy adults. We show that protein-derived amino acids appear rapidly in circulation 
immediately after protein ingestion. In particular, 13 ± 2 % (~5 grams) of dietary-protein derived 
amino acids became available in circulation within the first 60 min of the postprandial period. 
However, there is a ~60 min delay period after protein ingestion prior to a significant and sustained 
increase in both anabolic signaling mechanisms and the stimulation of muscle protein synthesis 
rates throughout a 300 min postprandial period. The anabolic effects of dietary amino acids on 
skeletal muscle tissue appear to be the most robust between 60-120 min after protein ingestion.  
Interestingly, protein oxidation was also highest between 60-120 min of the postprandial period 
and shows the amino acids were also being shifted to other metabolic processes beyond protein 
synthesis.  
 Defining the role of insulin and amino acids to regulate muscle anabolic responses to 
protein nutrition has made considerable progress. For example, it has been shown muscle protein 
synthesis rates respond in a dose-dependent manner to elevated amino acid availability despite 
insulin being clamped at postabsorptive concentrations (8). As such, insulin is considered to be 
permissive rather than modulatory for the stimulation of the postprandial muscle protein synthetic 
response. Here, we show that plasma insulin concentrations peaked at 30 min after protein 
ingestion (Figure 1B).  However, both mTORC1 phosphorylation and muscle protein synthesis 
rates were not significantly increased until 60-120 min after protein ingestion. These anabolic 
responses occurred without changes in skeletal muscle LAT1 protein content throughout the 
postprandial period. In addition to the role of LAT1 in amino acid transport, it is also believed to 
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play a role in amino acid sensing to activate mTORC1 signaling events (13). Our data suggests 
that perhaps the total amount of muscle LAT1 protein is not rate limiting for amino acid 
transport/sensing in response to protein ingestion, but does not discount the potential of nutrient 
stimuli to augment recruitment of amino acid transporters to the sarcolemma (11).  
Importantly, our study allowed us to directly compare the relationship between postprandial 
dietary protein derived amino acid availability and the subsequent increase in mTORC1 
phosphorylation and muscle protein synthesis rates. Our findings are in contrast to the previously 
demonstrated ‘muscle-full’ effect (1). Specifically, Atherton et al. (1) showed a brief stimulation 
of postprandial muscle protein synthesis between 45-90 min after protein ingestion followed by 
subsequent rapid decline to basal values. These findings were made despite another 90 min of 
continued elevated postprandial plasma and intramuscular amino acid concentrations and elevated 
anabolic signaling events. In the present work, we show a sustained increase in the muscle protein 
synthetic response throughout the late postprandial period. The discrepancy between our data and 
Atherton et al. (1) may relate to the digestion rate of the ingested protein source. For instance, we 
fed milk protein (80 % casein/20 % whey) whereas the previous researchers used whey protein 
(1). Thus, the ‘muscle full effect’ may only occur when plasma and intramuscular amino acid pools 
experience an amino acid delivery pattern that is initially very rapid but is not sustained during the 
later postprandial phase (i.e. after ~ 120-180 min). This effect is common after the ingestion of a 
rapidly digested source such as whey (3, 15). In contrast, we provided a combination of a fast (i.e. 
whey) and slow (i.e. casein) protein fractions (3), as contained within the natural food matrix of 
milk protein, and observed a more sustained release of dietary protein derived amino acids and 
subsequently maintained postprandial stimulation of muscle protein synthesis (Figure 9). 
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In conclusion, our findings show the rise in dietary amino acid appearance precedes the 
increase in the phosphorylated-state of mTORC1 and muscle protein synthesis rates. In addition, 
we show a sustained postprandial stimulation of muscle protein synthesis rates that coincides with 
sustained plasma amino acid availability and elevated mTORC1 signaling after protein ingestion. 
For optimal clinical nutrition strategies, our finding provide insight into the design of optimal pulse 
feeding strategies (i.e., 3-4 meals daily). Specifically, consumption of protein sources that provide 
a sustained delivery of dietary amino acids will result in the maintenance of the postprandial 
muscle protein synthetic response throughout a prolonged postprandial period.    
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2.6 Tables 
Table 2.1 Participant characteristics (n=10) 
Variable 
 
Age (y) 22 ± 1.3 
Weight (kg) 79.2 ± 4.9 
BMI (kg/m2) 24.8 ± 1.2 
Systolic BP (mmHg) 124.7 ± 3.9 
Diastolic BP (mmHg) 72.4 ± 3.9 
Fat (%) 16.6 ± 1.4 
Lean Body Mass (kg) 64.0 ± 3.7 
Fasting Glucose (mg/dL-1) 78.3 ± 1.0 
Energy Intake (J/d-1) 8740.4 ± 423.0 
Protein Intake (g/d-1) 113.0 ± 4.8 
Carbohydrate Intake (g/d-1) 228.7 ± 21.1 
Fat Intake  (g/d-1) 83.0 ± 1.17 
Data are mean ± SEM. 
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2.7 Figures 
Figure 2.1   
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 Blood glucose- (A) and plasma insulin (B) concentrations (mg·dL-1 and µIU·mL-1, respectively) 
in the fasted state and after ingestion of milk protein (38 g) in healthy young men (n=7). Dashed 
line refers to protein ingestion. Data were analyzed with one-way repeated-measures ANOVA 
(time). A LSD post hoc test was used to locate differences between means when significance was 
observed. Glucose (A); Insulin (B): All time effect, P<0.01. *Significantly different from fasted 
(t=0 min) (P<0.05). Data are mean ± SEM. 
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Figure 2.2  
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Plasma phenylalanine- (A), tyrosine- (B), and leucine (C) concentrations concentrations (µmol·L-
1) in the fasted state and after ingestion of milk protein (38 g) in healthy young men (n=7). Dashed 
line refers to protein ingestion. Data were analyzed with one-way repeated-measures ANOVA 
(time). A LSD post hoc test was used to locate differences between means when significance was 
observed. Phenylalanine (A); Tyrosine (B); Leucine (C): All time effect, P<0.01. *Significantly 
different from fasted (t=0 min) (P<0.05). Data are mean ± SEM.  
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Figure 2.3 
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Plasma L-[1-13C]phenylalanine- (A), L-[ring-2H5]phenylalanine- (B), and L-[ring-3,5-
2H2]tyrosine (C) enrichments (MPE) in the fasted state and after ingestion of milk protein (38 g) 
in healthy young men (n=7). Dashed line refers to protein ingestion. Data were analyzed with one-
way repeated-measures ANOVA (time). A LSD post hoc test was used to locate differences 
between means when significance was observed. L-[1-13C]phenylalanine (A); L-[ring-
2H5]phenylalanine (B L-[ring-3,5-
2H2]tyrosine (C): All time effect, P<0.01. *Significantly 
different from fasted (t=0 min) (P<0.05). Data are mean ± SEM. MPE, mole percent excess. 
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Figure 2.4 
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Exogenous phenylalanine Ra (A) (nmol phenylalanine·kg
-1·min-1) and dietary phenylalanine 
availability (%) in the fasted state (not shown for Pheplasma) and after ingestion of milk protein (38 
g) in healthy young men (n=7). Dashed line refers to protein ingestion. Data were analyzed with 
one-way repeated-measures ANOVA (time). A LSD post hoc test was used to locate differences 
between means when significance was observed. Exogenous Ra (A); Total Ra (B); Total Rd (C): 
All time effect, P<0.01. *Significantly different from fasted (t=0 min) (P<0.05). #Significantly 
different from 120-180, 180-240, and 240-300 min. Data are Mean ± SEM. Ra, rate of appearance. 
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Figure 2.5 
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Whole body protein breakdown- (A), oxidation- (B), synthesis- (C) and net balance (D) rates (nmol 
phenyalanine·kg-1·min-1) in the fasted state and after ingestion of milk protein (38 g) in healthy 
young men (n=7). Dashed line refers to protein ingestion. Data were analyzed with one-way 
repeated-measures ANOVA (time). A LSD post hoc test was used to locate differences between 
means when significance was observed. Whole body protein breakdown- (A), oxidation- (B), 
synthesis- (C) and net balance (D): All time effect, P<0.01. *Significantly different from fasted 
(t=0 min) (P<0.05). Data are Mean ± SEM.  
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Figure 2.6  
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Muscle free L-[1-13C]phenylalanine- (A) and L-[ring-2H5]phenylalanine- enrichments (MPE) in 
the fasted state and after ingestion of milk protein (38 g) in healthy young men (n=7). Dashed line 
refers to protein ingestion. Data were analyzed with one-way repeated-measures ANOVA (time). 
A LSD post hoc test was used to locate differences between means when significance was 
observed. L-[1-13C]phenylalanine (A); L-[ring-2H5]phenylalanine: All time effect, P<0.01. 
*Significantly different from fasted (t=0 min) (P<0.05). Data are mean ± SEM. 
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Figure 2.7  
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Total protein content of LAT1 (A) and phosphorylated state of mTORSer2448 (B) in the fasted state 
(t=0 min) and after ingestion of milk protein (38 g) in healthy young men (n=7). Data were 
analyzed with one-way repeated-measures ANOVA (time). A LSD post hoc test was used to locate 
differences between means when significance was observed. LAT1 (A): Time effect, P=0.53. 
mTORSer2448 (B): Time effect, P=0.02. *Significantly different from fasted (t=0 min) (P<0.05). 
Data are mean ± SEM. LAT1, Large neutral amino acid transporter small subunit 1; mTORC1, 
mammalian target of rapamycin complex 1. 
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Figure 2.8  
F
a
s
te
d
0
-6
0
 m
in
6
0
-1
2
0
 m
in
1
2
0
-1
8
0
 m
in
1
8
0
-3
0
0
 m
in
0 .0 0
0 .0 2
0 .0 4
0 .0 6
0 .0 8
*
M
y
o
f
ib
r
il
la
r
 
p
r
o
t
e
in
 
F
S
R
 
(
%
h
-
1
)
 
Myofibrillar protein synthesis expressed as FSR (%·h-1) in the fasted state and after ingestion of 
milk protein (38 g) in healthy young men (n=7). Data were analyzed with one-way repeated-
measures ANOVA (time). A LSD post hoc test was used to locate differences between means 
when significance was observed. Time effect, P=0.02. Data are mean ± SEM. FSR, fractional 
synthesis rates. 
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Figure 2.9  
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Time-dependent comparison between responses of myofibrillar protein FSR (%·h-1 absolute 
change from basal) and dietary phenylalanine availability (%) after ingestion of milk protein (38 
g) in healthy young men (n=7). Data are mean ± SEM. FSR, fractional synthesis rates.  
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CHAPTER 3: DEVELOPMENT OF INTRINSICALLY-LABELED EGGS AND 
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3.1 Abstract 
Background: Stable isotope amino acids are regularly used as tracers to examine whole body and 
muscle protein metabolism in humans. To accurately assess in vivo dietary protein digestion and 
absorption kinetics, it is required that the amino acid tracer is incorporated within the dietary 
protein food source (i.e., intrinsically-labeled protein). Objective: We assessed the practicality of 
producing intrinsically L-[5,5,5-2H3]leucine-labeled eggs and poultry meat through non-invasive 
oral tracer administration. Methods: A specifically formulated diet (containing 0.52% leucine) 
was supplemented with 0.3% L-[5,5,5-2H3]leucine and subsequently fed to 3 laying hens 
(Lohmann LSL Whites) for 55 d. On d 55, the hens were slaughtered and their meat, bones, and 
organs were harvested to determine tissue labeling. In experiment 1, two healthy young men (age: 
22 ± 1.5 y; BMI: 23.7 ± 0.5 kg/m2) ingested 18 g of L-[5,5,5-2H3]leucine-labeled egg protein. In 
experiment 2, two healthy young men (age: 20.0±0.0 y; BMI: 26.4±3.1 kg/m2) ingested 28 g of L-
[5,5,5-2H3]leucine-labeled poultry meat protein. Plasma samples (experiment 1 and 2) and muscle 
biopsies (experiment 1) were collected before and after labeled-food ingestion. Results: High 
tracer labeling (>20 mole percent excess, MPE) in the eggs was obtained after 7 d and maintained 
throughout the feeding protocol (P<0.05). Over a 55 d period, ~850 g of egg protein (145 eggs) 
was produced with a mean tracer enrichment of 22.0±0.8 MPE. Mean L-[5,5,5-2H3]leucine 
enrichment in the meat was 9.6±0.1 MPE. In experiment 1 and 2, the consumption of labeled eggs 
and poultry meat protein increased plasma L-[5,5,5-2H3]leucine enrichment with peak values of 
6.7±0.1 and 4.0±0.9 MPE, respectively. The 5 h postprandial increase in myofibrillar L-[5,5,5-
2H3]leucine enrichment after egg ingestion in healthy young men was 0.051±0.008 MPE 
(experiment 1). Conclusion: We have demonstrated the feasibility of producing intrinsically-
labeled eggs and poultry meat for use in human metabolic research. 
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3.2 Introduction 
Stable isotope labeled amino acids are regularly used as tracers to examine whole body and muscle 
protein metabolism in humans. The whole body and muscle protein synthetic response to food 
ingestion has been shown to be modulated by the pattern of postprandial (essential) amino acid 
availability (5, 10, 19, 28), which is mainly determined by the digestion and absorption kinetics of 
the ingested food source (9, 19). Thus, researchers have sought to develop novel approaches to 
assess dietary protein digestion and absorption kinetics and, more importantly from a biological 
regulatory standpoint, the subsequent dietary protein-derived plasma amino acid availability.  
 Intrinsic labeling of a dietary protein source with a stable isotope tracer is a novel approach 
used in human metabolic research to circumvent the differential amino acid intestinal absorption 
patterns between free amino acid tracer versus amino acids derived from the ingested food source 
(7). Thus, intrinsically labeled food proteins provide a tool to reliably model postprandial whole 
body protein metabolism in vivo in humans. In addition to whole body applications, the use of 
highly labeled food proteins (>30 mole percent excess; MPE) have allowed researchers to directly 
‘trace’ the use of dietary protein-derived amino acids for postprandial muscle protein accretion 
(29). 
To date, researchers have primarily focused on demonstrating the effectiveness of 
manufacturing intrinsically-labeled cow derived food products (i.e. milk and beef) by prolonged 
intravenous (I.V.) infusions of stable isotope tracer into lactating dairy cows (6, 25, 26). The 
purpose of this study was to extend on previous efforts in cows (6, 26, 29) and chickens (11, 13, 
21) to demonstrate the feasibility of producing nutritionally complete and intrinsically labeled 
dietary proteins (i.e. egg and poultry meat) at a modest production price point by the use of a non-
invasive oral tracer administration method in chickens. In addition, we wished to apply these 
 
102 
 
labeled foods in humans as a proof-of-principle to assess in vivo dietary protein digestion and 
absorption kinetics and subsequent postprandial muscle protein accretion. Our rationale behind 
this approach was: 1) chickens are naturally small animals, which makes their management and 
resource cost ideal for the researcher. We hypothesized that ~ 1/10th of the amount of tracer (45g) 
would be required to produce labeled proteins sufficiently enriched to ‘trace’ the dietary protein-
derived into human skeletal muscle tissue after its ingestion when compared to cow experiments 
(400 g) (29); 2) previous research applications with intrinsically labeled eggs have not assessed 
their suitability to model postprandial whole body and muscle protein synthesis in humans (11, 13, 
21) and; 3) egg protein is the current World Health Organization/Food and Agricultural 
Organization gold standard protein source, which will provide invaluable nutritional insight into 
the metabolism of this high quality protein (32). Therefore, egg protein is ideally suited to apply 
in human intervention trials with the endpoint of developing optimal guidelines for the retention 
and/or enhancement of protein mass and/or muscle health in various populations.  
 
3.3 Methods 
Development of intrinsically labeled eggs and poultry meat 
Tracer administration 
The diet of 3 egg laying hens (Lohmann LSL Whites, age: 29 wks; weight: 1.7 kg) was 
supplemented with 0.3% L-[5,5,5-2H3]leucine for 55 d with assistance from the Poultry Research 
Farm, Animal Science Laboratory, University of Illinois at Urbana-Champaign. Specifically, 45 g 
L-[5,5,5-2H3]leucine was mixed with 14,955 g of a specially formulated diet. In contrast to 
previous approaches that provided tracer on top of a normal mixed diet (13, 21), we used the 
approach by Evenepoel et al. (11) and formulated a diet to be deficient in (unlabeled) leucine in 
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order to minimize tracer oxidation and irreversible loss and to maximize recovery into protein  
(Supplemental Table 1). The diet was calculated to contain 0.52% leucine from the intact protein 
in the feed ingredients; the National Research Council (NRC) requirement for leucine is 0.82% 
(1). Thereafter, the diet was supplemented with 0.3% of L-[5,5,5-2H3]leucine to meet the 
requirement for leucine. All other amino acids were present at levels that were equal to or greater 
than the NRC requirements (1).  
The hens were adapted to the modified diet for 7 d prior to the administration of the tracer 
feeding protocol to confirm proper consumption of the diet. The diet fed on those 7 d mirrored the 
diet fed during the 55 d feeding trial with the exception that the diet was supplemented with 
unlabeled free leucine and not tracer. The average daily food intake of the hens over the 55 d period 
was ~86 g·d-1. Residual feed was recycled and fed on the subsequent days. The experiment and 
animal handling procedures were approved by the Institutional Animal Care and Use Committee 
(IACUC) at the University of Illinois. 
 
Egg and organ collection 
Eggs were collected daily and stored at 4°C. Subsequently, the eggs were processed under sterile 
conditions and an aliquot of both the white and yolk of each egg was collected for future analysis 
of L-[5,5,5-2H3]leucine enrichment by GC/MS (see below for details) prior to storage at -20°C. 
On d 55 of the feeding trial, the hens were killed with CO2. Immediately afterwards, the tissues 
were harvested and processed by an abattoir (Meat Science Laboratory, University of Illinois at 
Urbana-Champaign). Meat cuts (corresponding to the breast, drumstick, tenderloin, thigh, and 
wing), organs (the brain, crop, gizzard, heart, kidney, large intestine, liver, lungs, ovary, oviduct, 
small intestine and spleen), and bones (the femur, ilium, tibia, radius, and the femur’s marrow) 
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were individually packaged, labeled, and stored at -20°C until further analysis of L-[5,5,5-
2H3]leucine enrichment by GC/MS (see below for details).  
 
Egg protein and lipid analysis 
One egg, representative of the average weight of the eggs (i.e. ~52 g) collected during the 55 d 
feeding trial, was used for proximate analysis as described previously (23). In brief, the yolk and 
white were separated and homogenized in a food processor. Samples were dried at 110°C for 24 h 
and extracted in an azeotropic mixture of warm chloroform and methanol. Protein concentrations 
were determined by measuring nitrogen content using the combustion method (method 990.03; 
AOAC International, 2000; TruMac; LECO Corp., St. Joseph, MI). Moisture, protein, and 
extractible lipid analyses were performed in duplicate. 
 
Egg and tissue enrichment analysis 
The egg, meat and bone protein bound L-[5,5,5-2H3]leucine enrichments were determined by 
GC/MS analysis (Agilent 7890A GC/5975C; MSD, Palo Alto, CA, USA).  L-[5,5,5-2H3]leucine 
enrichment of the samples was determined by selective ion monitoring for leucine mass-to-charge 
(m/z) ratio at 302 (m+0) and 305 (m+3). For complete analysis details see Supplemental Methods. 
 
Human intervention trials 
All participants were informed about the experimental procedures to be used, the purpose of the 
study, and all potential risks before giving written consent. Both experiments conformed to all 
standards for the use of human subjects in research as outlined in the Helsinki Declaration and 
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were approved by the local Institutional Review Board at the University of Illinois at Urbana-
Champaign. 
 
Experimental protocol 
In experiment 1, 2 healthy young men (age: 22 ± 1.5 y; weight: 70.73 ± 4.04 kg; body mass index: 
23.7 ± 0.5 kg/m2) were studied during primed continuous intravenous infusion of L-[1-13C]leucine 
to assess postprandial handling after the ingestion of 18 g of intrinsically L-[5,5,5-2H3]leucine 
labeled eggs. In experiment 2, 2 healthy young men (age: 20.0 ± 0.0 y; weight: 94.6 ± 12.4 kg; 
body mass index: 26.4 ± 3.1 kg/m2) were studied to assess the feasibility of measuring postprandial 
release of dietary protein derived L-[5,5,5-2H3]leucine into circulation after the ingestion of 28 g 
intrinsically L-[5,5,5-2H3]leucine labeled protein contained in poultry meat. Arterialized blood 
samples were collected at t=-180, -120, -60 min (experiment 1), and -0 min (experiment 2) of 
the postabsorptive state and at t=30, 60, 90, 120, 180, 240 and 300 min (experiment 1 and 2) of 
the postprandial phase. Biopsies of the vastus lateralis were collected before (t=0 min) and after 
(t=300 min) the ingestion of 18 g of intrinsically L-[5,5,5-2H3]leucine labeled egg protein to assess 
the use of dietary protein derived amino acids for postprandial muscle protein accretion 
(experiment 1). No muscle biopsies were collected in experiment 2. 
 
Preparation of intrinsically labeled protein and meal composition 
In experiment 1, the intrinsically-labeled L-[5,5,5-2H3]leucine eggs were prepared by boiling the 
eggs for 12 min prior to peeling.  Subsequently, the whole eggs were freeze-dried and finely ground 
using a hand mortar and pestle. The eggs were mixed to achieve a homogeneous mixture and stored 
at -20°C. Participants received a beverage containing 18 g protein, 17 g fat, and 60 g carbohydrate 
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(50% sucrose: 50% maltodextrin blend) in a total volume of 400 mL water. The beverages were 
uniformly flavored by adding 1 mL of vanilla extract. The L-[5,5,5-2H3]leucine enrichment of 
these eggs fed to the participants was 21.2 MPE. In experiment 2, the intrinsically labeled L-
[5,5,5-2H3]leucine poultry meat was deboned and subsequently ground using a commercial meat 
grinder and stored at -20°C. The L-[5,5,5-2H3]leucine enrichment of the meat was 9.6 MPE. The 
ground poultry meat was thawed overnight in a refrigerator at 4° C. On the morning of the 
experiment, the 161 g ground chicken patty was prepared in a non-stick skillet until the inner 
temperature reached 65°C. Both participants ingested the meal within 10 min and were provided 
with 400 mL of water. Salt and pepper were added ad libitum. The protein content of the meal was 
28 g protein and 13 g fat. All isotopic enrichments of the intrinsically labeled food sources were 
determined by GC/MS analysis. 
 
Plasma analyses and muscle analyses 
Plasma amino acid concentrations and enrichments were determined by GC/MS analysis (Agilent 
7890A GC/5975C; MSD, Palo Alto, CA, USA). Briefly, plasma leucine enrichments were 
determined by ion monitoring at m/z 302 and 303 for unlabeled and labeled [1-13C]leucine, 
respectively; and m/z 302 and 305 for unlabeled and labeled L-[5,5,5-2H3]leucine, respectively. 
Plasma amino acid concentrations were determined by integrating amino acid peak areas in 
comparison to an internal standard (DL-p-chlorophenylalanine) using the AMDIS software 
package (v. 2.71, NISTTM) (17). Myofibrillar protein-enriched fractions were extracted from ~50 
mg of wet muscle. Myofibrillar protein enrichments were determined by 5500 QTRAP LC/MS/MS 
(Sciex, Framingham, MA). The L-[5,5,5-2H3]leucine enrichments of the myofibrillar protein 
bound samples were determined by multiple reaction monitoring (MRM) at m/z 132.0  86.0 and 
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135.0  89.0 for unlabeled and labeled L-[5,5,5-2H3]leucine, respectively. Software Analyst 1.6.2 
was used for data acquisition and analysis. For complete analysis details see Supplemental 
Methods. 
Calculations 
Whole-body amino acid kinetics were assessed in non-steady conditions by the ingestion of L-
[5,5,5-2H3]leucine eggs combined with IV infusion of L-[1-
13C]leucine. Total, exogenous, and 
endogenous rate of leucine appearance (Ra), and postprandial protein-derived leucine availability 
in the circulation (Leuplasma) were calculated using modified Steele’s equations (7, 10)  (see 
Supplemental Methods).  
 
Statistics 
Differences in tracer enrichment between the egg yolk and white were tested by a two-factor (time 
× treatment) analysis of variance (ANOVA) with repeated measures on the time factor. Differences 
between different meat cuts, organs, and bone tissue enrichments and concentrations were 
analyzed using a one-factor (condition) ANOVA. Time dependent differences in leucine Total Ra, 
Exo Ra, and Endo Ra as well as plasma enrichment were analyzed using a one-way repeated 
measures (time) ANOVA. When statistically significant interaction effects were observed, 
Bonferroni post hoc tests were performed to locate these differences. Statistical significance was 
set at P<0.05. Linear regression lines were fitted to the plasma L-[1-13C]leucine enrichments to 
assess the existence of any deviation in enrichment indicated by lines with a significant positive 
or negative slope (GraphPad Prism, version 6, La Jolla, CA). All calculations were performed 
using IBM SPSS Statistics (version 23, Chicago, IL, USA) unless otherwise designated. All data 
are expressed as mean ± SEMs.  
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3.4 Results 
Egg and poultry meat yield  
The hen-day egg production performance of the 3 hens was ~88 % over the 55 d feeding trial.  As 
such, a total of 145 labeled eggs (850 g of total protein) were produced over the 55 d protocol. A 
total of 322 g of poultry meat (absent of bone) was collected from the three hens resulting in 56 g 
of total meat protein. 
 
Egg and poultry organ tissue enrichments 
Consumption of the 0.3% L-[5,5,5-2H3]leucine enriched diet  increased the L-[5,5,5-
2H3]leucine 
enrichment in both the egg yolk and white during the 55 d protocol (Figure 1; P<0.001).  The L-
[5,5,5-2H3]leucine enrichments did not differ (P=0.30) between the egg yolk (22.8±1.0 MPE) and 
white (21.3±0.9 MPE). The rate of increase in L-[5,5,5-2H3]leucine enrichment over time did not 
differ between the egg yolk or white (P=0.42). Mean enrichment of the whole eggs was 22.0±0.9 
MPE. Based on the protein yield of the eggs (~850 g) and a measured leucine content of 8.9%, it 
was calculated 17 g of the 45 g of L-[5,5,5-2H3]leucine that was included in the diet was recovered 
in the eggs. This resulted in a tracer recovery of ~37 %. The L-[5,5,5-2H3]leucine enrichment of 
the various cuts of poultry meat are shown in Figure 2.  The L-[5,5,5-2H3]leucine enrichment of 
the collected poultry meat was 9.6 ± 0.1 MPE. Based on the protein yield of the meat (56 g) and 
an assumed leucine content of 7.8 % (2), the recovery of L-[5,5,5-2H3]leucine in the meat was 
calculated as ~1 %. The L-[5,5,5-2H3]leucine enrichment did not differ between the various meat 
cuts (P=0.57). However, as shown in Figure 3, the L-[5,5,5-2H3]leucine enrichments were 
different between the various collected organs. Specifically, the ovary was significantly different 
from the brain, large intestine, and gizzard (p<0.05); the oviduct was significantly different from 
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brain, and gizzard (p<0.05); the kidney was significantly different from gizzard (p<0.05); and the 
liver was significantly different from gizzard (p<0.05). The L-[5,5,5-2H3]leucine enrichments were 
different between the various collected bones with the highest enrichment observed in the femur’s 
marrow (P<0.001). 
 
Human plasma and muscle analysis 
Experiment 1: Plasma leucine concentrations increased after egg ingestion (P<0.05) (data not 
shown). Linear regression analysis indicated that the slopes of the plasma L-[1-13C]leucine 
enrichment over time curve were not different from zero (P=0.88) (data not shown). Plasma L-
[5,5,5-2H3]leucine enrichments trended (P=0.08) towards a gradual increase after egg ingestion 
with values peaking at 90 min (6.7±0.1 MPE) and thereafter enrichments declined during the late 
postprandial period (Figure 4A). Exogenous (dietary) leucine Ra increased rapidly after 
intrinsically-labeled egg ingestion with peak values obtained at 90 min and declined during the 
remaining postprandial phase (Figure 5). The total amount of egg protein-derived leucine that 
became available in systemic circulation after first-pass splanchnic extraction during the 5 h 
postprandial period was 71±4%. The endogenous leucine Ra in plasma decreased during the 
postprandial phase (data not shown). The incremental change in myofibrillar protein-bound L-
[5,5,5-2H3]leucine enrichment during the 0-300 min postprandial period after egg ingestion was 
0.051±0.008 MPE. Experiment 2: Plasma leucine concentrations increased after meat ingestion 
(P<0.05) (data not shown). Plasma L-[5,5,5-2H3]leucine enrichment gradually increased after the 
consumption of meat, however the data did not reach statistical significance (P=0.38). Peak 
enrichment values were obtained at 120 min (4.0±0.9 MPE) after which values declined during 
the late postprandial phase (Figure 4B). 
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3.5 Discussion 
Our work shows that intrinsically L-[5,5,5-2H3]leucine labeled eggs and meat can be produced by 
adding L-[5,5,5-2H3]leucine to the feed of laying hens. Moreover, egg proteins with L-[5,5,5-
2H3]leucine enrichments of >20 MPE were produced and allowed for the assessment of 
postprandial release of dietary protein derived leucine and subsequent postprandial muscle protein 
accretion from the ingested food source 
It is important to note that the rate of tracer recovery in the eggs was calculated to be ~37%, 
which is a 0.5 fold greater tracer recovery than previously reported by workers producing 
intrinsically labeled milk proteins using either L-[1-13C]phenylalanine (25, 29) or L-[1-13C]leucine 
(6).  We suspect that the use of leucine, which is relatively more abundant in egg (2) and tissue 
protein mass compared to phenylalanine (3), could have increased the incorporation of the tracer 
into the in vivo proteins. Moreover, our calculated tracer recovery of ~37% was similar to others 
who provided a diet low in unlabeled leucine to egg laying hens (i.e. ~40%) (11), but is greater 
than those who provided free leucine tracer on top of the normal diet (i.e. ~20%) (21). Since excess 
dietary amino acids are preferentially oxidized (15), we suspect substituting the tracer for 
unlabeled leucine resulted in decreased rates of oxidation and irreversible loss of tracer. In 
addition, oral consumption of tracer (as opposed to IV administration) presumably allowed us to 
increase recovery of L-[5,5,5-2H3]leucine into the eggs. Specifically, oral consumption of tracer 
results in first pass uptake of tracer by hepatic tissue when compared to I.V. tracer administration. 
Since certain components of the egg are partly produced in the liver prior to transport to the ovary 
(4), this could have further contributed to the high(er) recovery of tracer in the egg protein 
compared to milk proteins (10, 12, 23). Importantly, the modified diet did not impair egg 
production performance (90%) or the mean weight of the eggs (~52 g), which is considered a 
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typical egg weight for the Lohmann LSL White strain (27). Therefore, meeting the dietary amino 
acid requirements of laying hens by adding tracer to the diet represents an efficient means to 
maximize tracer recovery into protein and thus allowed for the production of highly enriched and 
nutritionally complete dietary egg proteins. 
In this study, we only recovered ~1% of tracer in the meat, which is lower than previous reports 
for the production of labeled beef via IV administration of tracer (i.e. ~6% recovery rate) (25). 
Indeed, the researchers used larger quantities and IV administration of tracer in the cows, which 
collectively would have allowed for greater relative amounts of tracer to be delivered to and 
subsequently taken up by skeletal muscle tissue given the ability to circumvent first pass uptake 
of the tracer by splanchnic tissue. In addition, the Lohmann LSL White strain are not birds bred 
for their meat, and thus would generally have a lower overall skeletal muscle mass and presumably 
lower rates of protein turnover compared to other chicken strains (Cornish and White Rock cross 
broilers) (18). Nevertheless, we still observed a muscle tissue enrichment of 9.6±0.1 MPE, which 
would be suitable for use in human metabolic research. 
As shown in Figure 3, there were differences in L-[5,5,5-2H3]leucine enrichment between the 
sampled organs of the laying hens. The tracer enrichments in the ovary and oviduct were amongst 
the highest of the sampled organs with L-[5,5,5-2H3]leucine enrichments of 24.0±0.2 and 24.0±0.5 
MPE, respectively. This is not surprising considering that the egg is fully matured in these tissues 
(4). L-[5,5,5-2H3]leucine enrichment was also found to be particularly high in the kidneys. This is 
representative of increased renal metabolic activity during the egg laying cycle as a mechanism to 
meet the increased calcium demand of egg-shell formation (12). In Table 1, we showed 
enrichment of L-[5,5,5-2H3]leucine in the bones of the laying hens. Although bone turnover is 
elevated during the laying cycle of the hens to meet the calcium demand of the egg shell (22), it is 
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well documented that avian bone turns over at a slower rate when compared to skeletal muscle 
tissue and the various cardiovascular (heart and lungs), digestive (intestines, liver and pancreas), 
excretory (liver and kidney) and reproductive (ovary and oviduct) organs (16). Caging of the hens 
likely further contributed to the low L-[5,5,5-2H3]leucine enrichment in the bones as limiting the 
hen’s activity would result in reduced loading of the bone (31) and consequently a reduced 
stimulus for bone remodeling. Not surprisingly, we observed high L-[5,5,5-2H3]leucine enrichment 
in the marrow of the femur (22.6±0.7 MPE) (Table 1). This is indicative of its hemopoietic 
activity, which involves the rapid synthesis of various blood proteins (20). 
In human proof-of-principle experiment 1, we showed that the ingestion of intrinsically L-
[5,5,5-2H3]leucine labeled eggs (21.2 MPE) resulted in rapid increase in postprandial L-[5,5,5-
2H3]leucine enrichment in the plasma (Figure 4A). Combining intrinsically labeled egg ingestion 
with primed continuous IV infusion of L-[1-13C]leucine allowed us to determine the postprandial 
release of dietary protein derived leucine in the circulation, which provides insight into the dietary 
protein digestion and absorption kinetics of the ingested food source. The percentage of the total 
amount of egg protein-derived leucine that makes it past first-pass splanchnic extraction and 
appeared in circulation throughout the 0-5 h postprandial period was 71±4%. This amount is 
similar to ingestion of other high quality protein sources such as whey and casein (10). In addition, 
we demonstrated that the ingestion of highly labeled eggs (21.2 MPE) would allow for the 
assessment of postprandial muscle protein accretion from the ingested food source independent of 
IV tracer infusions. Previously, this approach has only been performed with highly labeled (>30 
MPE) milk-derived proteins (8, 14, 19, 24, 29, 30). Such an approach would be advantageous in 
populations or settings where continuous IV infusions may not be easily applied (e.g. elderly, 
clinical populations, nutrition field studies).  
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In experiment 2, we showed that the ingestion of intrinsically L-[5,5,5-2H3]leucine labeled 
meat (9.6 MPE) resulted in an increase in postprandial L-[5,5,5-2H3]leucine enrichment in the 
plasma (Figure 4B). No attempt was made to ‘trace’ meat protein-derived L-[5,5,5-2H3]leucine 
into skeletal muscle as the  level of enrichment in the meat (9.6 MPE) would presumably be too 
low to enable its precise detection into skeletal muscle proteins. From a practical perspective, we 
have demonstrated the possibility producing labeled poultry meat to be used in human nutritional 
research to assess whole body protein kinetics. However, the meat protein yield per chicken is low 
(~19 g protein) and, as such, requires larger scale protocol consisting of multiple chickens to 
produce a larger meat protein yield for use in a larger scale human trial.  
In conclusion, we demonstrated the feasibility of producing intrinsically labeled eggs and meat 
for use in human metabolic research. A potential strong point of intrinsically labeled egg 
production is the relatively high tracer recovery rate, which allows for the production of highly 
enriched food proteins that can be produced at reasonable price point. This metabolic tracer “tool” 
of a gold standard reference protein (i.e. egg) could be applied to a variety of populations to 
advance our knowledge of the optimal nutritional factors that enhance whole body and muscle 
protein metabolism in humans. 
 
  
 
114 
 
3.6 Tables 
Table 3.1  Bone L-[5,5,5-2H3]leucine enrichment of Lohmann LSL White laying hens
1 
Bone Enrichment (MPE) 
Femur 3.0±0.6a 
Femur Marrow 22.6±0.7b 
Ilium 2.3±0.2a 
Tibia 2.9±0.7a 
Radius 2.9±0.7a 
 
1Values are means ± SEMs, n=3. Labeled means in a column without a common letter differ 
(P<0.001). MPE; mole percent excess. 
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3.7 Figures 
Figure 3.1 
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L-[5,5,5-2H3]leucine incorporation into the yolk and white protein fraction of laying hens 
(Lohmann LSL Whites) consuming a diet supplemented with 0.3% L-[5,5,5-2H3]leucine for 55 d. 
Values are means ± SEMs, n=3. *Different from d 0 (P<0.05). MPE, mole percent excess. 
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Figure 3.2 
 
L-[5,5,5-2H3]leucine enrichment of the various meat cuts and whole egg enrichment of laying 
hens(Lohmann LSL Whites) consuming a diet supplemented with 0.3% L-[5,5,5-2H3]leucine for 
55 d. Values are means ± SEMs, n=3. Labeled means without a common letter differ significantly 
(P<0.01). MPE, mole percent excess. 
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Figure 3.3 
L-[5,5,5-2H3]leucine enrichment of various organ tissue of laying hens (Lohmann LSL Whites) 
consuming a diet supplemented with 0.3% L-[5,5,5-2H3]leucine for 55 d. Values are means ± 
SEMs, n=3. Labeled means without a common letter differ significantly (P<0.05). MPE, mole 
percent excess. 
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Figure 3.4 
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Plasma L-[5,5,5-2H3]leucine enrichment in the postabsorptive state and after consumption of 
intrinsically-labeled eggs (A; Experiment 1) or meat (B; Experiment 2) in healthy young men. 
Values are means ± SEMs, n=2 per experiment. The dashed line refers to food ingestion. A 
(Experiment 1): P=0.08. B (Experiment 2): P=0.38. MPE, mole percent excess. 
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Figure 3.5 
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Exogenous leucine Ra in the postabsorptive state and after consumption of intrinsically-labeled 
eggs in healthy young men. Values are means ± SEMs, n=2. The dashed line refers to food 
ingestion. Data were analyzed using a one-way repeated measures (time) ANOVA. P=0.08. Ra, 
rate of appearance. 
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3.9 Supplemental methods 
Egg and tissue enrichment analysis 
The egg white and yolk protein bound L-[5,5,5-2H3]leucine enrichments were determined by 
adding a portion of the egg white or yolk to 500 μL of 0.6 м of ice-cold perchloric acid (PCA). 
The mixture was vortexed, centrifuged, and the supernatant was removed. The egg white and yolk 
protein pellets were washed with additional 0.6 м PCA. Subsequently, the egg protein pellets were 
washed with 500 µL of ethanol and lyophilized to dryness. The tissue protein bound L-[5,5,5-
2H3]leucine enrichments were determined from ~30 mg of wet weight meat, organ and bone tissue 
by homogenizing on ice using a Teflon pestle with 500 µL of 0.6 м PCA. The 30 mg wet tissue 
was randomly selected from the overall meat, organ, and bone mass. Samples were centrifuged 
and the supernatant was removed. The meat, organ, and bone protein pellets were washed, 
centrifuged, and lyophilized. The resulting freeze-dried protein pellets were hydrolyzed overnight 
at 110°C with 1.5 mL of 6 м hydrochloric acid (to liberate the amino acids. The free amino acids 
were purified using a selective filter, dried under vacuum, and re-suspended in 100 µL of pyridine 
to separate from inorganics. The obtained solution was dried under vacuum and derivatized with 
50µL of neat MTBSTFA+1%TBDMCS (Campbell Sci., Rockford, IL, USA) and 50 µL of 
acetonitrile (Fisher Sci., Fair Lawn, NJ, USA) for 4 h at 80°C. 3 L of sample was injected in split 
mode (10:1) into the GC/MS system consisting of an Agilent 7890 (Agilent Inc., Palo Alto, CA, 
USA) gas chromatograph, an Agilent 5975 mass selective detector and Agilent 7683B autosampler 
in Metabolomics Lab of Roy J. Carver Biotechnology Center, University of Illinois at Urbana-
Champaign. Protein bound L-[5,5,5-2H3]leucine enrichment of the samples were determined by 
selective ion monitoring for leucine mass-to-charge (m/z) ratio at 302 (m+0) and 305 (m+3). 
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Plasma analyses 
Plasma amino acid concentrations and enrichments were determined by GC/MS (Agilent 7890A 
GC/5975C; MSD, Palo Alto, CA, USA) in Metabolomics Lab of Roy J. Carver Biotechnology 
Center, University of Illinois at Urbana-Champaign. Plasma (200 µL) was extracted using 1 mL 
of a single phase mixture of isopropanol:acetonitrile:water (3:3:2, v/v) and was centrifuged for 10 
min at 4ºC. Subsequently, the supernatant was dried and the amino acids were converted into 
TBDMCS derivatives before analysis by GC/MS.  
 
Muscle analyses 
Myofibrillar proteins were extracted from ~50 mg of wet muscle by hand-homogenizing in ice-
cold homogenization buffer (10 µL∙mg-1) using a Teflon pestle. Homogenates were centrifuged at 
2000 × g for 10 min at 4ºC. The resultant supernatant was removed and the pellet was washed with 
500 µL distilled water. Subsequently, the samples were centrifuged at 700 × g for 10 min at 4ºC. 
The remaining myofibrillar proteins pellet was solubilized by adding 1 mL of 0.3 м NaOH and 
heating at 50ºC for 30 min with vortex mixing every 10 min. Samples were centrifuged at 10000 
× g for 5 min at 4ºC. The supernatant containing the myofibrillar enriched protein fraction was 
collected and the collagen pellet was discarded. Myofibrillar proteins were precipitated by adding 
1 mL of 1 м PCA and centrifuging at 2500 × g for 10 min at 4ºC. The myofibrillar protein pellet 
was washed twice with 70% ethanol. The amino acids were liberated by adding 2 mL of 6 м HCL 
and heating overnight at 110°C. The free amino acids were purified using cation exchange 
chromatography (Dowex 50W-X8-200 resin; Acros Organics, Geel, Belgium) before analysis by 
5500 QTRAP LC/MS/MS (Sciex, Framingham, MA) in Metabolomics Lab of Roy J. Carver 
Biotechnology Center, University of Illinois at Urbana-Champaign. The samples were dried and 
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re-suspended in 100 μL 60% methanol and centrifuged. Subsequently, samples were injected (5 
μL) and the LC separation was performed on a Thermo Hypercarb column (4.6 × 100 mm, 5 μm) 
with mobile phase A (0.1% formic acid in water) and mobile phase B (0.1% formic acid in 
acetontrile). The flow rate was 0.4 mL/min. Mass spectra were acquired under 
positive electrospray ionization (ESI) with the ion spray voltage at +5500 V.  The source 
temperature was 450 °C. The curtain gas, ion source gas 1, and ion source gas 2 were 35, 65, and 
55 psi, respectively. The L-[5,5,5-2H3]leucine enrichments of the myofibrillar protein bound 
samples were determined by multiple reaction monitoring (MRM) at m/z 132.0  86.0 and 135.0 
 89.0 for unlabeled and labeled L-[5,5,5-2H3]leucine, respectively. Software Analyst 1.6.2 was 
used for data acquisition and analysis.  
 
Calculations 
Total, exogenous, and endogenous rate of leucine appearance (Ra), and postprandial protein-
derived leucine availability in the circulation (Leuplasma) were calculated using modified Steele’s 
equations (1, 2). The specific equations used to calculate leucine fluxes were as follows: 
 
Total Ra =
Fiv - [pV × C(t)leu × 
dEiv
dt
]
Eiv(t)
               (1) 
Exo Ra =
Total Ra × Epo(t) + [pV × C(t)leu × 
dEpo
dt
]
Eprot
   (2) 
Endo Ra = Total Ra-Exo Ra-Fiv    (3) 
Leuplasma = (
AUCExo Ra
Leuprot
) × BW × 100   (4) 
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Total Ra is the appearance rate of total leucine calculated with the IV tracer (μmol · kg
-1 · min-1); 
where Fiv is the IV tracer infusion rate (0.13 µmol ∙ kg
-1 ∙ min-1); pV (0.125 L/kg-1) is the 
distribution volume (1); C(t) is the mean plasma leucine concentration between two consecutive 
time points (μmol · kg-1); dEiv/dt represents the time-dependent variations in plasma leucine 
enrichment (mole percent excess) derived from the IV tracer; and Eiv(t) is the mean plasma leucine 
enrichment (mole percent excess) derived from the IV tracer between two consecutive time points.  
Exo Ra is the plasma entry rate (μmol · kg
-1 · min-1) of dietary protein-derived leucine after first-
pass splanchnic extraction; Epo(t) is the mean plasma leucine enrichment based on the oral tracer 
between two consecutive time points (mole percent excess); dEpo/dt is the time-dependent 
variations of plasma leucine enrichment derived from the oral tracer (mole percent excess) ; and 
Eprot is the L-[5,5,5-
2H3]leucine enrichment of the dietary protein (21.2 mole percent excess). Endo 
Ra is the entry rate of endogenous leucine from whole body protein breakdown (μmol · kg
-1 · min-
1); Leuplasma represents the fraction of dietary leucine that appeared in circulation (%); where 
AUCExoRa represents the area under the time curve (AUC) of Exo Ra, which indicates the amount 
of dietary protein-derived leucine that appeared in the circulation during the 5 h postprandial 
period; Leuprot is the amount of dietary leucine  (11992 µmol) ingested and BW is the participants’ 
body weight (kg).  
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3.10 Supplemental tables 
Supplemental table 3.1. Diet of laying hens1. 
Ingredient g·kg-1 
Wheat 310.4 
Barley 269.7 
Sucrose 120.4 
Limestone 90.0 
Sunflower Meal 67.2 
Glutamic Acid 50.0 
Soybean Oil 40.0 
Dicalcium Phosphate 14.0 
L-Lysine-HCl 5.50 
Sodium Chloride 5.00 
Glycine 4.00 
L-Isoleucine 3.60 
DL-Methionine 3.50 
L-Valine 3.20 
L-[5,5,5-2H3]leucine  3.00 
L-Arginine 2.10 
Vitamin Mix2 2.00 
L-Phenylalanine 1.50 
Mineral Mix3 1.50 
L-Tryptophan 0.70 
1Diet provided to Lohmann LSL White laying hens during 55d feeding period, N=3.2 Provided per kg of diet: retinyl 
acetate, 4400 IU; cholecalciferol, 25 g; d,l--tocopheryl acetate, 11 IU; vitamin B12, 0.01 mg; riboflavin, 4.41 mg; 
D-Ca-pantothenate, 10.00 mg; niacin, 22.00 mg; menadione sodium bisulfite, 2.33 mg.3 Provided as mg per kg of diet: 
Mn, 75.00 from MnO; Fe, 75.00 from FeSO4∙7H2O; Zn, 75.00 from ZnO; Cu, 5.00 from CuSO4∙5H2O; I, 0.75 from 
ethylene diamine dihydroiodide; Se, 0.10 from Na2SeO3 
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CHAPTER 4: CONSUMPTION OF WHOLE EGGS PROMOTES GREATER 
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4.1 Abstract 
Background: Protein in the diet is commonly obtained from whole foods that contain various 
macro- and micro-nutrients. However, the effect of consuming protein within its nature food 
matrix on postprandial protein metabolism remains understudied in humans.  
Objective: We aimed to compare the whole body and muscle protein metabolic responses after 
consumption of whole eggs versus egg whites during exercise recovery in young males. 
Design: In crossover trials, 10 resistance-trained males (21±1 y; 88±3 kg; body fat: 16±1%) 
received primed continuous L-[ring-2H5]phenylalanine and L-[1-
13C]leucine infusions and 
performed a single bout of resistance exercise. After exercise, participants consumed intrinsically 
L-[5,5,5-2H3]leucine-labeled whole eggs (18 g protein, 17 g fat) or egg whites (18 g protein, 0 g 
fat). Repeated blood and muscle biopsies were collected to assess whole body leucine kinetics, 
intramuscular signaling, and myofibrillar protein synthesis. 
Results: Plasma appearance rates of protein-derived leucine was more rapid after consumption of 
egg whites than whole eggs (P=0.01). Total plasma availability of leucine over the 300 min 
postprandial period was similar (P=0.75) between ingestion of whole eggs (68±1%) and egg 
whites (66±2%) with no difference in whole body net leucine balance (P=0.87). Both whole egg 
and egg white conditions increased the phosphorylation of mammalian target of rapamycin 
complex 1, ribosomal protein S6 kinase 1, and eukaryotic translation initiation factor 4E-binding 
protein 1 during postexercise recovery (all P<0.05). However, whole egg ingestion increased the 
postexercise myofibrillar protein synthetic response to a greater extent than ingestion of egg whites 
(P=0.04). 
Conclusions: We show that the ingestion of whole eggs immediately after resistance exercise 
stimulates a greater stimulation of myofibrillar protein synthesis than the ingestion of egg whites 
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despite being matched for protein content in young males. Our data indicate that the ingestion of 
nutrient and protein dense foods differentially stimulate muscle anabolism versus protein centric 
foods.   
 
4.2 Introduction 
Dietary patterns that include the regular ingestion of high quality protein-dense foods are important 
to optimize the stimulation of postprandial muscle protein synthesis rates to augment skeletal 
muscle remodeling. Protein quality in human nutrition can be, at least partly, based on the 
bioavailability of dietary protein-derived amino acids in circulation to support whole body and 
muscle protein metabolic need. For example, studies have shown that various meal characteristics, 
such as protein source (9, 26) and ingested protein quantity (32), can influence the amount of 
dietary protein-derived amino acids available in circulation to stimulate postprandial muscle 
protein synthesis rates. However, most work has focused on the effects of consuming isolated 
protein fractions (e.g., dairy-based whey and casein and plant-based soy) dissolved in liquid 
beverages (7, 9, 12, 18, 19, 26-28, 34, 35, 41) with far less known about how the ingestion of 
nutrient- and protein-dense whole foods impact postprandial protein metabolism. This is 
significant as the ingestion of nutrient-dense whole foods, as compared to supplemental protein 
sources, is far a more common approach to achieve daily protein recommendations while 
concomitantly improving diet quality. 
To better define whole food protein quality in human nutrition, we developed intrinsically L-
[5,5,5-2H3]leucine eggs to allow for the detailed assessment of postprandial whole body and 
skeletal muscle protein metabolism in vivo in humans (44). Eggs are a nutritionally complete food 
source and commonly consumed at breakfast by U.S. adults (2). However, the removal of the yolk 
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is often promoted for improved health when multiple eggs are consumed. This an unsubstantiated 
belief related to the cholesterol and fat content of an egg yolk (25). The yolk is nutrient dense and 
contains nearly half of the total protein found in the egg and, as such, its removal is 
counterintuitive. Since nutrient-dense protein foods are often recommended to achieve protein 
recommendations (33), it is important to define how the ingestion of nutritionally complete and 
protein-dense foods modulates protein metabolism under a setting that includes other components 
of a healthy lifestyle (i.e., incorporation of regular exercise). 
Therefore, the purpose of this study was to compare whole body leucine kinetics and 
postprandial myofibrillar protein synthesis rates after the ingestion of whole eggs and 
isonitrogenous amounts of egg whites during recovery from resistance exercise in young males. In 
addition, we examined skeletal muscle amino acid transporter protein content and the 
phosphorylated-state of protein signaling molecules that may regulate changes in myofibrillar 
protein synthesis rates (15). We hypothesized that whole egg ingestion will delay the appearance 
rates of postprandial protein-derived amino acids in circulation, but will not modulate plasma 
amino acid availability or myofibrillar protein synthesis rates throughout a 0-300 min recovery 
period when compared to egg white ingestion in healthy young males.   
 
4.3 Methods 
Participants and ethical approval 
Ten healthy young males (mean ± SEM: age: 21±1 y) who were regularly engaged in structured 
resistance exercise training (mean ± SEM: training years: 5±1 y) volunteered for the study. 
Participant characteristics are presented in Table 1. All participants were deemed healthy based 
on responses to a routine medical screening questionnaire and had no prior history of participating 
 
135 
 
in stable isotope amino acid tracer experiments. All participants were informed about the 
experimental procedures to be used, the purpose of the study, and all potential risks before giving 
written consent. The study was approved by the Institutional Review Board at University of Illinois 
at Urbana-Champaign and conformed to standards for the use of human participants in research as 
outlined in the seventh revision of the Declaration of Helsinki.  
 
Experimental design 
A within-subject crossover design was used for this study. At least one week before the first 
infusion trial, participants reported to the laboratory for familiarization with the exercise 
equipment and for maximum strength testing as determined by their ten-repetition maximum (10-
RM) for leg press and leg extension. In addition, body weight and height were measured as well 
as body composition by dual-energy X-ray absorptiometry (Hologic QDR 4500A, Bedford, MA, 
USA). On a separate occasion, at least 3 d after initial maximum strength testing and at least 3 d 
before the first infusion trial, participants re-visited the lab to confirm their 10-RM for leg press 
and leg extension. The 10-RMs for leg press and leg extension (233±32 kg and 112±10 kg, 
respectively; means ± SEM) were used to set the workload for the infusion trials. Participants were 
instructed to refrain from vigorous physical activity for 3 d prior to each trial and to record their 
dietary intake using online food tracker (MyFitnessPal™) for 2 d before each trial. Participants 
were subsequently instructed to follow their food dairy as closely as possible during the 2 d leading 
into the second infusion trial while recording their dietary intake again. Average 2 d macronutrient 
intake was similar between the whole egg and egg whites trials (P=0.16) (Supplemental Table 
1). Participants were counterbalanced in random fashion to consume either whole eggs or egg 
whites for their first infusion trial. The time between crossover trials was 7-14 d (8±1 d). 
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Infusion protocol   
On both infusion trials, participants reported to the laboratory at 0700 h after an overnight fast. 
After collecting a baseline breath sample, a Teflon catheter was inserted into an antecubital vein 
for baseline blood sample collection (t=-210 min) and participants received priming doses of 
NaH13CO2 (2.35 mol·kg
-1), L-[1-13C]leucine (7.6 µmol·kg-1), and L-[ring-2H5]phenylalanine (2.0 
µmol·kg-1). Subsequently, a continuous intravenous infusion of L-[1-13C]leucine (0.10 µmol·kg-
1·min-1) and L-[ring-2H5]phenylalanine (0.05 µmol·kg
-1·min-1) was initiated (t=-210 min) and 
maintained over the infusion trials. A second Teflon catheter was inserted into a heated dorsal hand 
vein for repeated arterialized blood sampling and remained patent by a 0.9% saline drip. In the 
postabsorptive state of infusion trial 1, muscle biopsies were collected at t=-150 and -30 min of 
infusion to determine fasted myofibrillar protein synthesis rates, relative skeletal muscle amino 
acid transporter content, and anabolic-related signaling. In the subsequent cross-over trial only 1 
muscle biopsy was collected at t=-30 for anabolic-related signaling analysis and postabsorptive 
myofibrillar protein-bound tracer enrichment. After collection of the resting muscle biopsy at t=-
30 for both trials, the participants performed resistance exercise that consisted of 4 sets of 10 
repetitions at 80% of 10-RM for both leg press and leg extension exercise. The exercise external 
work (repetitions × load) was matched between the whole egg (9896 ± 52 kg) and egg whites trials 
(9893 ± 52 kg) (P=0.34). Immediately after completion of the exercise bout, participants consumed 
3 whole eggs or an equivalent amount of protein from egg whites (t=0 min). Participants were also 
provided 300 mL of water to consume with the meal. Completion of the meal marked the start of 
the postprandial phase (t=0 min) and additional muscle biopsies were collected at t=120 and 300 
min. Biopsies were collected from the middle region of the vastus lateralis (15 cm above the 
patella) with a Bergström needle modified for suction under local anesthesia (2% Lidocaine). The 
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postabsorptive muscle biopsies on trial 1 were collected from the same incision with the needle 
pointed to distal and proximal directions, respectively. The muscle biopsies obtained at t=120 and 
300 min of post-exercise recovery were collected from the contralateral leg through separate 
incisions (2-3 cm apart). All muscle biopsy samples were freed from any visible blood, adipose, 
and connective tissue immediately frozen in liquid nitrogen, and stored at -80˚C until subsequent 
analysis. Breath samples and arterialized blood samples and were collected every 30 or 60 min 
during the postabsorptive- and postprandial states. Total CO2 production rates were measured with 
a metabolic cart (TrueOne 2400, ParvoMedics, Sandy, UT) at regular intervals throughout the 
infusion trials. The blood samples were immediately analyzed for whole blood glucose 
concentrations (2300 Stat Plus, YSI Life Sciences, Springs, OH) and subsequently centrifuged at 
3000 × g for 10 min at 4°C. Aliquots of plasma were frozen and stored at -80°C until subsequent 
analysis. The breath samples were collected in 10 mL Vacutainers and stored at 20°C until 
subsequent determination of 13CO2 enrichment by isotope ratio mass spectrometry (IDmicro 
Breath, Compact Science Systems Ltd, Newcastle-Under-Lyme, UK).  
 
Meal composition 
The intrinsically L-[5,5,5-2H3]leucine labeled eggs were produced by supplementing the diet 
of laying hens (Lohmann LSL Whites) with 0.3% L-[5,5,5-2H3]leucine as described previously 
(44). A portion of the collected eggs had the yolks removed prior to storage at -20°C in aliquots of 
18 g protein. The other portion of eggs had the yolks and whites completely mixed prior to storage 
in aliquots of isonitrogenous amounts. The L-[5,5,5-2H3]leucine enrichment of the whole egg and 
egg white aliquots were determined by gas chromatography mass spectrometry (GC-MS) and 
averaged 28.6 and 26.1 mole percent excess (MPE), respectively. Proximate analyses for protein, 
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lipid, and carbohydrate concentrations were determined by using the combustion method (method 
990.03; AOAC International, 2000; TruMac; LECO Corp., USA) (44). Leucine content of the 
whole egg and egg white aliquots were determined by GC-MS with integration of amino acid peak 
areas compared to an internal standard (DL-p-chlorophenylalanine) using the AMDIS software 
package (v. 2.71; NIST) (23). Before the infusions, the egg aliquots were thawed overnight in a 
refrigerator at 4°C. On the morning of the experiment, the whole egg or whites were scrambled in 
a skillet until solid with no visible liquid remaining. The macronutrient composition and energy 
content was 18 g protein (1.57 g leucine), 17 g fat, and 226 kcals for the whole eggs and 18 g 
protein (1.60 g leucine), 0 g fat, and 73 kcals for the egg white treatments.  
 
Plasma analyses  
Plasma insulin concentrations were determined using a commercially available enzyme-linked 
immunosorbent assays (Alpco Diagnostics; Salem, NH). Plasma triglyceride concentrations were 
determined using a point-of-care chemistry analyzer (Piccolo Xpress Chemistry Analyzer, Abaxis, 
Union City, CA). Plasma amino acid concentrations and enrichments were determined by GC-MS 
analysis (Agilent 7890A GC/5975C; MSD, Little Falls, DE) as described in our previous work 
(44). Briefly, plasma samples were prepared for amino acid analysis using a mixture of 
isopropanol:acetonitrile:water (3:3:2, v/v) and centrifuged at 20000 × g for 10 min at 4ºC. 
Subsequently, the supernatant was dried and the amino acids converted into tert-butyldimethylsilyl 
(t-BDMS) derivatives prior to GC-MS analysis. Plasma L-[1-13C]leucine and L-[5,5,5-2H3]leucine 
enrichments were determined by ion monitoring at mass/charge (m/z) ratios 302 (m+0), 303 (m+1), 
and 305 (m+3) with m+0 representing the lowest molecule weight of the ion or unlabeled leucine. 
For L-[ring-2H5]phenylalanine, m/z 336 (m+0) and 341 (m+5) were monitored for unlabeled and 
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labeled phenylalanine, respectively. Plasma enrichment of the t-BDMS derivative of -[13C]-
ketoisocaproate (-KIC) was measured by GC-MS analysis by ion monitoring at mass/charge 
(m/z) ratios m/z 232 and 233. The plasma leucine concentrations were determined by integrating 
amino acid peak areas in comparison to U-[13C6]leucine as an internal standard with the use of the 
AMDIS software package (v. 2.71; NIST) (23). 
 
Muscle analysis 
Myofibrillar protein-enriched fractions were isolated from ~50 mg of wet tissue as described 
previously (44).  Myofibrillar-enriched protein pellets were hydrolyzed overnight in 6 м HCL at 
110°C. The resultant free amino acids were purified using cation exchange chromatography 
(Dowex 50W-X8-200 resin; Acros Organics, Geel, Belgium) and dried under vacuum. Free amino 
acids were re-suspended in 60% methanol and centrifuged before the myofibrillar protein-bound 
enrichments were determined by 5500 QTRAP liquid chromatography-tandem mass spectrometry 
(LC/MS/MS; Sciex, Framingham, MA). The myofibrillar protein-bound L-[ring-
2H5]phenylalanine enrichments were determined by multiple reaction monitoring (MRM) at m/z 
166.0  103.0 and 171.0  106.0 for unlabeled and labeled L-[ring-2H5]phenylalanine, 
respectively. Muscle intracellular free amino acids were extracted from a separate piece of wet 
muscle (~30 mg) using a Teflon-coated pestle and ice-cold 2% PCA and then centrifuged at 10000 
× g at 4˚C for 10 min. The supernatant was then collected and this process was repeated 2 more 
times. The supernatant was taken as the muscle intracellular free amino acids and subsequently 
purified using cation exchange chromatography (Dowex 50W-X8-200 resin; Acros Organics, 
Geel, Belgium) before analysis by LC/MS/MS. Muscle intracellular free L-[1-13C]leucine and L-
[5,5,5-2H3]leucine enrichments were measured by MRM at m/z 132.0  86.0, 133.0  87.0 and 
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135.0  89.0 for unlabeled and labeled leucine. For L-[ring-2H5]phenylalanine enrichments, 
MRM at171.0  106.0 for unlabeled and labeled phenylalanine were measured. Sciex Software 
Analyst 1.6.2 was used for data acquisition and analysis. 
 
Western Blotting 
A portion of whole muscle homogenates isolated during the myofibrillar protein extractions 
was used for Western Blotting analysis. The protein concentrations of the homogenates were 
determined by BCA protein assay (Thermo Fisher Scientific, Rockford, IL) and then used to 
prepare working samples of equal concentrations in Laemmli buffer and heated to 95°C for 5 min. 
Equal amounts of protein (10μg) were separated by SDS-PAGE and transferred to nitrocellulose 
membrane (wet transfer, 100V for 60 min) for antibody incubation. Membranes were blocked in 
5% fat-free milk at room temperature for 60 min, washed in Tris-buffered saline with 0.1% Tween 
20 (TBST) and incubated in primary antibody (Cell Signaling Technology; 1:1000) overnight at 
4°C to determine phosphorylation status of AMPKα at Thr172 (cat. 2535), mTOR at Ser2448 (cat. 
2971), ERK at Thr202/Tyr204 (cat. 4377), 4E-BP1 at Thr37/46 (cat. 9459), and eEF2 at Thr56 
(cat. 2331). The antibodies (Abcam; 1:1000) used to determine the relative protein content of 
skeletal muscle amino acid transporters were large neutral amino acid transporter small sub unit 1 
(SLC7A5/LAT1) (cat. ab85226), SLC3A/CD98 (cat. ab96721), and sodium-coupled neutral 
amino acid transporter 2 (SLC38A2/SNAT2) (cat. ab90677). Following overnight incubation of 
the primary antibody (4°C), membranes were then washed (3 x 5 min TBST), incubated in 
secondary antibody for 60 min at room temperature (1:20000 in 3% fat-free milk), and washed (3 
x 5 min TBST), prior to the detection with chemiluminescence (Millipore; cat. WBKLS0500). To 
determine the phosphorylation status of p70S6K1 at Thr389 (cat. 9205), 25ug of protein was 
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loaded followed by incubation in primary (overnight, 1:1000 in 5% bovine serum albumin) and 
secondary antibody (1:5000 in 5% fat-free milk). Bands were imaged using FluorChem E Imaging 
System (Protein Simple; Alpha Innotech, Santa Clara, CA). Bands were quantified using 
AlphaView SA software (Protein Simple) and normalized to Ponceau S staining; this approach has 
been validated as an alternative loading control (e.g., α-actin) for Western Blot analysis (36, 37). 
Calculations 
Whole-body leucine kinetics were assessed under non-steady conditions by the ingestion of L-
[5,5,5-2H3]leucine eggs combined with intravenous infusion of L-[1-
13C]leucine.Leucine 
oxidation was calculated from the appearance of the 13C-label in the expired CO2 using the -KIC 
reciprocal pool model with fractional bicarbonate retention factors of 0.7 and 0.83 for 
postabsorptive and postprandial states, respectively (22). For the other leucine fluxes, calculations 
were performed using the plasma L-[5,5,5-2H3]leucine and L-[1-
13C]leucine enrichments and 
leucine concentrations. Total, exogenous, and endogenous leucine rates of appearance (Ra) and 
total leucine rates of disappearance (Rd) were calculated with the use of modified Steele equations 
(8, 14). Furthermore, plasma protein-derived leucine availability, total leucine oxidation, non-
oxidative leucine disposal (NOLD), whole body leucine net balance, and whole body leucine 
retention were calculated (see Supplemental Methods for more details on calculations) (8, 14). 
Myofibrillar protein fractional synthesis rates (FSR) were calculated using the standard precursor-
product equation by dividing the increment in L-[ring-2H5]-phenylalanine enrichment in the 
myofibrillar protein pool by the weighted average of L-[ring-2H5]-phenylalanine enrichment in the 
plasma precursor pool over time.   
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Statistics 
A within-subject crossover design was used for this study. A power analysis based on previous 
research (9, 41) showed that an n=8 per condition was sufficient to detect differences in 
postprandial muscle protein synthesis between conditions when using a two sided statistical test 
(P<0.05, 80% power, f=1.2; G*power version 3.1.9.2, Kiel, Germany). Considering a potential 
dropout rate of 20% during the protocol, the final number of participants recruited was 10 per 
condition. Differences in time-dependent blood and muscle measurements were tested by 2-factor 
(time × condition) repeated-measures ANOVA. Differences in self-reported dietary intakes, 
exercise external loads, and the fraction of dietary protein derived leucine that appeared into 
plasma were tested by paired t-test. When statistically significant interaction effects were identified 
in the ANOVA, Bonferroni post hoc tests were performed to determine the differences between 
means for all significant main effects and interactions. For all analysis, differences were considered 
statistically significant at P<0.05. All calculations were performed using IBM SPSS Statistics 
(version 24, Chicago, IL) unless otherwise designated. All data are expressed as mean ± SEMs. 
 
4.4 Results 
Plasma metabolites and enrichments 
Plasma leucine concentrations increased after egg ingestion (time: P<0.001) with no 
differences between conditions (time × condition: P=0.76). Peak plasma leucine concentrations 
were observed at 150 min (210 ± 14 µmol·L-1) and 240 min (200 ± 11 µmol·L-1) after ingestion of 
egg whites and whole eggs, respectively (Figure 1A). Plasma glucose concentrations tended to 
decrease transiently at 60 min of the postprandial period (P=0.06) with no differences between 
conditions (time × condition: P=0.73) (Figure 1B). Plasma insulin concentrations rapidly 
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increased after egg ingestion (time: P<0.001) with no differences between conditions (time × 
condition: P=0.48) (Figure 1C). Plasma triglyceride concentrations were increased at 180 min 
after ingestion of whole eggs but not egg whites (time: P=0.007; time × condition: P=0.03) (Figure 
1D).  
Plasma L-[5,5,5-2H3]leucine enrichment rapidly increased after egg ingestion (time: P<0.001) 
with no differences between conditions (time × condition: P=0.37) (Figure 2A). Plasma L-[1-
13C]leucine enrichments decreased after whole egg and egg white ingestion (time effect: P<0.001) 
with no differences between conditions (time × condition: P=0.86) (Figure 2B). Plasma α-[13C] 
ketoisocaproate enrichments increased after egg ingestion (time effect: P<0.001) with no 
differences between conditions (time × condition: P=0.68) (Figure 2C). Plasma L-[ring-
2H5]phenylalanine enrichments declined after egg ingestion (time effect: P<0.001) with no 
differences between conditions (time × condition: P=0.78) (Figure 2D). 
 
Whole body leucine kinetics 
Exogenous leucine rates of appearance (representing the appearance of dietary protein-derived 
leucine into circulation) increased after whole egg and egg white ingestion (time effect: P<0.001; 
Figure 3A). Exogenous leucine appearance rates were higher between 15-75 min after ingestion 
of egg whites when compared to whole eggs , whereas exogenous leucine rates of appearance were 
higher between 150 and 300 min after whole egg ingestion min when compared to egg whites 
(time × condition: P=0.001). Thus, more rapid peak exogenous leucine appearance rates were 
observed at 75 min (529 ± 56 nmol·kg-1·min-1) versus 120 min (496 ± 38 nmol·kg-1·min-1) of the 
postprandial period after ingestion of egg whites and whole eggs, respectively. The fraction of 
dietary protein-derived leucine that appeared in circulation during the first 120 min of the 
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postprandial period was greater after egg white (34 ± 2%) than whole egg ingestion (25 ± 3 %) 
(P=0.02). However, the cumulative fraction of dietary protein-derived leucine that appeared in 
circulation throughout the 300 min postprandial period was similar between the egg white (68 ± 
1%) and whole egg conditions (66 ± 2 %) (P=0.75). Endogenous leucine rates of appearance 
(representing the appearance of leucine derived from whole-body protein breakdown into 
circulation) decreased after egg ingestion (time effect: P<0.001) with no differences between 
conditions (time × condition: P=0.17) Figure 3B). Total leucine rates of appearance increased 
after egg ingestion (time effect: P<0.001) with no differences between conditions (time × 
condition: P=0.83) (Figure 3C). Total leucine rates of disappearance increased after egg ingestion 
(time effect: P<0.001) with no differences between conditions (time × condition: P=0.84) (Figure 
3D).  
Area under the curves of fasted and fed rates of whole-body protein breakdown (Endo Ra), 
synthesis (NOLD), oxidation (Total Ox), and net balance (NOLD - Endo Ra) are presented in 
Figure 4. Regardless of condition, egg ingestion decreased whole body protein breakdown rates 
(time effect: P<0.001; time × condition: P=0.31) and increased whole body synthesis rates 
(P=0.031; time × condition: P=0.87), thereby resulting in an improved net protein balance when 
compared to fasted conditions (time effect: P<0.001; time × condition: P=0.39). Whole body 
leucine oxidation rates decreased (P=0.008) after egg ingestion with no differences between 
conditions (time × condition: P=0.74).   
Whole body net leucine retention improved after egg ingestion when compared to fasted values 
(time effect: P<0.001) with no difference between conditions (time × condition: P=0.70). Whole 
body leucine retention improved from negative fasted values of -354 ± 29 and -347 ± 20 to positive 
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fed values of 131 ± 33 and 123 ± 22 nmol leucine·kg-1·min-1 for egg whites and whole eggs, 
respectively. 
 
Intramuscular signaling and amino acid transporters  
There was no change in the relative protein content of skeletal muscle amino acid transporters 
(LAT1, CD98, or SNAT2) throughout post-exercise recovery (all time effect: P>0.05) (Figure 5). 
AMPKα phosphorylation decreased during post-exercise recovery (time effect: P<0.001) with no 
differences between conditions (time × condition: P=0.52) (Figure 6A). Phosphorylation of 
mTORC1 increased by 0.9 ± 0.3 and 0.6 ± 0.3 fold above fasting values at 300 min of post-exercise 
recovery (P=0.01) after whole egg and egg ingestion, respectively, with no differences between 
egg conditions (time × condition: P=0.58) (Figure 6B). Erk1/2 phosphorylation decreased during 
post-exercise recovery (time effect: P<0.001) with no differences between conditions (time × 
condition: P=0.64) (Figure 6C). Phosphorylation of p70S6K1 was elevated above fasted 
throughout postexercise recovery (time effect: P<0.001) with no differences between conditions 
(time × condition: P=0.49) (Figure 6D). 4E-BP1 phosphorylation was elevated throughout 
postexercise recovery (time effect: P<0.001) with no differences between conditions (time × 
condition: P=0.23) (Figure 6E). There was no change in the phosphorylated-state of eEF2 
phosphorylation, regardless of egg condition, during recovery from exercise (time effect: P=0.13) 
(Figure 6F). Representative blots are displayed in Supplemental Figure 1 and 2. 
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Muscle intracellular free enrichments 
Muscle intracellular free enrichments are presented in Table 2. Muscle-free L-[5,5,5-
2H3]leucine enrichment increased after egg ingestion (time effect: P<0.001) with no differences 
between conditions (time × condition: P=0.61). Muscle-free L-[1-13C]leucine enrichments 
remained steady over time (time effect: P=0.30) with no differences between conditions (time × 
condition: P=0.62). Muscle intracellular free L-[ring-2H5]phenylalanine were lower at t=-120 
when compared to time points t=0, 120, and 300 (all P<0.05) with no differences between 
conditions (P=0.63) or other time points (all P>0.05). 
 
Myofibrillar protein synthesis rates. 
Postexercise myofibrillar protein synthesis, based on the plasma L-[ring-2H5]phenylalanine 
precursor pool, increased above fasted values (0.015 ± 0.002 %·h-1) after egg white and whole egg 
ingestion (time effect: P=0.015) with a greater cumulative response (0-300 min) after whole egg 
ingestion (0.034 ± 0.004 %·h-1; 2.7 ± 0.5 fold above fasted) when compared to egg white ingestion 
(0.024 ± 0.002 %·h-1; 1.9 ± 0.4 fold above fasted) (time × condition: P=0.04) (Figure 7). The 
temporal pattern of change in the early (0-120 min) and late (120-300) postexercise myofibrillar 
protein synthetic responses were not different between the whole egg and egg white conditions 
(time × condition: P=0.54); however, both conditions were elevated above rest during the late and 
early postprandial phase (all P<0.05) (Figure 7 Inset). 
Similarly, the cumulative postexercise myofibrillar protein synthetic response, based on the 
muscle free L-[ring-2H5]phenylalanine precursor pool, tended to increase above fasted values (0.07 
± 0.011 %·h-1) (time effect: P=0.001) to a greater extend after whole egg ingestion (0.131 ± 0.017 
%·h-1; 2.1 ± 0.3 fold above fasted) when compared with egg white ingestion (0.88 ± 0.007 %·h-1; 
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1.6 ± 0.3 fold above fasted) (time × condition: P=0.05). Resistance exercise and egg ingestion, 
based on the muscle free as the precursor, showed a trend towards increasing myofibrillar protein 
synthesis rates above fasted values at 0-120 min and 120-300 min during postexercise recovery 
(time effect: P=0.12) with no differences between egg conditions (time × condition: P=0.53). 
Using the muscle free enrichment as the precursor, postexercise myofibrillar protein synthesis rates 
between 0-120 min were 0.140 ± 0.035 %·h-1 (2.5 ± 0.8 fold above fasted) and 0.098 ± 0.017 %·h-
1 (1.8 ± 0.6 fold above fasted) after whole egg and egg white ingestion, respectively. Postexercise 
myofibrillar protein synthesis rates, based on the muscle free precursor, between 120-300 min 
were 0.123 ± 0.027 %·h-1 (1.8 ± 0.3 fold above fasted) and 0.078 ± 0.013 %·h-1 (1.4 ± 0.4 fold 
above fasted) after whole egg and egg white ingestion, respectively.  
 
4.5 Discussion 
To our knowledge, we report for the first time the potentiation of exercise-mediated stimulation 
of postprandial myofibrillar protein synthesis rates in response to ingestion of whole eggs versus 
isonitrogenous amounts of egg whites in healthy young males. Our work points to the concept that 
dietary protein may display differential anabolic properties on skeletal muscle tissue when 
consumed within its natural food matrix.   
Similar to isolated protein sources (e.g., whey and casein) (7, 14), we also showed that 
consumption of protein-dense foods in the form of whole eggs and egg whites improved whole 
body net protein balance (Figure 4). While insight into whole body protein kinetics can provide 
valuable information on whole body protein remodeling and net anabolism, which are prerequisites 
for lean mass maintenance or growth, it is not uncommon that whole body protein kinetics may 
‘mask’ important changes within specific tissues, such a skeletal muscle (9). In particular, the 
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observed potentiation of postexercise myofibrillar protein synthesis rates in response to whole egg 
versus egg white ingestion was not observed on a whole body level in which there was an 
equivalent stimulation of whole body protein synthesis in both conditions.  
In an attempt to underpin how the ingestion of whole eggs supported a greater postexercise 
myofibrillar protein synthetic response when compared with egg whites, we studied various 
upstream factors that are often assumed to be regulatory for postprandial muscle anabolism. We 
showed more rapid appearance rates of protein-derived leucine into circulation and higher peak 
leucinemia after egg whites versus whole eggs ingestion (Figure 3), the latter of which is a similar 
pattern to previous studies using either isolated egg protein (31) or whole eggs (10). However, 
there were no differences between the total amount of dietary protein-derived leucine that became 
available in circulation throughout the 5 h postprandial period between the egg whites (68 ± 1%) 
and whole egg conditions (66 ± 2%). Similarly, there were no differences in the relative protein 
content of skeletal muscle amino acid transporters (such as LAT1, CD98, and SNAT2) (Figure 5) 
or muscle free L-[5,5,5-2H3]leucine enrichments during recovery from exercise between the egg 
conditions (Table 2). Collectively, these data imply that muscle amino acid sensing and/or amino 
acid uptake likely did not differentially contribute to the stimulation of postexercise myofibrillar 
protein synthesis rates between the egg conditions.  
In addition, the temporal assessment of various metabolic and molecular readouts often 
associated with the control of translation initiation and elongation, such as MAPK-related and 
mTORC1-related signaling pathways, did not reveal significant differences in phosphorylation 
between the egg conditions (Figure 6). The lack of differences in the phosphorylated-state of 
mTORC1-mediated signaling between the egg conditions could imply that this anabolic pathway 
was maximized from the prior performance of resistance exercise and food ingestion (9, 28, 31, 
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34), thereby overriding any subtle non-protein nutritive influences of whole egg consumption on 
mTORC-1 phosphorylation and its downstream targets. We also examined metabolic regulatory 
pathways and energy sensing protein phosphorylation. Similar to the other assessed molecular 
readouts there were no observed differences in the phosphorylated-state of AMPK or Erk1/2.  
The essential amino acid composition, and leucine in particular, are nearly identical between 
the egg conditions (1) and likely did not have an influential role in the muscle anabolic response. 
In addition to this, it would seem that the greater overall energy content, and subsequent 
insulinemia, within the whole egg (256 kcal) versus egg white (73 kcal) conditions likely did not 
influence the differential stimulation of the postprandial myofibrillar protein synthetic response.  
For example, it has been shown that only small amounts of plasma insulin concentrations (5 
μU∙mL-1) are required to maximize the muscle anabolic potential of elevated plasma amino acid 
availability in humans (13, 20). Moreover, the additional substrate (i.e. fat) for energy production 
with whole egg ingestion did not spare the use of amino acids for oxidative ‘fuel’ (Figure 4). It 
could be hypothesized, however, that the caloric difference between the whole egg and egg white 
conditions was not sufficient to spare amino acid oxidation as both meals provided were much 
lower in caloric content than the habitual diets of most of the resistance-trained young males in 
this study. Notwithstanding, previous reports have shown that additional energy to a protein 
containing meal does not amplify the anabolic properties of dietary amino acids  to stimulate 
postprandial muscle protein synthesis rates when compared to protein alone (12, 17-19, 40).    
Previous research has shown that other food components, beyond dietary amino acids, may 
have a supporting role in modulating postprandial muscle anabolism during recovery from 
exercise. For example, Elliot et al. (16) previously showed that whole milk ingestion immediately 
after resistance exercise resulted in greater amino acid leg uptake when compared to consumption 
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of isonitrogenous or isoenergetic amounts of skim milk in healthy young adults. Here, we showed 
a greater early (0-120 min) postprandial dietary-derived leucine availability after ingestion of egg 
whites (34 ± 2%) versus whole eggs (25 ± 3%). The greater postprandial plasma leucine 
availability after egg white versus whole egg ingestion, however, did not result in a greater early 
stimulation of the postprandial (0-120 min) myofibrillar protein synthetic response after ingestion 
of egg whites when compared to whole eggs. Given all this, it seems that perhaps ‘extra’ nutritional 
food constituents, and not simply a rapid aminoacidemia/leucinemia (7, 26, 35, 41), may also have 
a role in modulating the postprandial muscle protein synthetic response in healthy adults. For 
example, as part of its natural food matrix, the egg yolk contains various non-protein food 
components that may have anabolic properties such miRNAs (5), vitamins (11, 21), minerals (30) 
and lipids (e.g., phosphatidic- (24), palmitic- (46), and docosahexaenoic- acid (38)) by modifying 
pathways related to transcriptional and/or protein translational control. However, more work is 
required to systemically assess the role of such food components on modulating postprandial 
muscle protein synthesis rates in vivo in humans.  
It is important to note that despite recent modifications of dietary guidelines to reflect that 
total dietary cholesterol intake is often misrepresented as a risk factor for cardiovascular disease 
(39, 43), popular practice may still dictate the discarding of the yolk when multiple eggs are 
consumed in a meal. However, the yolk is nutrient dense and may contain a variety of important 
bioactive compounds such as lipids, micronutrients, antioxidant carotenoids, and miRNAs (6, 45). 
Therefore, the removal of the yolk and its associated vital nutrients from the eggs may limit their 
benefit to stimulate muscle protein synthesis rates as well as overall human health (3, 4, 6). Overall, 
our current work lends support for the recommendation that nutrient and protein dense foods are 
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cornerstones to meeting daily protein requirements to optimize muscle protein synthesis rates with 
exercise.  
In conclusion, we demonstrate that postexercise myofibrillar protein synthesis rates are 
stimulated to a greater extent after consuming whole eggs versus egg whites in healthy young 
males, despite being matched for protein content. We observed no differences between egg 
conditions in the commonly assumed regulators of postexercise muscle protein synthesis rates such 
as total postprandial plasma leucine availability, whole body leucine oxidation rates, skeletal 
muscle amino acid transport protein content, or molecular readouts associated with metabolic and 
anabolic protein signaling.  Given this, future work is required to identify the potential role of non-
protein food components to contribute to the stimulation of postprandial muscle protein synthesis 
rates in humans. This information is important as other nutritional components may contribute to 
food protein requirements, particularly when dietary protein is consumed in moderate amounts 
(~15-20 g).  
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4.6 Tables 
Table 4.1 Participant characteristics (n=10) 
Variable  
 
Age (y) 21 ± 1 
Weight (kg) 88 ± 3 
Fat (%) 16 ± 1 
Lean Body Mass (kg) 72 ± 2 
Systolic BP (mmHg) 121 ± 4 
Diastolic BP (mmHg) 70 ± 2 
Fasting Glucose (mg/dL-1) 76 ± 1 
10-RM Leg Press (kg) 242 ± 32 
10-RM Leg Extension (kg) 112 ± 10 
Data are mean ± SEMs. 
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Table 4.2. Muscle intracellular free tracer enrichments before and after egg ingestion.   
 
Tracer 
-150 min 
(n=5) 
-30 min 
(n=10) 
120 min 
(n=10) 
300 min 
(n=10) 
L-[5,5,5-2H3]leucine     
Egg whites  0 0 3.5 ± 0.5# 1.4 ± 0.2# 
Whole eggs  0 0 4.0 ± 0.4# 1.8 ± 0.1# 
L-[1-13C]leucine     
Egg whites  5.1 ± 0.6 5.1 ± 0.3 5.5 ± 0.5 4.8 ± 0.3 
Whole eggs  4.1 ± 0.5 4.9 ± 0.3 5.1 ± 0.5 5.2 ± 0.4 
L-[ring-2H5]phenylalanine     
Egg whites 0.8 ± 0.1 1.4 ± 0.1# 1.5 ± 0.2# 1.3 ± 0.1# 
Whole eggs 0.7 ± 0.1 1.3 ± 0.1# 1.3 ± 0.0# 1.3 ± 0.1# 
Data are mean ± SEMs. Muscle free L-[5,5,5-2H3]leucine-, L-[1-
13C]leucine-, and L-[ring-
2H5]phenylalanine enrichments in MPE in the fasted state and after consumption of egg whites or 
whole eggs in young males. Muscle biopsies at t=-150 and -30 min represent the fasted-state and 
t=120 and 300 min represent the postprandial-state.  Data were analyzed with a two-factor 
ANOVA with repeated measures on time. A Bonferroni post hoc test was used to locate differences 
between means for all significant interactions. L-[5,5,5-2H3]leucine: Time effect, P<0.001; Time 
× condition, P=0.61. L-[1-13C]leucine: Time effect, P=0.30; Time × condition, P=0.62. L-[ring-
2H5]phenylalanine (C): Time effect, P<0.001; Time × condition, P=0.54. 
#Significantly different 
from t=-150 min (P<0.05). MPE, mole percent excess.  
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4.7 Figures 
Figure 4.1   
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Data are mean ± SEMs. Plasma leucine (A), blood glucose (B), plasma insulin (C), and plasma 
triglycerides concentrations (D) in the fasted state and after consumption of egg whites or whole 
eggs in young males (n=10 per condition). Data are expressed as µmol·L-1 (A), mg·dL-1 (B), 
µIU·mL-1 (C), and µg·mL-1 (D), respectively. Gray area corresponds to the exercise bout; dashed 
line refers to egg ingestion. Data were analyzed with a two-factor ANOVA with repeated measures 
on time. A Bonferroni post hoc test was used to locate differences between means for all significant 
interactions. Leucine: Time effect, P<0.001; Time × condition, P=0.76. Glucose: Time effect, 
P=0.06; Time × condition, P=0.73. Insulin: Time effect, P<0.001; Time × condition P=0.484. 
Triglycerides: Time effect, P=0.007; Time × condition P=0.03. *Significantly different between 
egg conditions (P<0.05).  
 
156 
 
Figure 4.2 
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Plasma L-[5,5,5-2H3]leucine (A), L-[1-
13C]leucine (B), -[13C]-ketoisocaproate (C), and L-[ring-
2H5]phenylalanine (D) enrichments in the fasted state and after consumption of egg whites or 
whole eggs in young males (n=10 per condition). Data are expressed as MPE (A, B, and C) and 
APE (D), respectively. Gray area corresponds to the exercise bout; dashed line refers to egg 
ingestion. Data were analyzed with a two-factor ANOVA with repeated measures on time. A 
Bonferroni post hoc test was used to locate differences between means for all significant 
interactions. L-[5,5,5-2H3]leucine: Time effect, P<0.001; Time × condition, P=0.37. L-[1-
13C]leucine : Time effect, P<0.001; Time × condition, P=0.86. -[13C]-ketoisocaproate: Time 
effect, P<0.001; Time × condition, P=0.78. L-[ring-2H5]phenylalanine: Time effect, P<0.001; 
Time × condition, P=0.78. MPE, mole percent excess; APE, atom percent excess. 
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Figure 4.3 
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Data are mean ± SEMs. Whole body leucine kinetics over time in the fasted state and after 
consumption of egg whites or whole eggs in young males (n=10 per condition). Exogenous leucine 
Ra (A), endogenous leucine Ra (B), total leucine Ra (C), and total leucine Rd (D). Data are expressed 
as nmol leucine·kg-1·min-1. Gray area corresponds to the exercise bout; dashed line refers to egg 
ingestion. Data were analyzed with a two-factor ANOVA with repeated measures on time. A 
Bonferroni post hoc test was used to locate differences between means for all significant 
interactions. Exogenous Ra: Time effect, P<0.001; Time × condition, P=0.001. Endogenous Ra: 
Time effect, P<0.001; Time × condition, P=0.17. Total Ra: Time effect, P<0.001; Time × 
condition, P=0.83. Total Rd: Time effect, P<0.001; Time × condition, P=0.84. *Significantly 
different between egg conditions (P<0.05). Ra, rate of appearance; Rd, rate of disappearance. 
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Figure 4.4 
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Data are mean ± SEMs. Whole body leucine endogenous rate of appearance (Ra; marker of protein 
breakdown), non-oxidative leucine disposal (NOLD; marker of protein synthesis), leucine 
oxidation (oxidation) and net leucine balance expressed as the cumulative rates in the fasted state 
and after consumption of egg whites or whole eggs in young males (n=10 per condition). Data are 
expressed as nmol leucine·kg-1·min-1. Data were analyzed with a two-factor ANOVA with 
repeated measures on time. A Bonferroni post hoc test was used to locate differences between 
means for all significant interactions. Endogenous Ra: Time effect, P<0.001; Time × condition, 
P=0.31. NOLD: Time effect, P=0.031; Time × condition, P=0.87. Oxidation: Time effect, 
P<0.001; Time × condition, P=0.74. Net balance: Time effect, P<0.001; Time × condition, 
P=0.39. #Significantly different from fasted (P<0.05).  
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Figure 4.5 
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Data are mean ± SEMs. Skeletal muscle protein content of LAT1/SLC7A5 (A), CD98/SLC3A2 
(B), SNAT2/ SLC38A2 (C) in the fasted state and after consumption of egg whites or whole eggs 
in young males (n=10 per condition). Data are expressed as arbitrary units. Data were analyzed 
with a two-factor ANOVA with repeated measures on time.  
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Figure 4.5 (cont.) 
A Bonferroni post hoc test was used to locate differences between means for all significant 
interactions. LAT1/SLC7A5: Time effect, P=0.18; Time × condition, P=0.81. CD98/SLC3A2: 
Time effect, P=0.10; Time × condition, P=0.49. SNAT2/ SLC38A2: Time effect, P=0.12; Time × 
condition, P=0.16. LAT1, Large neutral amino acids transporter small subunit 1; SNAT2, sodium-
coupled neutral amino acid transporter 2. 
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Figure 4.6 
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Data are mean ± SEMs. Phosphorylation status of AMPKαThr172 (A), mTORSer2448 (B), 
ERKThr202/Tyr204 (C), p70S6K1Thr389 (D), 4E-BP1Thr37/46 (E),  and eEF2Thr56 (F) in the fasted state 
and after consumption of egg whites or whole eggs in young males (n=10 per condition).  
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Figure 4.6 (cont.) 
Data are expressed as arbitrary units. Data were analyzed with a two-factor ANOVA with repeated 
measures on time. A Bonferroni post hoc test was used to locate differences between means for all 
significant interactions. p-AMPKαThr172: Time effect, P<0.001; Time × condition, P=0.52. 
mTORSer2448: Time effect, P=0.010; Time × condition, P=0.577. ERK 1/2Thr202/Tyr204: Time effect, 
P<0.001; Time × condition, P=0.64. p70S6K1Thr389: Time effect, P<0.001; Time × condition, 
P=0.49. 4E-BP1Thr37/46: Time effect, P<0.001; Time × condition, P=0.23. eEF2Thr56: Time effect, 
P=0.13; Time × condition, P=0.41. #Significantly different from fasted (P<0.05). †Significantly 
different from 120 min. AMPKα, adenosine monophosphate-activated protein kinase alpha; 
mTORC1, mammalian target of rapamycin complex 1; ERK, extracellular signal–regulated 
kinases, p70S6K1, 70 kDa S6 protein kinase 1; 4E-BP1, eukaryotic translation initiation factor 
4E-binding protein 1; eEF2,  eukaryotic translation elongation factor 2.  
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Figure 4.7 
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Data are mean ± SEMs. Myofibrillar protein synthesis rates in the fasted state and after 
consumption of egg whites or whole eggs in young males (n=10 per condition). Data are expressed 
as FSR (%·h-1). The inset shows the temporal responsiveness of myofibrillar protein synthesis 
rates during the early (0-120 min) and late (120-300 min) exercise recovery periods. Data were 
analyzed with a two-factor ANOVA with repeated measures on time. A Bonferroni post hoc test 
was used to locate differences between means for all significant interactions. FSR: Time effect, 
P=0.02; Time × condition, P=0.04. Inset FSR: Time effect, P=0.04; Time × condition, P=0.50. 
#Significantly different from fasted (P<0.05). *Significantly different between egg conditions 
(P<0.05). Data are Mean ± SEM. FSR, fractional synthesis rates. 
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4.9 Supplemental methods 
Calculations 
Total, exogenous, and endogenous leucine rates of appearance (Ra), postprandial circulating 
protein-derived leucine availability, total leucine rate of disappearance (Rd), total leucine 
oxidation, non-oxidative leucine disposal (NOLD) and net balance were calculated with the use of 
modified Steele’s equations (1, 2). The specific equations used to calculate leucine fluxes were as 
follows: 
 
Total Ra =
Fiv - [pV × C(t)leu × 
dEiv
dt
]
Eiv(t)
               (1) 
 
Total Ra (Eq. 1) is the plasma appearance rate of total leucine calculated with the IV tracer (nmol 
· kg-1 · min-1); where Fiv is the IV tracer infusion rate (e.g. 130 nmol ∙ kg
-1 ∙ min-1 for leucine); pV 
(0.125 L/kg-1) is the distribution volume (8); C(t) is the mean plasma leucine concentration 
between two consecutive time points (nmol · kg-1); dEiv/dt represents the time-dependent variations 
in plasma leucine enrichment (mole percent excess) derived from the IV tracer; and Eiv(t) is the 
mean plasma leucine enrichment (mole percent excess) derived from the IV tracer between two 
consecutive time points. 
 
Exo Ra =
Total Ra × Epo(t) + [pV × C(t)leu × 
dEpo
dt
]
Eprot
  (2) 
 
Exo Ra (Eq. 2) is the plasma entry rate (nmol · kg
-1 · min-1) of dietary protein-derived leucine after 
first-pass splanchnic extraction; where Epo(t) is the mean plasma leucine enrichment based on the 
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oral tracer between two consecutive time points (mole percent excess); dEpo/dt is the time-
dependent variations of plasma leucine enrichment derived from the oral tracer (mole percent 
excess); and Eprot is the leucine tracer enrichment of the dietary protein (mole percent excess). 
 
Endo Ra = Total Ra-Exo Ra-Fiv   (3) 
 
Endo Ra  (Eq. 3) is the plasma entry rate of endogenous leucine from whole-body protein 
breakdown (nmol · kg-1 · min-1); where Fiv is the IV tracer infusion rate as in Eq. 1; and Exo Ra is 
the plasma entry rate of dietary protein-derived leucine as in Eq. 2. 
 
Leuplasma = (
AUCExo Ra
Leuprot
) × BW × 100   (4) 
 
Leuplasma  (Eq. 4) represents the fraction of dietary leucine that appeared in the plasma (%); where 
AUCExoRa represents the area under the time curve (AUC) of Exo Ra, which indicates the amount 
of dietary protein-derived leucine that appeared in the circulation during the measured postprandial 
period; and Leuprot is the amount of dietary leucine ingested (12209520 and 12005432 nmol for 
egg whites and whole eggs, respecitvely) and BW is the participants’ body weight (kg).  
 
Total Ox =
Vco2 × Eco2
Eα-KIC
  x 
1
k
       (5) 
 
Total Ox (Eq. 5) is the rate of total leucine oxidation calculated with the IV tracer (nmol · kg-1 · 
min-1);  where VCO2 is CO2 production (nmol · kg
-1 · min-1); ECO2 is 
13C enrichment in expired CO2;  
Eα-KIC is plasma 
13C-α-KIC enrichment, which best represents the precursor for irreversible 
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decarboxylation of leucine (29); and k is the fractional bicarbonate retention factor correcting for 
incomplete recovery of 13CO2 in breath with chosen values of 0.7 and 0.83 for the fasted and fed 
state, respectively (22, 42). 
 
Rd = Total Ra-(pV x dC/dt)    (6) 
 
Total Rd  (Eq. 6) is the plasma leucine disappearance rate of calculated with the IV tracer (nmol · 
kg-1 · min-1); where dC/dt is the difference in plasma leucine concentration between two 
consecutive time points; and pV is the distribution volume as in Eq. 1. 
 
NOLD =  Total Rd-Total Ox    (7) 
 
NOLD (Eq. 7) is the plasma disappearance rate of total leucine used for protein synthesis (nmol · 
kg-1 · min-1); where Total Rd  is the plasma disappearance rate of total leucine as in Eq 6.; and Total 
Ox is the rate of total leucine oxidation as in Eq. 5. 
 
Net Balance = NOLD -Endo Ra   (8) 
 
Net Balance (Eq. 8) is the difference between NOLD (i.e. protein synthesis) as in Eq 7. and Endo 
Ra (i.e. protein breakdown) as in Eq. 3. 
 
Leuretention  = Leuprot + Fiv - Total Ox  (9) 
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Leuretention (Eq. 9) represents the leucine intake (meal and IV infusion) that is retained in the body 
(nmol · kg-1 · min-1); where Leuprot is the amount of dietary leucine ingested as in Eq. 4., under the 
assumption that all dietary leucine ingested is effectively absorbed; Fiv is the IV tracer infusion 
rate as in Eq. 1; and Total Ox is the rate of total leucine oxidation as in Eq. 5. 
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4.10 Supplemental tables 
Supplemental table 4.1 Self-reported dietary intake during 2d prior to infusion trials. 
  Whole eggs 
(n=10) 
Egg whites 
(n=10) 
P-value 
Energy (kcal/d-1) 2705 ± 163 2827 ± 88 0.16 
Protein (g/kg-1 body weight ·d-1) 1.9 ± 0.2 2.0 ± 0.2 0.38 
Carbohydrate (g/kg-1 body weight ·d-1) 3.5 ± 0.3 3.6 ± 0.3 0.20 
Fat (g/kg-1 body weight ·d-1) 1.0 ± 0.2 1.1 ± 0.2 0.22 
Data are mean ± SEMs. 
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4.11 Supplemental figures 
Supplemental figure 4.1 
Time       Fast              120              300 
 
Condition   EW    EGG      EW     EGG    EW    EGG       
AMPKα  
mTORC1  
Erk1/2  
p70S6K1  
4E-BP1  
eEF2  
Representative blots for the phosphorylation status of AMPKαThr172, mTORSer2448, ERKThr202/Tyr204, 
P70S6K1Thr389, 4E-BP1Thr37/46, eEF2Thr56 in the fasted state (t=-30 min) and after consumption 
(t=120 and 300 min) of egg whites or whole eggs during post-exercise recovery in young men. 
AMPKα, adenosine monophosphate-activated protein kinase alpha; mTORC1, mammalian target 
of rapamycin complex 1; ERK, extracellular signal–regulated kinases, p70S6K1, 70 kDa S6 
protein kinase 1; 4E-BP1, eukaryotic translation initiation factor 4E-binding protein 1; eEF2, 
eukaryotic translation elongation factor 2. 
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Supplemental figure 4.2  
Time       Fast               120              300 
 
Condition   EW    EGG      EW      EGG    EW    EGG       
LAT1  
CD98  
SNAT2  
Representative blots for total protein content of  LAT1, CD98, and  SNAT2 in the fasted state (t=-
30 min) and after consumption (t=120 and 300 min) of egg whites or whole eggs in young men. 
Large neutral amino acids transporter small subunit 1; SNAT2, sodium-coupled neutral amino acid 
transporter 2. 
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5.1 Abstract 
Background: Maintenance hemodialysis (MHD) patients experience substantial skeletal muscle 
wasting. Thus, the attenuation of muscle mass loss is mandatory for the maintenance of physical 
performance and improved quality of life. The regular ingestion of protein-rich meals are 
recommended to offset this skeletal muscle protein loss. However, the protein metabolic responses 
before and after food ingestion remains undefined in MHD patients. Objective: To provide insight 
into whole body and muscle protein metabolism before and after food ingestion in MHD patients 
on a non-dialysis day. Design: Eight maintenance hemodialysis (MHD) patients (age: 56±5 y: 
BMI: 32±2) and eight controls (age: 50±2 y: BMI: 31±1) received primed continuous L-[ring-
2H5]phenylalanine- and L-[1-
13C]leucine infusions. Participants consumed a mixed meal (546 
kcal; 20 g protein, 59 g carbohydrates, 26 g fat) with protein provided as L-[5,5,5-2H3]leucine 
labeled eggs. Breath, blood, and muscle biopsies were collected to determine whole body amino 
acid kinetics and myofibrillar protein synthesis rates. Results: Postprandial dietary-amino acid 
availability in circulation tended to be reduced in MHD patients (43 ± 5%) vs. controls (56 ± 5%)  
(P=0.06). Breath 13CO2 enrichments (indicative of leucine oxidation) were lower in MHD patients 
vs. controls (P=0.02). Basal myofibrillar protein synthesis rates were ~ 2.5-fold higher in MHD 
patients (0.032 ± 0.005 %·h-1) vs. controls (0.014 ± 0.002 %·h-1) (P=0.02). Meal ingestion failed 
to increase myofibrillar protein synthesis rates in MHD patients (-0.001 ± 0.008 %·h-1) and 
controls (absolute change from basal: 0.006 ± 0.004 %·h-1) (P=0.58). Conclusion: Basal-state 
muscle protein synthesis rates are elevated in MHD patients and protein-rich meal consumption 
did not elicit a postprandial rise in muscle protein synthesis rates in MHD patients, which may be 
attributed to reduced dietary amino acid availability after eating a meal.   
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5.2 Introduction 
Chronic kidney disease (CKD) is estimated to be present in 11-13% of the overall global 
population (17) making it an important public health problem. Moreover, the prevalence of CKD 
is expected to further increase in the next decades (3) due to increasing incidences of lifestyle 
diseases such as hypertension, obesity and diabetes, which are leading causes for the development 
of renal failure (24). The most severe form of chronic renal failure is end-stage-renal-disease, with 
maintenance hemodialysis (MHD) as the most common treatment strategy. MHD patients 
experience a number of metabolic derangements including skeletal muscle wasting (48). MHD 
patients lose ~1-3 kg muscle mass annually (32), resulting in reduced physical function (21) and 
increased risk for morbidity and mortality (16). Thus, preventative strategies to attenuate muscle 
mass loss are mandatory to improve the quality of life in MHD patients. The underlying 
mechanisms of skeletal muscle wasting in MHD patients are likely multifactorial and include: 
chronic inflammation, reduced protein intake, metabolic acidosis, insulin resistance, hormonal 
abnormalities, increased substrate oxidation, and a loss of nutrients/amino acids during dialysis 
(47).  
In healthy individuals, the maintenance of skeletal muscle mass is primarily determined by the 
postprandial stimulation of muscle protein synthesis after each meal. However, the effects of food 
ingestion on the stimulation of the postprandial muscle protein synthetic response in MHD patients 
remains to be firmly established. It has been demonstrated that dialysis increased basal-state 
muscle protein synthesis rates with an even greater elevation in protein breakdown rates (19, 34). 
As a result, this negative net protein balance induced by the dialysis procedure results in net 
skeletal muscle- and whole body catabolism (19). A troublesome issue for the maintenance of lean 
body mass (muscle) is that skeletal muscle- and whole body catabolism persists for several hours 
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after dialysis (19), suggesting prolonged post-dialysis disturbances in whole body- and skeletal 
muscle protein metabolism in MHD patients.  
What is noteworthy is that the dialysis procedure itself results in ~20 % losses of circulating 
amino acids in the dialysate (14, 18), thus creating a need for replacement of amino acids by protein 
supplementation during and/or after dialysis. It is promising that intradialytic protein feeding can 
mitigate some of the amino acid losses on a whole body- (31, 45) and skeletal muscle level (31). 
However, due to concerns regarding patient safety and staff burden, meal consumption during 
dialysis is not common practice in the US (22). Therefore, consumption of protein-dense meals in 
between dialysis treatments represents an alternative dietary strategy to limit skeletal muscle 
protein loss in MHD patients. Besides the dialysis procedure itself, impaired protein metabolism 
resulting from a chronic inflammatory state (40), acidosis (26), increased substrate oxidation (4) 
and/or chronic illnesses (e.g., insulin resistance (35), and obesity (5)) may pose further challenges 
for the improvement of skeletal muscle health in this patient population. To limit losses in skeletal 
muscle mass, protein intakes of  ≥ 1.2 g/kg-1 bodyweight/d-1 are often recommended (1). However, 
the effectiveness of protein-rich meal consumption on skeletal muscle and whole body protein 
turnover in MHD patients outside of the dialysis period is not well-defined.  
Therefore, the purpose of this study was to characterize the whole body and muscle protein 
metabolic responses after mixed meal ingestion on a non-dialysis day in MHD patients and 
compare these responses to control subjects. To accomplish this aim, we combined contemporary 
stable isotope tracer methodology with the ingestion of intrinsically L-[5,5,5-2H3]leucine-labeled 
protein (44) to allow for the detailed assessment of postprandial protein handling in MHD patients 
and controls.  
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5.3 Methods 
Participants and ethical approval 
Eight maintenance hemodialysis (MHD) patients (mean ± SEM: age: 56±5 y: BMI: 32±2) and 
eight controls volunteered for this study (mean ± SEM: age: 50±2 y: BMI: 31±1). The participants 
were matched for age, sex, BMI and insulin resistance (as defined by HOMA IR). Full participant 
characteristics are presented in Table 1. MHD patients and controls subjects were deemed eligible 
based on responses to a routine medical screening questionnaire, routine blood panels and an in-
person interview by the researchers. All participants were informed about the experimental 
procedures to be used, the purpose of the study, and all potential risks before giving written consent 
and had no prior of participating in stable isotope amino acid tracer experiments. For MHD 
patients, we requested physician clearance from their nephrologist to further ensure it was safe for 
the patient to participate in this study. The study was approved by the Institutional Review Board 
at University of Illinois at Urbana-Champaign and conformed to standards for the use of human 
participants in research as outlined in the seventh revision of the Declaration of Helsinki.  
 
Screening protocol 
Body weight and height were measured as well as body composition by dual-energy X-ray 
absorptiometry (Hologic QDR 4500A, Bedford, MA, USA). Participants were instructed to refrain 
from vigorous physical activity for 3 d prior to each trial and maintain their habitual dietary pattern. 
Furthermore, MHD patients were instructed to maintain daily medication as prescribed by their 
health-care provider. A single exception one diabetic MHD patient, who refrained from insulin 
injection during the infusion trial. The classes of medication were as follows: phosphatase binders 
(number of patients: 8), calcimimetics (8), ACE inhibitors (6), NSAIDs (6), beta-blockers (4), 
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calcium channel blockers (4), diuretics (4), statins (4), proton pump inhibitors (3), xanthine oxidase 
inhibitors (anti-gout) (3), opioids (3), vasodilators (2), P2Y12 (platelet) inhibitors (2), serotonin-
reuptake inhibitor (anti-depressant) (2), anti-histamine (1), prokinetic (1), immunosuppressant (1). 
 All participants consumed a standardized meal of the same composition (320 kcal; 22 g 
protein, 43 g carbohydrates, 7 g fat) the evening prior to the infusion trial, after which participants 
were instructed to remain fasted. A 2-d dietary-recall was performed using dietary analysis 
software (Nutritionist ProTM, Version 2.1.13, Axxya Systems, Redmond, WA). Average 2-d 
protein intake tended to be lower in MHD patients (0.9 ± 0.14 g·kg-1 bodyweight·d-1) when 
compared to control subjects (1.14 ± 0.05 g·kg-1 bodyweight·d-1) (P=0.07) with no differences in 
other macronutrients (all, P>0.05) (Supplemental Table 1).  
 
Infusion protocol   
On the day of the infusion trial, participants reported to the laboratory at 0700 h after an 
overnight fast. MHD patients were studied during a day without dialysis, having dialyzed the day 
before. At the start of the trial, a Teflon catheter was inserted into an antecubital vein for baseline 
blood sample collection (t=-180 min) after which participants received priming doses of 
NaH13CO2 (2.35 mol·kg
-1), L-[1-13C]leucine (7.6 µmol·kg-1 FFM), and L-[ring-
2H5]phenylalanine (2.0 µmol·kg
-1 FFM). Subsequently, a continuous intravenous infusion of L-[1-
13C]leucine (0.10 µmol·kg-1 FFM ·min-1) and L-[ring-2H5]phenylalanine (0.05 µmol·kg
-1 
FFM·min-1) was initiated (t=-180 min) and maintained over the infusion trial. A second Teflon 
catheter was inserted into a heated dorsal hand vein of the same arm for repeated arterialized blood 
sampling and remained patent by a 0.9% saline drip. In the postabsorptive state of the infusion 
trial, muscle biopsies were collected at t=-120 and -0 min of infusion to determine fasting 
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myofibrillar protein synthesis rates. After collection of the basal muscle biopsy at t=-0 min, 
participants consumed a mixed macronutrient meal containing 20 g of dietary protein (see section 
below for further details). Completion of the meal marked the start of the postprandial phase (t=0 
min) and an additional muscle biopsy was collected 300 min to determine postprandial myofibrillar 
protein synthesis rates. Biopsies were collected from the middle region of the vastus lateralis (15 
cm above the patella) with a Bergström needle modified for suction under local anesthesia (2% 
Lidocaine). The postabsorptive muscle biopsies were collected from the same incision with the 
needle pointed to distal and proximal directions, respectively. The postprandial biopsy was 
collected through a separate incision 2-3 cm above the postabsorptive incision. All biopsy samples 
were freed from any visible blood, adipose, and connective tissue immediately frozen in liquid 
nitrogen, and stored at -80˚C until subsequent analysis. Arterialized blood samples and were 
collected every 30 or 60 min during the postabsorptive- and postprandial states. The blood samples 
were immediately analyzed for whole blood glucose concentrations (2300 Stat Plus, YSI Life 
Sciences, Springs, OH) and subsequently centrifuged at 3000 × g for 10 min at 4°C. Aliquots of 
plasma were frozen and stored at -80°C until subsequent analysis.  
 
Meal composition 
Participants ingested a meal consisting of three scrambled  L-[5,5,5-2H3]leucine labeled eggs, 
one slice of toasted white bread, 300 ml of apple juice, and 10 grams of cow butter (546 kcal; 20 
g protein, 59 g carbohydrates, 26 g fat). We chose this meal as this is a typical breakfast that is 
recommended for this patient population (2). The intrinsically L-[5,5,5-2H3]leucine labeled eggs 
were produced by supplementing the diet of laying hens (Lohmann LSL Whites) with 0.3% L-
[5,5,5-2H3]leucine as described previously (44). The L-[5,5,5-
2H3]leucine enrichment of the eggs 
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determined by gas chromatography mass spectrometry (GC-MS) and averaged 13.1 mole percent 
excess (MPE). Proximate analyses for protein, lipid, and carbohydrate concentrations of the eggs 
were determined by using the combustion method (method 990.03; AOAC International, 2000; 
TruMac; LECO Corp., USA) (44). For the other foods, macronutrient composition was determined 
from their respective food labels. Leucine content of the whole eggs (1.6 g) were determined by 
GC-MS with integration of amino acid peak areas compared to an internal standard (DL-p-
chlorophenylalanine) using the AMDIS software package (v. 2.71; NIST) (20).  
 
Blood analyses  
Blood metabolites were determined using a point-of-care chemistry analyzer (Piccolo Xpress 
Chemistry Analyzer, Abaxis, Union City, CA). Plasma insulin concentrations were determined 
using a commercially available enzyme-linked immunosorbent assays (Alpco Diagnostics; Salem, 
NH). Plasma amino acid concentrations and enrichments were determined by GC-MS analysis 
(Agilent 7890A GC/5975C; MSD, Little Falls, DE) as described in our previous work (44). 
Briefly, plasma samples were prepared for amino acid analysis using a mixture of 
isopropanol:acetonitrile:water (3:3:2, v/v) and centrifuged at 20000 × g for 10 min at 4ºC. 
Subsequently, the supernatant was dried and the amino acids converted into tert-butyldimethylsilyl 
(t-BDMS) derivatives prior to GC-MS analysis. Plasma L-[1-13C]leucine and L-[5,5,5-2H3]leucine 
enrichments were determined by ion monitoring at mass/charge (m/z) ratios 302 (m+0), 303 (m+1), 
and 305 (m+3) with m+0 representing the lowest molecule weight of the ion or unlabeled leucine. 
For L-[ring-2H5]phenylalanine, m/z 336 (m+0) and 341 (m+5) were monitored for unlabeled and 
labeled phenylalanine, respectively. The plasma leucine concentrations were determined by 
 
187 
 
integrating amino acid peak areas in comparison to U-[13C6]leucine as an internal standard with 
the use of the AMDIS software package (v. 2.71; NIST) (20). 
 
Muscle analysis 
Myofibrillar protein-enriched fractions were isolated from ~50 mg of wet tissue as described 
previously (44). Myofibrillar-enriched protein pellets were hydrolyzed overnight in 6 м HCL at 
110°C. The resultant free amino acids were purified using cation exchange chromatography 
(Dowex 50W-X8-200 resin; Acros Organics, Geel, Belgium) and dried under vacuum. Free amino 
acids were re-suspended in 60% methanol and centrifuged before the myofibrillar protein-bound 
enrichments were determined by 5500 QTRAP liquid chromatography-tandem mass spectrometry 
(LC/MS/MS; Sciex, Framingham, MA). The myofibrillar protein-bound L-[ring-
2H5]phenylalanine enrichments were determined by multiple reaction monitoring (MRM) at m/z 
166.0  103.0 and 171.0  106.0 for unlabeled and labeled L-[ring-2H5]phenylalanine, 
respectively. Sciex Software Analyst 1.6.2 was used for data acquisition and analysis. 
 
Calculations 
Whole-body leucine kinetics were assessed under non-steady conditions by the ingestion of L-
[5,5,5-2H3]leucine eggs combined with intravenous infusion of L-[1-
13C]leucine. Total, 
exogenous, and endogenous leucine rates of appearance (Ra) were calculated with the use of 
modified Steele equations (7, 11). Myofibrillar protein fractional synthesis rates (FSR) were 
calculated using the standard precursor-product equation by dividing the increment in L-[ring-
2H5]-phenylalanine enrichment in the myofibrillar protein pool by the weighted average of L-[ring-
2H5]-phenylalanine enrichment in the plasma precursor pool over time.   
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Statistics 
A parallel design was used for this study. Differences in time-dependent blood and muscle 
measurements were tested by 2-factor (time × group) repeated-measures ANOVA. Differences in 
participant characteristics, dietary intakes and the fraction of dietary protein derived leucine that 
appeared into plasma were tested by unpaired t-test. When statistically significant interaction 
effects were identified in the ANOVA, Bonferroni post hoc tests were performed to determine the 
differences between means for all significant main effects and interactions. For all analysis, 
differences were considered statistically significant at P<0.05. All calculations were performed 
using IBM SPSS Statistics (version 24, Chicago, IL). All data are expressed as mean ± SEMs. 
 
5.4 Results 
Metabolites and tracer enrichments 
Plasma leucine concentrations after meal consumption increased (time effect: P<0.001) with 
no differences between MHD patients and controls (time × group: P=0.59) (Figure 1A). However, 
the area-under-the-curve (AUC) of postprandial leucine concentrations was higher in controls 
when compared to MHD patients (P=0.05). Peak postprandial plasma leucine concentrations were 
observed at 180 min (243 ± 15 µmol·L-1) and 240 min (275 ± 23 µmol·L-1) after meal consumption 
in MHD patients and controls, respectively (Figure 1A). Plasma glucose concentrations increased 
after meal consumption (time effect: P<0.001) to a greater extend in MHD patients when compared 
to controls (time × group: P=0.05) (Figure 1B). Plasma insulin concentrations increased after meal 
ingestion (time: P<0.001) with no differences between MHD patients and controls (time × group: 
P=0.29) (Figure 1C).  
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Plasma L-[5,5,5-2H3]leucine enrichment increased after meal ingestion (time effect: P<0.001) 
with no differences between MHD patients and controls (time × group: P=0.38) (Figure 2A). 
Plasma L-[1-13C]leucine enrichments remained steady throughout the trial (time effect: P=0.50) 
with no differences between MHD patients and controls (time × group: P=0.64) (Figure 2B). 
Breath 13CO2 enrichments (indicating the use irreversible loss of leucine to oxidation) increased 
after meal ingestion (P<0.001) and with no differences between MHD patients and controls (time 
× group: P=0.39) (Figure 2B). However, the area-under-the-curve (AUC) of breath 13CO2 
enrichments was higher in controls when compared to MHD patients (P=0.02).  Plasma L-[ring-
2H5]phenylalanine enrichments decreased after meal consumption (P<0.01) with no differences 
between groups (time × group: P=0.30) (Figure 2D). 
 
Whole body leucine kinetics 
Exogenous leucine rates of appearance (representing the appearance of dietary protein-derived 
leucine into circulation) increased after meal consumption (time effect: P<0.001) and tended to be 
lower in MHD patients when compared to controls (time × group: P=0.10) (Figure 3A). Peak 
exogenous leucine appearance rates after meal ingestion were observed at 120 min (409 ± 62 
nmol·kg-1·min-1) and 180 min (479 ± 54 nmol·kg-1·min-1) for MHD patients and controls, 
respectively. Cumulative dietary-derived leucine availability tended to be reduced in MHD 
patients (43 ± 5%) when compared to controls (56 ± 5 %) (P=0.06) (Inset Figure 3A). Endogenous 
leucine rates of appearance (representing the appearance of leucine derived from whole-body 
protein breakdown into circulation) remained unchanged after meal consumption (time effect: 
P=0.20) with no differences between MHD patients and controls (time × group: P=0.55) (Figure 
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3B). Total leucine rates of appearance remained unchanged after meal consumption (time effect: 
P=0.79) with no differences between conditions (time × group: P=0.95) (Figure 3C).  
 
Myofibrillar protein synthesis rates 
Basal rates of myofibrillar protein synthesis were ~ 2.5-fold higher in MHD patients (0.032 ± 0.005 
%·h-1) when compared to controls (0.014 ± 0.002 %·h-1) (group effect: P=0.02) (Figure 4).  
However, meal ingestion did not increase myofibrillar protein synthesis rates in MHD patients 
(absolute change from basal: -0.001 ± 0.008 %·h-1) or controls (absolute change from basal: 0.006 
± 0.004 %·h-1) (time effect: P=0.58; time × group: P=0.33) (Figure 4). 
5.5 Discussion 
MHD patients suffer substantial muscle mass loss (32), which impairs physical performance 
and metabolic health. As such, preventative strategies are required to attenuate muscle mass loss 
in MHD patients to improve their quality of life. In healthy people, protein ingestion is a main 
anabolic stimuli to skeletal muscle tissue. However, the whole body and muscle protein metabolic 
responses before and after food ingestion remains undefined in MHD patients. In this study, we 
demonstrated that basal-state myofibrillar protein synthesis rates are ~2.5-fold elevated in MHD 
patients when compared with controls. In addition, we show impairments in postprandial protein 
handling after the consumption of a protein- and nutrient dense meal in MHD patients. Thus, both 
defects in post absorptive and postprandial protein metabolic responses are likely contributing to 
the muscle mass loss in MHD patients.  
Previously, it was demonstrated that dialysis results in prolonged whole body and skeletal 
muscle catabolism that persists for several hours after dialysis (19). The elevated basal rates of 
myofibrillar protein synthesis observed in the current study are likely indicative of a prolonged 
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hypercatabolic-state that is carried over to non-dialysis days (12, 33). For example, elevated post 
absorptive muscle protein synthesis rates are commonly observed in hyper-catabolic situations 
such as burn patients (30). The excessive muscle proteolysis results in an increased intramuscular 
amino acid availability to support the elevated basal muscle protein synthesis rates in burn patients 
(6). Indeed, we did not directly measure muscle protein breakdown rates in this study. However, 
other reports suggested elevated basal-state skeletal muscle proteolysis in MHD patients (9). In 
particular, the presence of systemic low-grade chronic inflammation (15) and the use of statins 
have been demonstrated to increase skeletal muscle protein degradation rates (43) both of which 
were common in the studied MHD patients (table 1). Again, the intracellular amino acids derived 
from excessive proteolysis could provide a further explanation for the elevated muscle protein 
synthesis rates in the basal-state in MHD patients vs. controls (6).   
As a result of renal failure, skeletal muscle protein degradation increases and becomes the 
primary endogenous source of amino acids (8) to support protein turnover in vital organs such as 
the liver, gut and heart (38). Therefore, increased protein intake (≥ 1.2 g/kg-1 bodyweight/d-1) is 
often recommended for MHD patients to offset these protein losses (1). Interestingly, we show a 
tendency for reduced dietary protein derived leucine release into circulation in MHD patients vs. 
controls. Moreover, the recovery of breath 13C (indicative of postprandial leucine oxidation) was 
significantly lower in MHD patients vs. controls. The lower postprandial protein derived amino 
acid availability in circulation in MHD patients (43 ± 5%) vs controls (56 ± 5%) may relate to 
increased splanchnic sequestration of amino acids. Specifically, MHD patients are commonly 
characterized by several splanchnic abnormalities such as intestinal small bacterial overgrowth 
(42), gastrointestinal inflammation (39), gut motility disorders (41), hypergastrinemia (27), and 
increased hepatic protein synthesis (34). In any case, we show for the first time that dietary protein 
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digestion and absorption kinetics are impaired in this patient population, which is limiting amino 
acid availability to skeletal muscle tissue. This provides further support that high(er) protein 
intakes may be required to compensate for these impairments in protein digestion and absorption 
to maximize dietary amino acid availability in MHD patients.  
In this study, we assessed whole-body protein proteolytic responses in the basal- and 
postprandial-states in MHD patients. Previously, Veenemans et al. (45) demonstrated that protein 
consumption on a non-dialysis day improved whole body protein turnover through reductions in 
protein breakdown. However, we did not observe a reduction in whole body protein breakdown in 
our study. Dissociation between measurements of whole body- and skeletal muscle protein 
metabolism in MHD patients is not uncommon (19, 34). In particular the proteolytic response is 
often aggravated  on the level of the muscle, pertaining to the important role of this organ to supply 
amino acids to other vital organs with chronic renal failure (13). 
 It is noteworthy that in this study we provided a breakfast meal (containing 20 g of dietary 
protein) that is typically recommended for the MHD patient population (2). However, the lack of 
inhibition in postprandial whole body protein breakdown rates after meal ingestion in the control 
group suggests that the protein amount provided was not optimal. It has been shown that ingested 
protein amounts of  >35 g are necessary to inhibit whole protein breakdown rates (25) and stimulate 
muscle protein synthesis (36) in healthy aging populations. Unfortunately, such high intakes of 
dietary protein are generally not achieved by MHD patients (37). Thus, there is a need for 
alternative strategies to improve the postprandial muscle protein synthetic response to the 
consumption of a protein containing meal. Given the ability of exercise to enhance sensitivity of 
muscle protein synthesis rates to the anabolic properties of amino acids (10), it seems that exercise 
prior to food ingestion represents a logical adjunct strategy to nutritional intake. In particular, the 
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exercise-induced enhancement in postprandial muscle protein synthesis rates (28) may result in an 
improved net protein balance and potentially mitigate some of the muscle protein losses in MHD 
patients.  
 From a study design standpoint, muscle protein synthesis rates have been shown to be 
influenced by a number of factors such as: age (46), obesity (5), insulin resistance (35), metabolic 
acidosis (26), and habitual physical activity level (29). To rule out the influence of several non-
uremic factors on protein synthesis, we intentionally recruited sedentary controls that were 
matched for age, gender, and presence of obesity and insulin resistance. In addition, the MHD 
patients in this study were corrected for metabolic acidosis through routine bicarbonate 
supplementation. 
 In conclusion, we demonstrated that basal-state muscle protein synthesis rates are elevated in 
MHD patients when compared to controls. Given that these measurement were made on a non-
dialysis day, this highlights there is a hyper-catabolic state that is maintained well beyond the 
dialysis period. Furthermore, we demonstrated that consumption of a protein-rich meal by MHD 
patients did not elicit a postprandial rise in muscle protein synthesis rates. This finding can be 
explained by impairments in protein digestion and absorption and subsequent reductions in dietary 
amino acid availability in circulation for the stimulation of muscle protein synthesis rates. 
Furthermore, the presence of several co-morbidities such as inflammation, and the use of 
medication such as statins could have further negatively impacted protein metabolism in MHD 
patients. Skeletal muscle maintenance is one of the most important predictors of survival in this 
population (23). Therefore, future strategies involving the consumption of greater amounts of 
dietary protein and/or increases in physical activity should become a focus of treatment strategies 
to improve the protein metabolic responses in MHD patients. 
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5.7 Tables 
Table 5.1. Participant characteristics   
MHD patients 
(n = 8) 
Controls 
(n = 8) 
P-value 
Dialysis period (y) 5 ± 1 - - 
Age, (y) 56 ± 5 50 ± 2 0.23 
Male Sex, No. (%) 6 (75%) 6 (75%) - 
Weight (kg) 94 ± 9 94 ± 4 0.98 
BMI (kg/m2) 32 ± 2 31 ± 1 0.56 
Fat (%) 31 ± 3 29 ± 2 0.75 
Lean body mass (kg) 61 ± 5 65 ± 4 0.58 
Systolic BP (mmHg) 144 ± 5* 129 ± 4 0.04 
Diastolic BP (mmHg) 78 ± 4 83 ± 6 0.77 
Statins, No % 4 (50 %) 0 (100 %) - 
Blood metabolites    
Fasting Glucose (mg/dL-1) 95 ± 11 89 ± 3 0.57 
    HOMA-IR 3.9 ± 0.9 4.0 ± 0.6 0.57 
    Blood urea nitrogen (mg/dL-1) 32 ± 3* 15 ± 1 <0.001 
    Creatinine (mg/dL-1) 7.4 ± 0.9* 1.1 ± 0.1 <0.001 
    eGFR (mL/min-1/1.73m2) 9 ± 1* 82 ± 6 <0.001 
    Total CO2 (mEq/L
-1) 23 ± 2 21 ± 1 0.40 
    C-reactive protein (mg/L
-1) 16 ± 2 <5.0 - 
    Albumin (g/dL-1) 3.6 ± 0.1* 3.9 ± 0.1 0.04 
Co-morbidities, No. (%)    
    Hypertension 8 (100 %) 2 (25 %) - 
    Diabetes mellitus 1 (12.5 %) 0 (0 %) - 
    Obesity  4 (50 %) 4 (50 %) - 
    Secondary hyperparathyroidism 8 (100 %) 0 (0 %) - 
    Arthritis  8 (100 %) 0 (0 %) - 
    Neuropathy 2 (25 %)  0 (0 %) - 
    History of cardiovascular disease 2 (25 %) 1 (12.5 %) - 
    Hematological disease 2 (25 %) 0 (0 %) - 
    Gastroesophageal reflux disease       1 (12.5 %) 0 (0 %) - 
    Liver disease 2 (25 %) 0 (0 %) - 
Data are mean ± SEMs, unless stated otherwise. 
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5.8 Figures 
Figure 5.1  
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Data are mean ± SEMs. Plasma leucine (A), blood glucose (B), and plasma insulin concentrations 
(C) in the basal state and after meal consumption in MHD patients (n=8) and controls (n=8). Insets 
show the areas under the time curves for the fed-state. Dashed line refers to meal ingestion.  
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Figure 5.1 (cont.) 
Data were analyzed with a two-factor (time × group) ANOVA. The areas under the time curves 
were analyzed using an independent samples t-test. Bonferroni post hoc test was used to locate 
differences between means for all significant interactions. Leucine: time effect, P<0.001; group 
effect, P=0.33; time × group: P=0.59. Glucose: time effect, P<0.001; group effect, P=0.03; time 
× group: P=0.05. Insulin: time effect, P<0.001; group effect, P=0.51: time × group: P=0.29.  
*Significantly different between conditions (P<0.05).  
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Figure 5.2 
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Plasma L-[5,5,5-2H3]leucine (A), L-[1-
13C]leucine (B), L-[ring-2H5]phenylalanine (C) and breath 
13CO2 (D) enrichments over time in the basal state and after meal consumption in MHD patients 
(n=8) and controls (n=6). Data are expressed as MPE (A, B, and C) and APE (D), respectively. 
Dashed line refers to meal ingestion. Data were analyzed with a two-factor (time × group) 
ANOVA. A Bonferroni post hoc test was used to locate differences between means for all 
significant interactions. L-[5,5,5-2H3]leucine: time effect, P<0.001; group effect, P=0.15; time × 
group: P=0.38. L-[1-13C]leucine: time effect, P=0.50; group effect, P=0.99; time × group: P=0.64. 
L-[ring-2H5]phenylalanine: time effect, P<0.01; group effect, P=0.40: time × group: P=0.30.  
13CO2: Time effect, P<0.001; Group effect, P=0.02; time × group: P=0.39. APE, atom percent 
excess; MPE, mole percent excess. 
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Figure 5.3 
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Figure 5.3 (cont.) 
Data are mean ± SEMs. Exogenous leucine Ra (A), endogenous leucine Ra (B), total leucine Ra 
(C) over time in the basal state and after meal consumption in MHD patients (n=8) and controls 
(n=6). Data are expressed as nmol leucine·kg-1·min-1. Dashed line refers to meal ingestion. Data 
were analyzed with a two-factor (time × group) ANOVA. The areas under the time curves were 
analyzed using an independent samples t-test. A Bonferroni post hoc test was used to locate 
differences between means for all significant interactions. Exogenous leucine Ra: time effect, 
P<0.001; group effect, P=0.08: time × group: P=0.10. Dietary amino acid availability: P=0.06. 
Endogenous leucine Ra: time effect, P=0.20; group effect, P=0.76: time × group: P=0.55. Total 
leucine Ra: time effect, P=0.79; group effect, P=0.53: time × group: P=0.95. Data are Mean ± 
SEM. Ra, rate of appearance;  
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Figure 5.4 
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Myofibrillar protein synthesis rates in the basal state and after meal consumption in MHD patients 
(n=8) and controls (n=6). Data are expressed as FSR (%·h-1). Data were analyzed with a two-factor 
ANOVA with repeated measures on time. A Bonferroni post hoc test was used to locate differences 
between means for all significant interactions. FSR: time effect, P=0.58; group effect, P=0.02: 
time × group: P=0.33. *Different between groups (P<0.05). Data are Mean ± SEM. FSR, fractional 
synthesis rates. 
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CHAPTER 6: GENERAL DISCUSSION 
The overarching aim of this dissertation was to improve the understanding of the nutritional 
modulation of postprandial protein metabolism after the consumption of protein-dense whole 
foods during resting and post-exercise recovery conditions in both healthy and diseased 
individuals. Previous work has focused on the regulation of postprandial protein metabolism after 
the consumption of isolated protein fractions (9, 11-14, 17, 18, 21, 22, 24, 26-28, 33, 35, 42, 44, 
50, 51, 59, 62, 63) or ingestion of free form, crystalline amino acids (8, 16, 30, 32, 40, 41, 52, 53, 
56, 57). However, this is not representative of normal human eating behavior. In this dissertation, 
we gained new information related to postprandial protein metabolism in response to whole food 
ingestion with health and disease. This Chapter will highlight the major findings from Chapters 2-
5 and outline any potential limitations of the studies. Future areas for further research will also be 
discussed.  
 
6.1 Chapter 2: Sustained postprandial muscle protein synthesis rates after protein ingestion 
in healthy young males 
For the first study of this dissertation, we wished to establish a clear time course of the 
relationship between dietary-derived amino acid availability in circulation and the subsequent 
stimulation of muscle protein synthesis after protein consumption in healthy young adults. This 
information is important for the development of more effective clinical feeding strategies aimed 
at muscle mass maintenance.  
It was previously demonstrated that rates of muscle protein synthesis after feeding are very 
short lived and rapidly return to basal values despite continued elevated postprandial amino acid 
concentrations and intramuscular anabolic signaling phosphorylation (5). However, these findings 
 
210 
 
were made after the consumption of ‘fast’ digested whey protein. It is not common practice for a 
a single meal or clinical feeding formulas to include only one isolated protein source. In Chapter 
2, we demonstrated that protein blends consisting of ‘fast’ whey and ‘slow’ casein (20/80 blend) 
results in sustained muscle protein synthesis rates during a prolonged 300 min postprandial period.  
These data illustrate that consumption of protein sources, which result in a gradual release of 
postprandial protein derived amino acids into circulation and ultimately a more sustained ‘anabolic 
drive’ to skeletal muscle tissue are preferred. To this end, nutritional supplements and/or clinical 
feeding formulas designed to support muscle mass maintenance will benefit from mixed protein 
blends (or mixed meal combinations) to maximize the postprandial stimulation of muscle protein 
synthesis rates under the time curve.  
 
Study limitations and future directions: 
An important limitation of the study is that we provided concentrated milk protein containing 
low amounts of the other macronutrients (4 g carbohydrates, 1 g of fat). Indeed, protein is generally 
consumed with other macronutrients which may slow down the rate at which dietary amino acids 
become available in circulation (14, 21, 22). Nevertheless, when measured over prolonged 
postprandial phase, total dietary amino acid availability and postprandial stimulation of muscle 
protein synthesis rates seems unaffected with macronutrient co-ingestion (14, 21, 22). Thus the 
sustained postprandial stimulation of muscle protein synthesis as observed in Chapter 2 is perhaps 
expected with whole food sources as well.  
 
  
 
211 
 
6.2 Chapter 3: Development of intrinsically-labeled eggs and poultry meat for use in human 
metabolic research 
In Chapter 2, we used an innovative tool referred to as intrinsically-labeled milk protein that 
allows the researcher to directly assess the rate of protein digestion and amino acid absorption and 
subsequent circulating dietary amino acid availability in humans. Plasma amino acid availability 
is an independent and important factor that regulates whole-body and muscle protein metabolism 
after the ingestion of a protein-containing meal (17, 26). Previously, researchers have focused on 
producing intrinsically-labeled cow derived food products (i.e. milk and beef) for use in human 
metabolic research (6-8). The labeled milk and beef were produced by prolonged intravenous (IV) 
infusions of stable isotope tracer into lactating dairy cows for ~7 days. However, producing labeled 
diary food protein in this manner requires large amounts of people-power and financial resources 
due to the infrastructure required to house and maintain lactating dairy cows. What is noteworthy 
is that Evenepoel et al. (20) suggested a simple and non-invasive method of producing intrinsically 
labeled protein foods by supplementing the feed of laying hens with an amino acid tracer. 
We built on this work by supplementing a specifically formulated low-leucine diet (containing 
0.52% leucine) with 0.3% L-[5,5,5-2H3]leucine and subsequently feeding this diet to 3 laying hens 
(Lohmann LSL Whites) for 55 d. We demonstrated that high tracer labeling (>20 mole percent 
excess, MPE) in the eggs was obtained after 7 d and maintained throughout the feeding protocol. 
Importantly, the modified diet did not impair egg production performance (90%) or the mean 
weight of the eggs (~52 g), which is considered a typical egg weight for the Lohmann LSL White 
strain (48). The rate of tracer recovery in the eggs was calculated to be ~37 %, which is a 0.5 fold 
greater tracer recovery than previously reported by workers producing intrinsically labeled milk 
proteins using either L-[1-13C]phenylalanine (36, 55) or L-[1-13C]leucine (10).  Over a 55 d period, 
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a total of ~850 g of egg protein (145 eggs) was produced with a mean tracer enrichment of 22.0 ± 
0.8 MPE. Subsequently, we confirmed in experimental human trials that the consumption of 
labeled eggs increased plasma L-[5,5,5-2H3]leucine enrichment to a peak values of 6.7 ± 0.1 MPE, 
which is more than enough to reliably study postprandial dietary amino acid availability (which 
requires ~ 0.5 MPE).  
Overall, we demonstrated the feasibility of producing intrinsically labeled eggs for use in 
human metabolic research. In particular, we demonstrated the feasibility of producing nutritionally 
complete and intrinsically labeled dietary proteins at a modest production price point by the use of 
a non-invasive oral tracer administration method in chickens.  
 
Study limitations and future directions: 
Previously, researchers have demonstrated that the amino acid tracer from highly labeled (>30 
MPE) milk-derived proteins can be ‘traced’ directly into myofibrillar protein (15, 23, 26, 34, 55, 
60). Such an approach would be advantageous in populations or settings where continuous IV 
infusions may not be easily applied (e.g. elderly, clinical populations, nutrition field studies). An 
important limitation of our work was that direct measurement of egg-derived L-[5,5,5-2H3]leucine 
incorporation in myofibrillar proteins was only possible in physically smaller participants (<60 
kg). The amino acid (L-[5,5,5-2H3]leucine) labeling in our eggs was ‘only’ 22 MPE and was 
presumably not high enough to reliably detect the incorporation of the tracer in skeletal muscle 
proteins. Enriching the diet (e.g., both the food and drinking water) with more L-[5,5,5-2H3]leucine 
or a ‘heavier’ tracer (i.e. 13C6 or D10 leucine) could allow for more reliable detection of the tracer 
in human skeletal muscle tissue. However, this would also increase the price of production. 
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6.3 Chapter 4: Consumption of whole eggs promotes greater stimulation of postexercise 
muscle protein synthesis than consumption of isonitrogenous amount of egg whites in young 
men 
The addition of other macronutrients (i.e. fat and carbohydrates) to isolated dairy protein drinks 
have previously been shown to modulate protein digestion and absorption kinetics, without 
modulating the cumulative postprandial stimulation of muscle protein synthesis rates when 
compared to the  ingestion of only protein (14, 21, 22). However, little is known about how mixed 
meal combinations influence circulating postprandial dietary amino acid availability and the 
subsequent stimulation of muscle protein synthesis rates when fat is ingested as part of a natural 
food matrix. 
It was previously demonstrated that consumption of whole milk resulted in greater net amino 
acid retention in the leg muscle when compared to skim milk ingestion that was matched for 
protein content (19). The workers were unable to find a clear explanation for their findings, 
however, it was believed that the addition of a non-protein nutrient such as fat somehow improved 
the muscle anabolic response. With consumption of multiple eggs, the yolk is often discarded due 
to the long held belief that the regular consumption of cholesterol contained in the yolk will 
increase risk of cardiovascular disease (49, 54). From a sports nutrition standpoint, the yolk is 
often discarded based on the belief that fat slows down protein digestion and absorption and 
subsequent delivery of amino acids to the muscle as well as the extra energy might influence body 
composition (fat mass gain).  
In Chapter 4, we compared the consumption of three whole eggs (18 g protein and 17 g fat) 
to an equivalent amount of protein from egg whites (18 g protein and 0 g fat) on the stimulation of 
postexercise muscle protein synthesis rates. In contrast to our hypothesis (no differences in 
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postprandial stimulation of muscle protein synthesis between the ingestion of whole eggs and egg 
whites), we found that whole eggs resulted in greater postprandial rates of muscle protein synthesis 
when compared to egg whites. However, we did not observe differences on the whole-body level 
between the egg conditions. This underlines the importance of obtaining measurements of protein 
synthesis directly on the level of the muscle vs. the whole body when attempting to define optimal 
strategies for muscle mass maintenance.   
A strong suit of this study was its randomized crossover design where each subject performed 
two trials (separated by ~ 1 week) and thus minimized inter-subject variability in the responses. 
The order on which they received the whole eggs and egg whites was randomized such that half 
the participants received whole eggs on their first trial, while the other half received egg whites 
and vice versa.  
To elucidate why whole egg ingestion resulted in greater postprandial stimulation of muscle 
protein synthesis when compared with egg whites, we examined various factors that are 
acknowledged to dictate the postprandial muscle protein synthetic response. These factors include: 
1.) the amino acid composition of the ingested food source, 2.) protein digestion and splanchnic 
release of dietary amino acids into circulation, 3.) peak plasma leucine concentrations, 4.) whole 
body leucine oxidation rates, 5.) skeletal muscle amino acid transporter content, 5.) anabolic 
signaling phosphorylation, and 6.) metabolic sensors. However, none of these factors provided a 
clear indication for the greater anabolic property of whole egg ingestion vs. egg whites in healthy 
men in this study.  
Overall, we showed that discarding the yolk from the egg limits the postprandial stimulation 
of muscle protein synthesis rates during post-exercise recovery in young males. The yolk is 
nutrient dense and may contain a variety of important bioactive compounds such as lipids, 
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micronutrients, antioxidant carotenoids, and miRNAs (7, 58). Therefore, besides limiting 
postprandial skeletal muscle anabolic, the removal of the yolk and its associated vital nutrients 
may also limit their benefit to improve overall human health (3, 4, 7). Chapter 4 lends support for 
the recommendation that nutrient and protein dense foods should be the cornerstones to meeting 
daily protein requirements to optimize muscle protein synthesis rates.  
 
Study limitations and future directions: 
An obvious ‘limitation’ of the study was the lack of revealing a clear mechanism as to why 
whole egg vs. egg white ingestion resulted in greater postprandial stimulation of muscle protein 
synthesis rates. Within the current study we measured phoshorylation status of various molecular 
readouts related to mTORC1 and MAPK-pathways. The lack of differences in the phosphorylated-
state of molecular readouts between the egg conditions could imply that this anabolic pathway was 
maximized from the prior performance of resistance exercise and food ingestion (11, 29, 31, 43), 
thereby overriding any subtle non-protein nutritive influences of whole egg consumption on 
mTORC-1 phosphorylation and its downstream targets. Moreover, the phosphorylated state of 
mTORC1 does not provide the dynamics of mTORC1. For increased translation (i.e. protein 
synthesis), mTORC1 needs to localize towards to the surface of the lysosome compartment where 
mTORC1 can bind with its well-known activator Ras homolog enriched in brain (Rheb) (47). 
Future analysis will be performed if mTORC1 resides in closer proximity to the lysosome after 
whole egg vs egg white ingestion.  
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6.4 Chapter 5: Differential whole body and skeletal muscle protein metabolic responses to 
mixed meal ingestion in maintenance hemodialysis patients. 
After studying postprandial protein metabolism in healthy young individuals, we wished to 
extend our focus of the study of postprandial protein metabolism after whole food ingestion to 
more clinical population. Maintenance hemodialysis (MHD) patients experience severe skeletal 
muscle wasting for a number of reasons including: chronic inflammation, reduced protein intake, 
metabolic acidosis, insulin resistance, hormonal abnormalities, and a loss of nutrients/amino acids 
during dialysis (61). To offset the losses of skeletal muscle proteins, the consumption of protein-
rich meals are recommended for this patient populations (1). However, little is known about the 
protein metabolic responses after food ingestion in MHD patients. 
To fill this research gap, we recruited 8 MHD patients and 8 controls, matched for age, BMI 
and several co-morbidities known to influence protein metabolism (e.g. insulin resistance (39) and 
obesity (6)). We observed that basal rates of muscle protein synthesis were ~ 2.5 fold elevated in 
MHD patients when compared to controls, which suggests hypercatabolism in MHD patients (37, 
38). Noteworthy is that measurements were made on a non-dialysis day; suggesting prolonged 
hypercatabolism that is maintained well beyond the dialysis period. In addition, we demonstrated 
that consumption of protein-rich meal (20 g protein, 560 kcal) typically recommended to dialysis 
patients did not elicit rise a postprandial rise in muscle protein synthesis rates (2). Using the 
research tool of L-[5,5,5-2H3]leucine labeled eggs, we were able to demonstrate reduced 
circulating dietary amino acid availability in MHD patients when compared to controls. The 
reduced amino acid availability to skeletal muscle tissue could have led to the inability to improve 
postprandial muscle protein synthesis rates in MHD patients after eating a meal. We attribute the 
reductions in dietary amino acid availability to splanchnic abnormalities, commonly witnessed in 
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MHD patients. In addition, the large number of co-morbidities (such as hyperthyroidism and 
inflammation) and high medicinal use (such as statins) could have further negatively impacted 
protein metabolism in this patient population. 
 
Study limitations and future directions: 
A possible limitation of the study was that the MHD patients experienced a number of non-
uremic co-morbidities (e.g. gastroesophageal reflux disease, liver disease, hematological disease) 
that could have further impacted our findings. While this makes it difficult to untangle the effects 
of kidney failure on protein metabolism per se, the presence of a variety of co-morbidities is 
representative of a typical MHD patient. The goal of this research was to explore whether the 
consumption of a protein-rich mixed meal, commonly recommended for this population, can 
stimulate postprandial muscle protein synthesis rates and thus set a benchmark for future studies 
to explore more effective strategied to potentially offset some of the losses in skeletal muscle 
proteins. We were unable to elicit a feeding-induced stimulation in muscle protein synthesis rates 
in the controls, which may point towards the idea that we did not feed enough protein. In particular 
we fed 20 g of dietary protein, whereas it was previously suggest that ingested protein amounts of  
> 35 g are necessary to inhibit whole protein breakdown rates (25) and stimulate muscle protein 
synthesis (45) in aging populations. Unfortunately, such high intakes of dietary protein are 
generally not achieved by MHD patients (46), suggesting a need for alternative strategies improve 
postprandial protein metabolism in MHD patients. Given the ability of exercise to enhance 
sensitivity of muscle protein synthesis rates to the anabolic properties of amino acids (12), it seems 
that exercise prior to food ingestion represents a logical adjunct strategy to nutritional intake in 
this patient population. 
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6.5 Conclusions 
The studies in this thesis lend support for the recommendation that the ingestion of whole foods 
should form the cornerstone for meeting daily protein requirements. Specifically, we show that 
postprandial muscle protein synthesis rates are strongly regulated after whole food ingestion and 
exercise. We also demonstrated that muscle protein rates are negatively altered in chronic renal 
failure, and could not be rescued with the ingestion of a protein dense meal alone. Clinical 
strategies to improve skeletal muscle health should involve a combination of increased physical 
activity and protein-dense whole food consumption.  
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APPENDIX A: PROTOCOLS 
A.1 Hen tissue and egg protein extraction 
This section describes the extraction procedures utilized in Chapter 3 to determine the tracer 
enrichment of the main protein fractions in the egg (i.e. white and yolk) and the enrichments of 
the tissues of the egg laying hens. 
SUPPLIES NEEDED: 
1. Teflon Pestle 
2. 1.5 ml Eppendorf Tube 
3. 4.0 ml Glass Top Vial and Cap 
4. Hydrion Ph Paper 
 
REAGENTS NEEDED: 
1. 0.6 м Perchloric Acid (PCA)  
2. 70 % Ethanol (ETOH) 
3. 6 м Hydrochloric Acid (HCL) 
4. 6 м Sodium Hydroxide (NaOH) 
5. 0.1 м HCL  
PROTOCOL: 
1. Place 20-25 mg of sample in 1.5 ml Eppendorf tube and add 500 µL of .6 M PCA 
2. Homogenize with Teflon Pestle and vortex. 
3. Spin at 3600 × g for 5 min (4°C). 
4. Remove supernatant (1st shot) and discard. 
5. Add 500 µL of .6 м PCA to pellet and vortex. 
6. Spin at 3600 × g for 5 min (4°C). 
7. Remove supernatant (2st shot) and discard. 
8. Add 500 µL of 70% ETOH to pellet and vortex. 
9. Spin at 3600 × g for 5 min (4°C). 
10. Remove supernatant (3rd) shot and discard. 
11. Poke hole in lid of Eppendorf and freeze dry. 
12. Transfer pellet to 4 mL glass screw top vial and add 1.5 mL 6 м HCL 
13. Hydrolyze overnight (> 12 h) at (110°C) 
14. Add 6 м Sodium Hydroxide (1.45 mL) and confirm if neutral with pH paper (if not add 
increments of 0.1 mL).  
15. Vortex glass vials and pipet out sample into Eppendorf tube (1.5 mL). 
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16. Pipet 1.5 mL out of the Eppendorf tube and run the sample through a .22 µm filter 
attached to a 4 mL glass screw top vial. 
17. Continue until you have pipetted and ran the entire sample (3 mL total) through .22 µm 
filter. 
18. Dry sample in SpeedVac concentrator, dissolve sample in 100 μL 0.1 м HCl. 
19. Ready for derivatization and amino acid analysis on GC-MS. 
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A.2 Plasma amino acid extractions for amino acid quantifications  
This section describes the extraction procedures and analysis performed in Chapter 3-5 to 
determine the amino acid concentrations in the plasma of participants.  
SUPPLIES NEEDED: 
1. 1.5 ml Eppendorf Tubes 
 
REAGENTS NEEDED: 
2. MIX A (3:3:2: Acetonitrile:Isopropanol:ddH2O) 
3. INTERNAL STANDARD (13C9-Phenylalanine and 13C6-Leucine or p-
chlorophenylalanine at 1 mg/mL) 
4. 0.1 M HCL  
EXTRACTION PROTOCOL: 
4. Put 1 mL of MIX A (3:3:2: Acetonitrile:Isopropanol:ddH2O) in an empty Eppendorf. 
5. Put 10 ul of IS in the Eppendorf with MIX A. 
6. Put 0.2 mL of Plasma in the Eppendorf with MIX A and IS and vortex. 
7. Place the mixed sample in freezer (- 20°C) for 30 min. 
8. Spin at 20800 × g for 10 min (4°C). 
9. Transfer 1.0 mL of supernatant to new Eppendorf. 
10. Ready for derivatization and amino acid analysis on GC-MS. 
 
NOTE: Do not analyze IV-infused (i.e. [2H5]phenylalanine and/or [
13C]leucine) or dietary-derived 
tracers ([2H3]leucine) from the samples that have the [
13C9]phenylalanine and [
13C6]Leucine 
Internal Standard (IS) added! The IS will artificially ‘enrich’ the enrichments of the IV and dietary-
derived tracer. In that case use ‘Plasma Amino Acid Extraction for Tracer Enrichments’ protocol 
to determine the IV and dietary-derived tracer enrichments. 
 
QUANTIFICATIONS PROTOCOL: 
1. Open Amdis_32 (chemdata.nist.gov 
2. Go to FILE  BATCH JOB  CREATE AND RUN JOB) 
3. Go to ADD and select all GC/MS output files to analyze (always labeled x.D; e.g., 1.D, 
2.D etc). 
4. Select SIMPLE as ANALYSIS TYPE. 
5. Open TXT file with excel and quantify all individuals amino acids relative to IS (i.e. IS is 
always 1). 
6. Plot this ratio to the generated standard curve to find the corresponding amino acid 
concentration in um/l. 
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A.3 Plasma amino acid extractions for tracer enrichments 
This section describes the extraction procedures utilized in Chapters 2-5 to determine the 
amino acid tracer enrichment in the plasma of participants. 
SUPPLIES NEEDED: 
1. 1.5 ml Eppendorf Tubes 
 
REAGENTS NEEDED: 
1. MIX A (3:3:2: Acetonitrile:Isopropanol:ddH2O) 
EXTRACTION PROTOCOL: 
1. Put 1 mL of MIX A (3:3:2: Acetonitrile:Isopropanol:ddH2O) in an empty Eppendorf. 
2. Put 0.2 mL of Plasma in the Eppendorf with MIX A and vortex. 
3. Place the mixed sample in freezer (- 20°C) for 30 min. 
4. Spin at 20800 × g for 10 min (4°C). 
5. Transfer 1.0 mL of supernatant to new Eppendorf. 
6. Ready for derivatization and amino acid analysis on GC-MS. 
 
ENRICHMENT ANALYSIS PROTOCOL: 
1. Open RTR data analysis (MSD ChemStation) 
2. Go to CHROMATOGRAM  EXTRACT ION CHROMATOGRAM and select the 
IONS to monitor (e.g, 302, 303 and 305 for unlabeled and labeled L-[1-13C]leucine; L-
[5,5,5-2H3]leucine, respectively). 
3. Click A/B tab next to mouse cursor icon and check MANUAL INTEGRATION box. 
4. Select the entire area below the peak of interest (e.g., leucine) and go to 
CHROMATOGRAM  PERCENT REPORT 
5. Find the value of corresponding corrected area as the integrated peak.  
6. Express the peaks as a TTR (tracer-to-tracee) for each sample (with subtraction of the 
‘baseline’ sample). 
7. Convert to MPE (mole percent excess) using the following formula: MPE = TTR / (1 + 
TTR) x 100 
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A.4 Myofibrillar protein extraction protocol 
This section describes the extraction procedures utilized in Chapters 2-5 to isolate myofibrillar 
proteins for tracer analysis and generate whole muscle homogenate to perform Western Blot 
analysis. Myofibrillar protein-bound tracer enrichments can reliably obtained from 5-10 mg of 
muscle, however since we also performed Western Blot analysis a larger piece of ~50 mg of 
muscle was used (to provide for enough whole muscle homogenate).  
SUPPLIES NEEDED: 
1. Teflon Pestles 
2. 2 ml Eppendorf Tube 
3. 4 ml Glass Top Vial 
 
REAGENTS NEEDED: 
1. 0.3 м Sodium Hydroxide (NaOH) 
2. 1 м Perchloric Acid (PCA) 
3. 70 % Ethanol (EtOH):  
4. 6 м HCL 
PREPARATION: 
1. Label Eppendorfs: MYO, WEST and BRAD prior to protocol. 
2. Make Homogenization Buffer (see below).  
HOMOGENIZATION BUFFER RECIPE  
SUPPLIES NEEDED: 
1. 500 mL beker 
2. 10 ml Falcon Tubes  
 
REAGENTS NEEDED: 
3. 50 mM Tris-HCL pH 7.4 
4. 150 mM Sodium Chloride (NaCL) 
5. 1 mM  phenylmethylsulfonyl fluoride (PMSF)  
6. 10 % nonyl phenoxypolyethoxylethanol-40 (NP-40) 
7. 0.5 g Sodium Deoxycholate Powder 
8. Sodium Dodecyl Sulfate (SDS) Powder 
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TO MAKE HOMOGENIZATION BUFFER: 
1. To 50 mL ddH2O add: 790 mg Tris-Base and 900 mg NaCL 
2. pH to 7.4 with HCL (6 or 12 м) 
3. Add 10 mL of 10 % NP-40 
4. Add 0.5 g Sodium Deoxycholate Powder 
5. Add 0.1 g SDS powder 
6. Fill to 100 mL with ddH2O (add however much ddH2O until beker is at 100 mL line). 
7. Store in 10 mL aliquots at -20°C.  
MUSCLE HOMOGENIZATION PROCEDURE FOR MYOFIBRILLAR AND 
SARCOPLASMIC PROTEINS 
8. Add 1 Roche Complete Mini with EDTA Protease Inhibitor and 1 Roche PhosStop to 10 
mL of homogenization buffer prior to starting homogenization (vortex to fully dissolve). 
9. Add 10 μL/mg of homogenization buffer to a 50 mg sample in an Eppendorf labeled MYO 
10. Homogenize with Teflon pestle on ice. 
11. Spin at 700 × g for 5 min (4°C). 
12. Transfer supernatant to new Eppendorf labelled WEST, transfer 5 μL from the tube labeled 
WEST to BRAD (use small RNA tubes). 
13. Freeze MYO, WEST and BRAD at -80°C to process later. 
 
MYOFIBRILLAR ISOLATION 
1. Add 500 μL of ddH2O to Eppendorf labeled MYO and vortex. 
2. Spin at 700 × g for 10 min at (4°C). 
3. Discard supernatant. 
4. Add 1 mL of 0.3 м NaOH to the pellet and vortex. 
5. Put samples in heating block at 50°C for 30 min (vortex every 10 min).  
6. Spin at 10000 × g for 5 min. 
7. Transfer supernatant (this is your myofibrillar portion) to 4-ml screw top glass vials. 
8. Add 1 mL of 0.3 м NaOH to the pellet that is left in Eppendorf and vortex. 
9. Spin at 10000 × g for 5 min (4°C). 
10. Again transfer supernatant (this is your myofibrillar portion) to 4-ml screw top glass vials 
that already have the supernatant from the previous step (you now have collected the 
myofibrillar proteins twice) 
11. The pellet remaining in the Eppendorfs can now be frozen at -80°C as COLLAGEN. 
12. Add 1 mL of 1 м PCA to 4-ml glass vials (should see snow globe effect). 
13. Spin 15 min at 3000 × g (4°C). (this is the max the glass vials can be spun at or else they 
are at risk of breaking) 
14. Remove supernatant and discard (use transfer pipets). 
15. Add 1 mL of 70 % EtOH to sample (DO NOT VORTEX OR ADD ETOH DIRECTLY 
TO PELLET; RATHER PIPET IT DOWN SIDE OF GLASS). 
16. Spin for 15 min at 3000 × g (4°C). 
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17. Remove supernatant (EtOH) and discard. 
18. Add 2.0 ml of 6 м HCL to sample. 
19. Hydrolyze overnight at (110°C). 
20. Purify amino acids over Dowex Cation Exchange Column (See ‘Dowex Purification 
Protocol’ below). 
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A.5 Mixed muscle and intracellular muscle free extraction protocol 
This section describes the extraction procedures utilized in Chapters 2-5 to isolate mixed 
muscle proteins and obtain the intracellular (IC) muscle free amino acids, which can subsequently 
be used to determine IC muscle free tracer enrichment. IC muscle free tracer enrichments can 
reliably obtained from ~10 mg of muscle. 
SUPPLIES NEEDED: 
1. Teflon Pestle 
2. 2.0 ml Eppendorf Tube 
3. 4.0 ml Glass Top Vial and Cap 
 
REAGENTS NEEDED: 
1. 0.6 м Perchloric Acid (PCA)  
2. 70 % Ethanol (ETOH) 
3. 6 м Hydrochloric Acid (HCL) 
4. 0.1 м HCL  
PROTOCOL: 
1. Place 10-15 mg of sample in 2.0 mL Eppendorf tube and add 500 µL of .6 M PCA. 
2. Homogenize with Teflon Pestle and vortex. 
3. Spin at 3600 × g for 5 min (4°C). 
4. Remove supernatant (1st shot) and place in 2.0ml Eppendorf labeled IC. 
5. Add 500 µL of .6 м PCA to pellet and vortex. 
6. Spin at 3600 × g for 5 min (4°C). 
7. Remove supernatant (2st shot) and place in 2.0ml Eppendorf labeled IC. 
8. Add 500 µL of 70% ETOH to pellet and vortex. 
9. Spin at 3600 × g for 5 min (4°C). 
10. Remove supernatant (3rd) shot and place in 2.0ml Eppendorf labeled IC. 
11. Leave IC at room temp if going to column the next day (See ‘Dowex Purification 
Protocol’ below); otherwise freeze at -80°C.  
12. Free mixed muscle protein pellet at -80°C for possible future analysis. 
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A.6 Mixed plasma protein extraction protocol 
This section describes the extraction procedures utilized in Chapters 2 and 4 to extract mixed 
plasma proteins (i.e. albumin) from a baseline plasma sample (before administering tracer). This 
methods assumes that every protein in the body is similar in terms of ‘background’ tracer 
enrichment. Thus enrichment of the plasma protein is used as a surrogate for muscle tracer 
enrichment and is used to deduct ‘background’ tracer enrichment from the muscle free intracellular 
enrichments. 
SUPPLIES NEEDED: 
1. Teflon Pestle 
2. 1.5 ml Eppendorf Tube 
3. 4.0 ml Glass Top Vial and Cap 
 
REAGENTS NEEDED: 
1. 2 % Perchloric Acid (PCA)  
2. 70 % Ethanol (ETOH) 
3. 6 м Hydrochloric Acid (HCL) 
PROTOCOL: 
1. Add 500 µL of 2 % PCA to empty 2.0ml Eppendorf 
2. Add 200 µL of plasma to Eppendorf with PCA and vortex. 
3. Spin at 10000 × g for 5 min (4°C). 
4. Discard supernatant. 
5. Add 500 µL of ddH20 to pellet and vortex. 
6. Spin at 10000 × g for 5 min (4°C). 
7. Discard supernatant. 
8. Add 500 µL of 70% ETOH to pellet and vortex. 
9. Spin at 10000 × g for 5 min (4°C). 
10. Discard supernatant. 
11. Poke hole in lid of Eppendorf and freeze dry. 
12. Transfer pellet to 4 mL glass screw top vial and add 1.5 mL 6 м HCL 
13. Hydrolyze overnight at (110°C). 
14. Purify amino acids over Dowex Cation Exchange Column (See ‘Dowex Purification 
Protocol’ below). 
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A.7 Dowex purification protocol 
This section describes the cation-exchanges procedures utilized in Chapters 3-6 to purify the 
plasma, myofibrillar- and intracellular muscle free amino acids prior to analysis by LC-MS/MS.   
SUPPLIES NEEDED: 
1. 1000 mL beker 
2. Stir Bar 
3. Hydrion Ph Paper 
 
REAGENTS NEEDED: 
1. Dowex™ 50WX8-200 ion-exchange resin 
2. 4 M NH4OH (FOR DOWEX PREPARATION) 
3. 2 M NH4OH (FOR COLUMN CLEAN UP) 
4. 1 M HCL  
5. 0.1 M HCL 
DOWEX PREPARATION: 
1. Weigh out 200 g of Dowex Resin in a 1000 mL beker. 
2. Add 500 mL of water and stir for 5 min on stir plate. 
3. Wash with ddH2O (add ddH2O let resin sink to the bottom and discard water). 
4. Keep repeating until solution is neutral (check regularly with PH Paper).  
5. Add 500 mL of 4 м NH4OH and stir for 15 min on stir plate. 
6. Let Resin settle to bottom and discard NH4OH (check PH with PH Paper, should be very 
basic) 
7. Wash with ddH2O (add ddH2O let resin sink to the bottom and discard water). 
8. Keep repeating until solution is neutral (check regularly with PH Paper).  
9. Store in fridge with a little layer of 0.1 m HCL on top of it (to ensure Resin does not dry 
out). 
COLUMN PREPARATION: 
1. Pull out plunger of 5 mL syringe. 
2. Add small amount of glass wool to syringe (to fill up syringe to 1 mL mark). Push the wool 
down firmly with a pen. 
COLUMN CLEAN UP: 
1. Add 2 mL of ddH2O to samples that have been hydrolyzed overnight. 
2. Add 1 mL of ddH2O to syringe. 
3. Add 1 mL of Dowex Resin to each of the columns (keep it consistent across all columns). 
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4. Add 1.5 mL of 2 м NH4OH to each of the columns to elute contaminants. 
5. Test with PH Paper, repeat if not blue.  
6. Add 3 mL of water to each column and repeat until neutral (keep track of the amount of 
‘shots’ you add). 
7. Add 1.5 mL of 1 м HCL to charge column. 
8. Test with PH Paper, repeat if not red (keep track of the amount of ‘shots’ you add). 1 shot 
is generally enough. 
9. Add samples to columns. 
10. Add 3 mL of water to each column and repeat until neutral (keep track of the amount of 
‘shots’ you add). 
11. WORK WITH YOUR TEST COLUMN FOR THE NEXT STEPS TO DETERMINE THE 
AMOUNT OF NH4OH YOU NEED (undershoot with 500 μL for your samples). 
12. Add NH4OH to your test column in 500 μL increments until pH is basic (pH paper is blue).  
13. Record amount of ‘shots’ you added and substract by one ‘shot’ for your actual samples 
(thus you are erring on the safe side for eluting the amino acids). 1 shot is generally enough. 
14. Place columns on top of labelled culture tubes in order to collect the eluted amino acids. 
15. Add 4 ml of 2 м NH4OH to elute all amino acids the column. 
16. Dry down in Speedvac for 4 h (first 2h at 65 °C). 
17. Label eppendorfs. 
18. Reconstitute dried down sample in 0.1 м HCL (50 mg/ml sample) and transfer to labeled 
eppendorfs. 
19. Store in Freezer (-80°C). When submitting for analysis by LC-MS/MS provide only 20 μL 
of total sample (which is 1000 μL for 50 mg muscle piece).  
 
